
<html lang="en"     class="pb-page"  data-request-id="f7a3c55f-6238-48ca-8390-aaca2629384f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-14;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b00736"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents" /></meta><meta name="dc.Creator" content="Jiong  Zhang" /></meta><meta name="dc.Creator" content="Jinyi  Zhang" /></meta><meta name="dc.Creator" content="Guiyun  Hao" /></meta><meta name="dc.Creator" content="Weixiang  Xin" /></meta><meta name="dc.Creator" content="Fei  Yang" /></meta><meta name="dc.Creator" content="Mingyan  Zhu" /></meta><meta name="dc.Creator" content="Huchen  Zhou" /></meta><meta name="dc.Description" content="Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an ..." /></meta><meta name="Description" content="Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 20, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00736" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00736" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00736" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00736" /></link>
        
    
    

<title>Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00736" /></meta><meta property="og:title" content="Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0020.jpeg" /></meta><meta property="og:description" content="Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug. Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far. In this study, we report the design, synthesis, and anticancer structure–activity relationship of a series of 7-propanamide benzoxaboroles. Compounds 103 and 115 showed potent activity against ovarian cancer cells with IC50 values of 33 and 21 nM, respectively. Apoptosis was induced by these compounds and colony formation was effectively inhibited. Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00736"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00736">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00736&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00736&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00736&amp;href=/doi/10.1021/acs.jmedchem.9b00736" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6765-6784</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00711" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00774" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jiong Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiong++Zhang">Jiong Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jinyi Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinyi Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinyi++Zhang">Jinyi Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guiyun Hao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guiyun Hao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guiyun++Hao">Guiyun Hao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weixiang Xin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weixiang Xin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weixiang++Xin">Weixiang Xin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fei Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fei Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Yang">Fei Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mingyan Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mingyan Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mingyan++Zhu">Mingyan Zhu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0328-5470" title="Orcid link">http://orcid.org/0000-0003-0328-5470</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Huchen Zhou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huchen Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Microbial Metabolism, School of Pharmacy, Shanghai Jiao Tong University, 200240 Shanghai, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9ff7fce5f7f0eadfecf5ebeab1fafbeab1fcf1"><span class="__cf_email__" data-cfemail="2c444f564443596c5f46585902494859024f42">[email protected]</span></a>. Phone: (+86) 21-34206721. Fax: (+86) 21-34204457.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huchen++Zhou">Huchen Zhou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5474-2320" title="Orcid link">http://orcid.org/0000-0002-5474-2320</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00736&amp;href=/doi/10.1021%2Facs.jmedchem.9b00736" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6765–6784</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 20, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 May 2019</li><li><span class="item_label"><b>Published</b> online</span>20 June 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00736" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00736</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6765%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJiong%2BZhang%252C%2BJinyi%2BZhang%252C%2BGuiyun%2BHao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D14%26contentID%3Dacs.jmedchem.9b00736%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2B7-Propanamide%2BBenzoxaboroles%2Bas%2BPotent%2BAnticancer%2BAgents%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6784%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00736"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3486</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00736" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jiong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jinyi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Guiyun&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Weixiang&quot;,&quot;last_name&quot;:&quot;Xin&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Mingyan&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Huchen&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6765-6784&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00736&quot;},&quot;abstract&quot;:&quot;Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug. Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far. In this study, we report the design, synthesis, and anticancer structure–activity relationship of a series of 7-propanamide benzoxaboroles. Compounds 103 and 115 showed potent activity against ovarian cancer cells with IC50 values of 33 and 21 nM, respectively. Apoptosis was induced by these compounds and colony formation was effectively inhibited. Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00736&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00736" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00736&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00736" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00736&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00736" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00736&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00736&amp;href=/doi/10.1021/acs.jmedchem.9b00736" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00736" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00736" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00736%26sid%3Dliteratum%253Aachs%26pmid%3D31264855%26genre%3Darticle%26aulast%3DZhang%26date%3D2019%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2B7-Propanamide%2BBenzoxaboroles%2Bas%2BPotent%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D14%26spage%3D6765%26epage%3D6784%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/jmcmar.2019.62.issue-14/20190725/jmcmar.2019.62.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Benzoxaboroles, as a novel class of bioactive molecules with unique physicochemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug. Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far. In this study, we report the design, synthesis, and anticancer structure–activity relationship of a series of 7-propanamide benzoxaboroles. Compounds <b>103</b> and <b>115</b> showed potent activity against ovarian cancer cells with IC<sub>50</sub> values of 33 and 21 nM, respectively. Apoptosis was induced by these compounds and colony formation was effectively inhibited. Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the past 15 years, boron-containing compounds have gradually emerged as a novel class of useful structures that possess fascinating chemical properties and unique biological activitites.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Due to the rare existence of boron-containing organic compounds in nature and the historical lack of experience in the development of boron-containing drugs, they are largely ignored in drug discovery with assumed concerns on their toxicity and lack of druglikeness. In 2003, the first approved boron-containing drug, i.e., bortezomib (Velcade) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a boronic acid-based proteasome inhibitor, was used for the treatment of multiple myeloma.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Interestingly, although benzoxaboroles, a class of cyclic boronic acids, were first synthesized and studied in the 1950s,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> their medical use had remained literally unknown for 50 years until tavaborole (<b>tb</b>, Kerydin) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was approved in 2014 as a topical treatment of fungal infection of the toenails.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> As the second benzoxaborole drug, crisaborole (Eucrisa) was approved in 2016 as a nonsteroidal topical treatment of atopic dermatitis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> There are also a number of compounds in the pipelines as well, including acoziborole for trypanosomiasis, GSK656 for tuberculosis, and AN13762 for malaria.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> We have reported a number of potent antiparasitic and antibacterial benzoxaboroles such as compounds <b>1a</b> and <b>1b</b> in the past.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13−17)</a> At the same time, antiviral and anti-inflammatory properties have also been reported by researchers.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of bortezomib, tavaborole, crisaborole, and compounds <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Today, cancer still remains one of the major causes of human death despite efforts and progress in the past decades. About 2.8 and 0.6 million cancer deaths occurred in 2015 alone in China<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and the United States,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> respectively. While chemotherapy remains the main treatment, clinically used anticancer drugs are generally limited by toxicity, side effects, and resistance.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Thus, it remains urgent to develop novel anticancer agents.</div><div class="NLM_p last">Benzoxaboroles have unique physicochemical properties that are distinct from any previously known drug classes.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> In light of their recently proven druglikeness and success in anti-infective application, it is imperative and urgent to explore the potential of benzoxaboroles as anticancer agents. However, an investigation of their anticancer activity has been lacking to date. Although several preliminary efforts toward this goal have been reported, the anticancer activity of benzoxaboroles has not been convincingly defined in those studies.<a onclick="showRef(event, 'ref24 ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref29">(24,25,29)</a> We have previously reported a small group of chalcone–benzoxaborole hybrids as preliminary anticancer agents.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Here, we report the design, synthesis, and structure–activity relationship of a series of 7-propanamide benzoxaboroles with potent anticancer activity. Compounds <b>103</b> and <b>115</b> showed inhibitory activity against ovarian cancer cells with IC<sub>50</sub> values of 33 and 21 nM, respectively, and excellent selectivity between cancerous and normal cells. They effectively induced cancer cell apoptosis and inhibited colony formation. Furthermore, they demonstrated satisfactory efficacy and safety in ovarian tumor xenograft mouse model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Various amines were synthesized following the procedure shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Analines <b>4</b> and <b>5</b> were prepared by <i>tert</i>-butyloxycarbonyl (Boc) protection of the corresponding aminoalkylated analines <b>2</b> and <b>3</b>. The acetylenylanalines <b>12</b>–<b>14</b> were prepared from iodoanilines <b>6</b>–<b>8</b> by installation of the trimethylsilylacetylenyl group under the conditions of Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, and triethylamine (TEA) followed by removal of the trimethylsilyl group by KOH. Phenylanalines <b>36</b>–<b>55</b> were prepared by the Suzuki–Miyaura coupling reaction of arylboronic acids <b>15</b>–<b>32</b> and bromoanilines <b>33</b>–<b>35</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Amine Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, tetrahydrofuran (THF); (b) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, THF, TEA; (c) KOH, MeOH; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, sat. aqueous (aq) Na<sub>2</sub>CO<sub>3</sub>, EtOH, toluene.</p></p></figure><div class="NLM_p">The 7-propanamide benzoxaborole derivatives <b>66</b>–<b>115</b> were prepared following the procedures shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The key aldehyde intermediate <b>62</b> was prepared as we previously reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Aldehyde <b>62</b> was converted to ester <b>63</b> by the Wittig reaction. Compound <b>63</b> underwent reduction by Pd/C and H<sub>2</sub> and hydrolysis under alkaline condition, to give carboxylic acid <b>65</b>. Subsequent condensation with various amines under the conditions of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) gave the 7-propanamide benzoxaboroles <b>66</b>–<b>115</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-Propanamide Benzoxaboroles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KMnO<sub>4</sub>, <i>t</i>-BuOH, H<sub>2</sub>O; (b) SOCl<sub>2</sub>; (c) MeOH, Et<sub>3</sub>N; (d) LiBH<sub>4</sub>, MeOH, THF; (e) dihydropyran, <i>p</i>-TsOH–H<sub>2</sub>O, dimethylformamide (DMF); (f) <i>n</i>-BuLi, B(<i>i-</i>PrO)<sub>3</sub>, THF; (g) 6 M HCl, MeOH; (h) pyridinium chlorochromate (PCC), Celite, dichloromethane (DCM); (i) ethyl (triphenylphosphoranylidene)acetate, toluene; (j) Pd/C, H<sub>2</sub>, EtOH; (k) NaOH, MeOH, H<sub>2</sub>O; (l) RNH<sub>2</sub>, EDCI, DCM.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, acrylate <b>63</b> was hydrolyzed to acrylic acid <b>126</b>, which was subsequently coupled with analine to give acrylamide <b>127</b>. Compounds <b>129</b>–<b>132</b> were prepared by the condensation of hydrocinnamic acid and corresponding amines. Meanwhile, three nonboron analogues <b>145</b>–<b>147</b> were synthesized as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>C. First, the diol <b>59</b> was converted to mono-methoxymethyl (MOM)-protected compound <b>133</b>, which was oxidized by PCC to give aldehyde <b>134</b>. Ester <b>135</b> was obtained by the Wittig reaction and then reduced to <b>136</b>. Next, a vinyl group was introduced by the Stille reaction to give compound <b>137</b>, which was subsequently hydrolyzed under alkaline condition. Next, condensation with various amines gave compounds <b>139</b>–<b>141</b>, which was followed by oxidation of the vinyl group to give aldehydes <b>142</b>–<b>144</b>. Finally, compounds <b>142</b>–<b>144</b> were hydrolyzed, which was followed by cyclization under the acidic condition to provide lactols <b>145</b>–<b>147</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogue Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, MeOH, H<sub>2</sub>O; (b) RNH<sub>2</sub>, EDCI, DCM; (c) methoxymethyl chloride (MOMCl), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), THF; (d) PCC, Celite, DCM; (e) ethyl (triphenylphosphoranylidene)acetate, toluene; (f) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O; (g) tributyl(vinyl)tin, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF; (h) NaIO<sub>4</sub>, K<sub>2</sub>OsO<sub>4</sub>, THF, H<sub>2</sub>O; (i) 4 M aqueous HCl, THF.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Discovery of Initial Hit Compound <b>69</b></h3><div class="NLM_p">To explore the therapeutic value of benzoxaborole derivatives with high efficiency, we have previously developed a type of versatile formyl benzoxaborole intermediates that could be obtained in large scale and rapidly derivatized into benzoxaboroles bearing a variety of functional groups at the 4-, 5-, 6-, or 7-position of the phenyl ring.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The 7-propionic acid derivative <b>65</b> was consequently obtained and found to possess potent antimalarial activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, it did not show any antiproliferation activity on cancer cells. To explore the anticancer potential of benzoxaboroles, the amide analogues <b>66</b>–<b>72</b> were synthesized. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>66</b>–<b>68</b> with aliphatic chains showed no inhibitory activity on cancer cell proliferation. Interestingly, the phenyl compound <b>69</b> gave submicromolar inhibitory potency on the three cancer cell lines tested (SKOV3: ovarian carcinoma; MDA-MB231: breast cancer; HCT116: colon colorectal carcinoma), while toxicity was low on normal cells (WI-38: human lung fibroblast). However, when the phenyl group was spaced by one or two carbons from the amide bond (compounds <b>70</b> and <b>71</b>), the anticancer potency was abolished. The thiazolyl substitution in compound <b>72</b> also gave abolished activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Effect of Compounds <b>65</b>–<b>72</b> on Cancerous and Normal Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> indicates compound concentration required to inhibit cell viability by 50%. Values are expressed as the mean of triplicate experiments.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Modification on Phenyl Group of Compound <b>69</b> Did Not Improve Antiproliferation Potency</h3><div class="NLM_p">We explored the effect of various substitutions of the phenyl ring of compound <b>69</b> on its anticancer activity, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. First, the para-substituted phenyl groups (compounds <b>73</b>–<b>84</b>) were explored. The fluoro compound <b>73</b> gave submicromolar activity that was slightly weaker than the unsubstituted compound <b>69</b>. When the larger halogen atoms were introduced, the inhibitory activity gradually decreased from chloro compound <b>74</b> to iodo compound <b>76</b> that showed near-100-fold decreased activity compared to the fluoro compound <b>73</b>. Analogues <b>77</b>–<b>84</b> also showed a similar tendency of lower activity associated with bulkier substituents. The methyl and methoxy compounds <b>77</b> and <b>80</b> gave submicromolar activity, while larger substituents in compounds <b>78</b>, <b>79</b>, <b>81</b>, <b>83</b>, and <b>84</b> all gave significantly diminished activity. However, an exception is compound <b>82</b> with a bulky Boc group that showed significantly higher activity than its shorter analogue <b>81</b>, which may be due to the flexibility of alkyl chain by addition of an extra carbon atom. Next, we investigated the effect of moving the substituents from para- to meta- and ortho-positions. The <i>m</i>-bromo analogue <b>85</b> showed improved potency compared to the <i>p</i>-bromo compound <b>75</b>. The <i>m</i>-iodo compound <b>86</b> also showed similar tendency. This observation implied that the meta-position may be a favorable spot for further optimization. Therefore, larger groups such as isopropyl and acetylenyl were introduced into the meta-position in compounds <b>87</b> and <b>88</b>, which both showed submicromolar activity. Interestingly, the ortho-substituted analogues <b>89</b> and <b>90</b> also showed good activity. The disubstituted and trisubstituted analogues showed diminished activity as shown by compounds <b>92</b> and <b>93</b>. However, the m,p-disubstituted analogue <b>91</b> gave good inhibitory activity. Thus, the simple halogen or alkyl modifications on the phenyl ring only achieved inhibitory activity comparable to the unsubstituted compound <b>69</b>. This series of compounds implied that bulky groups may be tolerated as demonstrated by compound <b>82</b>, and substitutions at the ortho- and meta-position of the phenyl ring are more favorable than the para-substitution. At the same time, it was demonstrated that selectivity between cancerous and normal cells is tunable depending on the substitution patterns. For example, compound <b>82</b> showed nearly no selectivity while compound <b>77</b> showed good selectivity, although these two compounds possess similar antiproliferative potency. Thus, it proved feasible to fine-tune the structure–activity relationship to obtain good selectivity between cancerous and normal cells while retaining the antiproliferative potency. These observations led to the design and synthesis of the naphthyl and biphenyl compounds in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> to improve the potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Effect of Compounds <b>73</b>–<b>93</b> on Cancerous and Normal Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> indicates compound concentration required to inhibit cell viability by 50%. Values are expressed as the mean of triplicate experiments.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Effect of Compounds <b>94</b>–<b>115</b> on Cancerous and Normal Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0014.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0015.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> indicates compound concentration required to inhibit cell viability by 50%. Values are expressed as the mean of triplicate experiments.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Discovery of Biphenyl Compounds with Significantly Improved Antiproliferation Potency</h3><div class="NLM_p last">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the 1-naphthyl compound <b>94</b> showed antiproliferation activity comparable to the phenyl compound <b>69</b>, but its selectivity between cancer cells and normal cells was low. The 2-naphthyl analogue <b>95</b> showed a 10-fold decrease of potency. Next, biphenyl compounds <b>96</b>–<b>98</b> were explored. The biphenyl-2-yl and 4-yl compounds <b>96</b> and <b>98</b> only showed moderate activity; however, the 3-yl compound <b>97</b> showed submicromolar potency and good selectivity between cancerous and normal cells. Based on this observation and the chemical accessibility of various biphenyls, we took compound <b>97</b> for further structural modification. Introduction of a fluoro atom at the 4′-position gave compound <b>100</b>, which is the first compound with IC<sub>50</sub> value below 100 nM in this work. It also showed good selectivity (ca. 44-fold) between SKOV3 and normal cells. However, the 3′-fluoro compound <b>99</b> and the chloro compounds <b>101</b> and <b>102</b> only gave slightly diminished potency. When the hydrogen-bond acceptor group, methoxy, was installed in compounds <b>103</b>–<b>105</b>, the potency was further improved for all three compounds. The most potent compound <b>103</b> gave an IC<sub>50</sub> value as low as 33 nM, which is the most active compound so far in this study. At the same time, it also showed good selectivity between cancerous and normal cells (ca. 100-fold selectivity: SKOV3 vs WI-38 cells). When the methoxy group was replaced by the electronegative trifluoromethyl group (compounds <b>106</b> and <b>107</b>), they showed more than 10-fold decrease of activity. The thioether, trifluoromethyl, and cyano derivatives <b>108</b>–<b>113</b> all showed submicromolar activity that is comparable to the unsubstituted compound <b>97</b>, but no improvement of potency. When acetyl group, which is a hydrogen-bond acceptor, was introduced in compounds <b>114</b> and <b>115</b>, the potency was significantly improved. Especially in compound <b>115</b>, an IC<sub>50</sub> value of 21 nM on SKOV3 cells was achieved, which represents the highest potency in this study. It also showed good selectivity between cancerous and normal cells (ca. 180-fold selectivity: SKOV3 vs WI-38 cells), which is better than the low-potency compounds such as the phenyl compound <b>69</b> (ca. 150-fold selectivity: SKOV3 vs WI-38 cells). We believe with a further elucidation of the intracellular targets, there is sufficient space to further improve the selectivity by rational design.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Both Oxaborole Ring and 7-Propanamide Substitution Are Essential for Antiproliferation Potency</h3><div class="NLM_p">To evaluate the essentiality of the oxaborole moiety and the 7-propanamide substitution, a number of control compounds were synthesized and tested as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. In compounds <b>103</b>, <b>105</b>, and <b>115</b>, when the substituting position on the phenyl was changed from 7- to 4-, 5-, and 6- as in compounds <b>116</b>–<b>124</b>, the antiproliferation activity was significantly diminished. Furthermore, the parent benzoxaborole <b>125</b> and the antifungal drug tavaborole (<b>tb</b>) did not show any antiproliferation activity at all, which suggests that the 7-propanamide substitution is essential for the antiproliferation activity. Compound <b>127</b> with a double bond showed abolished activity compared to its saturated counterpart <b>69</b>, which suggests that the saturated chain is favorable owing to its conformational flexibility. When the oxaborole ring was removed as in compounds <b>129</b>–<b>132</b> or when the boron was replaced by carbon as in lactols <b>145</b>–<b>147</b>, they showed either completely abolished activity or significantly diminished activity compared to their corresponding benzoxaboroles <b>69</b>, <b>103</b>, <b>105</b>, and <b>115</b>. This observation suggests that the oxaborole moiety is essential for the antiproliferation activity. Thus, both the oxaborole ring and the 7-propanamide substitution are essential for the potent antiproliferation activity of the compounds in this study.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Effect of Compounds <b>116</b>–<b>147</b> on Cancer Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0017.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0018.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> indicates compound concentration required to inhibit cell viability by 50%. Values are expressed as the mean of triplicate experiments.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Membrane Permeability and Pharmacokinetic (PK) Profile of Compounds <b>103</b> and <b>115</b></h3><div class="NLM_p">Compounds <b>103</b> and <b>115</b> were evaluated for their membrane permeability and pharmacokinetic properties. Compound <b>103</b> showed high permeability in the caco-2 assay with a high <i>P</i><sub>app</sub> (A → B 19.5 and B → A 26.5 × 10<sup>–6</sup> cm/s) and a low efflux ratio of 1.36. Compound <b>115</b> showed a medium permeability with a moderate <i>P</i><sub>app</sub> (A → B 3.95 and B → A 2.23 × 10<sup>–6</sup> cm/s) and a low efflux ratio of 0.56. In the PK study as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, when dosed orally at 10 mg/kg, compound <b>103</b> showed an oral (po) bioavailability of 19.5% and a half-life (<i>T</i><sub>1/2</sub>) of 2.2 h, while compound <b>115</b> has a very low bioavailability of 4.6%, which may be ascribed to its relatively low permeability and a half-life (<i>T</i><sub>1/2</sub>) of 2.0 h. Both compounds showed reasonable peak plasma concentration (<i>C</i><sub>max</sub>) (434 and 373 ng/mL) and area under the curve (AUC) values of 551 and 1920 h ng/mL, respectively.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Oral (po) and Intravenous (iv) Pharmacokinetic (PK) Parameters<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> of Compounds <b>103</b> and <b>115</b> in SD Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (h ng/mL)</th><th class="colsep0 rowsep0" align="center">CL (mL/(h kg))</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (mL/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="char" char="."><b>103</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">551</td><td class="colsep0 rowsep0" align="left">3750</td><td class="colsep0 rowsep0" align="left">7630</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">434</td><td class="colsep0 rowsep0" align="char" char=".">547</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">19.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>115</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1920</td><td class="colsep0 rowsep0" align="left">1050</td><td class="colsep0 rowsep0" align="left">882</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">373</td><td class="colsep0 rowsep0" align="char" char=".">459</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">4.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">PK parameters were based on mean plasma concentration–time profiles of three animals per time points. PK parameters were calculated by noncompartmental analysis using DAS 2.0.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Apoptosis Was Induced by Compound <b>103</b></h3><div class="NLM_p">To determine whether the proliferative inhibition induced by compound <b>103</b> was attributed to apoptosis, SKOV3 cells were treated with vehicle and compound <b>103</b> at different concentrations (1, 3, or 10 μM) for 48 h and then stained with annexin V–fluorescein isothiocyanate (FITC) and propidium iodide (PI). As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the percentages of apoptotic SKOV3 cells were determined by flow cytometry. Compound <b>103</b> induced apoptosis in a concentration-dependent manner, resulting in 28.2, 31.6, and 51.3% of apoptotic cells (early and late apoptosis) at 1, 3, and 10 μM, respectively.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Induction of apoptosis on SKOV3 cells by compound <b>103</b>: flow cytometry analysis of apoptotic SKOV3 cells induced by compound <b>103</b> at different concentrations. Cells were treated with vehicle or compound <b>103</b> at 1.0, 3.0, and 10 μM for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cleavage of Poly(ADP-ribose) Polymerase (PARP) and Caspase 3/9 Was Induced by Compound <b>103</b></h3><div class="NLM_p">To further elucidate the potential mechanisms of apoptosis induced by compound <b>103</b>, cleaved PARP and caspase 3/9 were determined by Western blotting as the markers of apoptosis. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, treatment of H460 cells with compound <b>103</b> triggered cleavage of PARP and caspase 3/9 at low concentrations, which indicated that compound <b>103</b> induced the apoptosis at least partially through the cleavage of caspase 3/9 and PARP.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of biological markers for apoptosis induction by compound <b>103</b> on H460 cells for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Colony Formation Was Inhibited by Compound <b>103</b></h3><div class="NLM_p">The ability of compound <b>103</b> to inhibit the colony formation of SKOV3 cells was tested. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, the exposure of SKOV3 cells to low concentrations of compound <b>103</b> resulted in a significant inhibition of colony formation. The cancer cell growth was completely abolished at the concentration of 500 nM and above.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibitory effects of compound <b>103</b> on colony formation of SKOV3 cells. (A) Cells were treated with compound <b>103</b> at various concentrations. Digital image was taken and all visible colonies were counted. (B) Data were normalized to untreated control. The error bars represent standard deviations from triplicates. The statistical significance was obtained with one-way analysis of variance (ANOVA) (<i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Tumor Growth in Xenograft Mouse Model Was Reduced</h3><div class="NLM_p">Finally, we evaluated the in vivo efficacy of compounds <b>103</b> and <b>115</b> in SKOV3 xenograft mouse model. Six BALB/c mice per group were administered via intraperitoneal injection with vehicle, compounds <b>103</b> and <b>115</b>, at a dosage of 2 and 10 mg/kg, respectively, once a day for 33 days. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compounds <b>103</b> and <b>115</b> both significantly inhibited tumor growth in a dose-dependent manner as measured by tumor volume and weight. At the same time, the body weight of the treated mice did not show any significant decrease, which implied that the two compounds may have desired toxicity properties, but further comprehensive toxicity evaluation is needed.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo anticancer activity of compounds <b>103</b> and <b>115</b> on SKOV3 xenograft mouse model. Female nude BALB/c mice were administered by intraperitoneal injection with vehicle, compounds <b>103</b> and <b>115</b>, at a dosage of 2 and 10 mg/kg, respectively (<i>n</i> = 6 each group), once a day for 33 days. Average tumor volume (A, B), average body weight (C, D), and average tumor weight (E, F) were measured every 3 days. Data are expressed as the mean ± standard error (<i>n</i> = 6). * indicates <i>P</i> < 0.05 and ** indicates <i>P</i> < 0.01 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Benzoxaboroles, as a novel class of bioactive molecules with unique chemical properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug. Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking to date. In this work, based on an antimalarial benzoxaborole <b>65</b>, which does not show any anticancer activity, a series of 7-propanamide derivatives were designed and synthesized to give an initial hit compound <b>69</b>, which showed submicromolar antiproliferation activity on three cancer cell lines. Further structure–activity relationship studies found that replacement of the phenyl by biphenyl and installation of hydrogen-bond acceptor group were critical for the significant improvement of antiproliferation potency. Both the benzoxaborole moiety and the 7-propanamide modifications are essential for the anticancer activity. Thus, it led to the identification of a series of potent anticancer compounds. Among them, the most potent compound <b>115</b> showed an IC<sub>50</sub> value of 21 nM on ovarian cancer cells and near-200-fold selectivity versus normal cells. More importantly, it also demonstrated in vivo efficacy and low toxicity on tumor xenograft mouse model at a dosage of 2 and 10 mg/kg.</div><div class="NLM_p last">This work is the first to show that benzoxaboroles may serve as potent and efficacious anticancer agents. Although there are existing reports commenting on their anticancer activity, the reported potency at cellular level was not ideal and in vivo efficacy was not reported.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> However, the intracellular target of our benzxoaboroles remains to be elucidated. They were demonstrated to effectively induce cancer cell apoptosis through the caspase 3/9 and PARP pathways and inhibited colony formation. In previous reports, the biological activities of benzoxaboroles were mainly assessed by phenotypic screening while the cellular targets largely remained unknown. Although leucyl-tRNA synthetases (LeuRS) have been identified as the cellular target of the antifungal benzoxaborole tavaborole,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> compounds <b>103</b> and <b>115</b> did not inhibit human LeuRS, which is consistent with our previously reported observation that the eukaryotic helix blocked the 7-position of the benzoxaborole.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Tavaborole did not show any anticancer activity, either. At the same time, benzoxaborole has been used as a novel chemotype in the development of enzyme inhibitors. An interesting example was the carbonic anhydrase inhibitors reported by Winum and Simone et al.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> As a continuous development, we are currently making efforts to decipher the cellular targets of the anticancer benzoxaboroles reported herein.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry: General Procedures</h3><div class="NLM_p last">All solvents and reagents were purchased from commercial suppliers and used without further purification if not indicated. Column chromatography was performed using Huanghai silica gel (48–75 μm). NMR spectra were recorded on AVANCE 400 (Bruker). Chemical shifts (δ) are expressed in parts per million (ppm) relative to residual solvent as an internal reference. High-resolution mass spectroscopy (HRMS) images were obtained on an Agilent 6530 accurate-mass quadrupole time-of-flight LC/MS. High-performance liquid chromatography (HPLC) analysis was performed on an Agilent 1200 with a flow rate of 1 mL/min and a gradient of 10% MeCN/90% H<sub>2</sub>O to 100% MeCN in 20 min using a diode array detector. An Agilent Eclipse XDB-C18 column (4.6 mm × 150 mm, 5 μm) was used. Purity was based on the integrated UV chromatogram (220 nm). All compounds used for biological evaluation have purity of ≥95%. Melting points were measured on a SGWX-4 melting point apparatus.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>t</i>-Butyl (4-Aminophenyl)carbamate (<b>4</b>)</h3><div class="NLM_p last">To a solution of <i>p</i>-aminoanaline (3.24 g, 30 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.52 g, 11 mmol) in THF (30 mL) was added Boc<sub>2</sub>O (2.18 g, 10 mmol) dropwise over 0.5 h. After stirred overnight at room temperature (rt), the mixture was diluted with H<sub>2</sub>O (70 mL) and extracted with DCM (50 mL × 3). The organic phase was combined, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuum followed by purification on silica gel column chromatography (petroleum ether/EtOAc = 2:1) to give compound <b>4</b> (2.02 g, 100%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub>): δ 8.77 (s, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 2H), 6.46 (d, <i>J</i> = 8.2 Hz, 2H), 4.72 (s, 2H), 1.44 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 153.0, 143.8, 128.4, 120.1, 113.8, 78.0, 28.1 ppm.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>t</i>-Butyl (4-Aminobenzyl)carbamate (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> (0.97 g, 53.4%) was prepared following a similar procedure to compound <b>4</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.07 (d, <i>J</i> = 8.2 Hz, 2H), 6.64 (d, <i>J</i> = 8.2 Hz, 2H), 4.70 (s, 1H), 4.18 (d, <i>J</i> = 5.2 Hz, 2H), 3.64 (s, 2H), 1.45 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.8, 145.6, 128.8, 128.7, 115.1, 79.2, 44.3, 28.4 ppm.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-((Trimethylsilyl)ethynyl)aniline (<b>9</b>)</h3><div class="NLM_p last">To a solution of 2-iodoaniline (1.1 g, 5.0 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (105.3 mg, 0.15 mmol), and CuI (19.0 mg, 0.1 mmol) in a mixture of dry THF (10 mL) and TEA (3 mL) was added trimethylsilylacetylene (915 μL, 7.0 mmol) dropwise over 1 h. After stirred overnight at rt, the mixture was evaporated in vacuum and the residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 50:1) to obtain compound <b>9</b> as a yellow oil (797 mg, 83.9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.13 (d, <i>J</i> = 7.6 Hz, 1H), 7.07 (dd, <i>J</i> = 8.0, 7.6 Hz, 1H), 6.71 (d, <i>J</i> = 8.0 Hz, 1H), 6.49 (t, <i>J</i> = 7.6 Hz, 1H), 5.28 (s, 2H), 0.24 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.7, 131.6, 129.9, 115.7, 113.7, 105.4, 102.6, 98.6, 0.0 ppm.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-((Trimethylsilyl)ethynyl)aniline (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> (888 mg, 93.4%) was prepared following a similar procedure to compound <b>9</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.99 (t, <i>J</i> = 7.8 Hz, 1H), 6.63 (s, 1H), 6.57 (t, <i>J</i> = 7.8 Hz, 2H), 5.20 (s, 2H), 0.20 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 129.6, 122.9, 119.4, 117.0, 115.3, 106.8, 92.7, 0.5 ppm.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-((Trimethylsilyl)ethynyl)aniline (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> (565 mg, 59.4%) was prepared following a similar procedure to compound <b>9</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.49 (d, <i>J</i> = 8.4 Hz, 2H), 5.53 (s, 2H), 0.18 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 150.1, 137.5, 133.3, 117.0, 113.9, 108.6, 107.9, 90.5, 0.7 ppm.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Ethynylaniline (<b>12</b>)</h3><div class="NLM_p last">To a solution of KOH (4.46 g, 32.3 mmol) in MeOH (20 mL) was added a solution of <b>9</b> (612 mg, 3.23 mmol) in DCM (20 mL). After stirred at rt for 3 h, the reaction mixture was filtered. The filtrate was concentrated and purified by silica gel column chromatography (petroleum ether/EtOAc = 10:1) to obtain compound <b>12</b> as a yellow oil (210 mg, 55.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33 (d, <i>J</i> = 7.6 Hz, 1H), 7.15 (dd, <i>J</i> = 8.0, 7.6 Hz, 1H), 6.71–6.66 (m, 2H), 4.24 (s, 2H), 3.38 (s, 1H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 148.5, 132.6, 130.1, 117.8, 114.3, 106.6, 82.4, 80.6 ppm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-Ethynylaniline (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> (208 mg, 43.1%) was prepared following a similar procedure to compound <b>12</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.00 (t, <i>J</i> = 7.8 Hz, 1H), 6.64 (s, 1H), 6.59–6.57 (m, 2H), 5.20 (s, 2H), 3.96 (s, 1H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 129.6, 122.4, 119.5, 117.0, 115.2, 84.9, 79.5 ppm.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Ethynylaniline (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> (267 mg, 64.4%) was prepared following a similar procedure to compound <b>12</b> as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.11 (d, <i>J</i> = 8.6 Hz, 2H), 6.50 (d, <i>J</i> = 8.6 Hz, 2H), 5.49 (s, 2H), 3.76 (s, 1H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.4, 132.7, 113.4, 107.6, 85.0, 77.1 ppm.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1,1′-Biphenyl-2-amine (<b>36</b>)</h3><div class="NLM_p last">To a solution of 2-bromoaniline (1.0 g, 5.8 mmol) in a mixture of toluene (25 mL) and EtOH (9 mL) were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (203.5 mg, 0.29 mmol), phenylboronic acid (708 mg, 5.8 mmol), and sat aq Na<sub>2</sub>CO<sub>3</sub> (3 mL). The reaction mixture was refluxed overnight under nitrogen atmosphere. The reaction mixture was diluted with H<sub>2</sub>O (30 mL) and extracted with DCM (30 mL × 3). The organic phase was combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuum. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 25:1) to obtain compound <b>36</b> as a white solid (837 mg, 85.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.46–7.40 (m, 4H), 7.33 (t, <i>J</i> = 7.0 Hz, 1H), 7.04 (t, <i>J</i> = 7.6 Hz, 1H), 6.97 (d, <i>J</i> = 7.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.63 (t, <i>J</i> = 7.4 Hz, 1H), 4.75 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 144.9, 139.6, 129.9, 128.7, 128.5, 128.1, 126.7, 125.7, 116.7, 115.2 ppm.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1,1′-Biphenyl-3-amine (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> (338.7 mg, 68.9%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.58–7.56 (m, 2H), 7.44–7.40 (m, 2H), 7.33 (t, <i>J</i> = 7.4 Hz, 1H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 7.00 (d, <i>J</i> = 7.6 Hz, 1H), 6.91 (t, <i>J</i> = 2.0 Hz, 1H), 6.68 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 4.24 (s, 2H), 3.71 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 146.7, 142.4, 141.3, 129.6, 128.6, 127.2, 127.1, 117.6, 114.0, 113.8 ppm.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1,1′-Biphenyl-4-amine (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> (195.2 mg, 39.7%) was prepared following a similar procedure to compound <b>36</b> as a brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.55–7.53 (m, 2H), 7.43–7.38 (m, 4H), 7.27 (t, <i>J</i> = 7.4 Hz, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 2H), 3.74 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 145.8, 141.1, 131.6, 128.6, 128.0, 126.4, 126.2, 115.4 ppm.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3′-Fluoro-1,1′-biphenyl-3-amine (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (493.4 mg, 90.7%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.46 (dd, <i>J</i> = 10.8, 7.8 Hz, 1H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.35 (d, <i>J</i> = 10.8 Hz, 1H), 7.17–7.12 (m, 1H), 7.11 (t, <i>J</i> = 7.8 Hz, 1H), 6.87 (s, 1H), 6.80 (d, <i>J</i> = 7.8 Hz, 1H), 6.61 (d, <i>J</i> = 7.8 Hz, 1H), 5.19 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.5 (d, <i>J</i> = 241.8 Hz), 149.1, 143.5 (d, <i>J</i> = 7.6 Hz), 139.4 (d, <i>J</i> = 2.1 Hz), 130.6 (d, <i>J</i> = 8.6 Hz), 129.5, 122.4, 114.4, 113.7, 113.6 (d, <i>J</i> = 20.8 Hz), 113.9 (d, <i>J</i> = 21.6 Hz), 112.1 ppm.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4′-Fluoro-1,1′-biphenyl-3-amine (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> (407.8 mg, 75.1%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.51 (dd, <i>J</i> = 8.8, 5.4 Hz, 2H), 7.22 (t, <i>J</i> = 7.8 Hz, 1H), 7.10 (t, <i>J</i> = 8.8 Hz, 2H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 6.85 (t, <i>J</i> = 2.0 Hz, 1H), 6.67 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 3.71 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.3 (d, <i>J</i> = 244.4 Hz), 146.7, 141.4, 137.4 (d, <i>J</i> = 3.3 Hz), 129.7, 128.5 (d, <i>J</i> = 7.9 Hz), 117.4, 115.4 (d, <i>J</i> = 21.3 Hz), 114.0, 113.6 ppm.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3′-Chloro-1,1′-biphenyl-3-amine (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> (481.1 mg, 81.3%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.57 (s, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.45 (t, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.11 (t, <i>J</i> = 7.8 Hz, 1H), 6.85 (s, 1H), 6.79 (d, <i>J</i> = 7.8 Hz, 1H), 6.60 (d, <i>J</i> = 7.8 Hz, 1H), 5.19 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.1, 143.2, 139.2, 133.4, 130.5, 129.5, 126.8, 126.0, 125.0, 114.2, 113.7, 112.0 ppm.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4′-Chloro-1,1′-biphenyl-3-amine (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> (564.0 mg, 95.3%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.56 (d, <i>J</i> = 8.6 Hz, 2H), 7.47 (d, <i>J</i> = 8.6 Hz, 2H), 7.10 (t, <i>J</i> = 7.8 Hz, 1H), 6.82 (s, 1H), 6.76 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (d, <i>J</i> = 7.8 Hz, 1H), 5.18 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 139.8, 139.5, 131.9, 129.5, 128.7, 128.2, 114.3, 113.5, 112.0 ppm.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3′-Methoxy-1,1′-biphenyl-3-amine (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> (465.0 mg, 70.9%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.33 (t, <i>J</i> = 8.0 Hz, 1H), 7.12–7.05 (m, 3H), 6.89 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.83 (t, <i>J</i> = 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 7.6 Hz, 1H), 6.56 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 5.13 (s, 2H), 3.80 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 159.5, 149.0, 142.6, 140.7, 129.7, 129.3, 118.8, 114.4, 113.2, 112.6, 112.1, 111.9, 55.0 ppm.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4′-Methoxy-1,1′-biphenyl-3-amine (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> (347.5 mg, 60.1%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.49 (d, <i>J</i> = 8.8 Hz, 2H), 7.20 (t, <i>J</i> = 8.0 Hz, 1H), 6.97–6.94 (m, 3H), 6.87 (t, <i>J</i> = 2.0 Hz, 1H), 6.64 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 3.85 (s, 3H), 3.72 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.0, 146.7, 142.0, 133.9, 129.6, 128.1, 117.3, 114.0, 113.5, 113.4, 55.3 ppm.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3′,5′-Methoxy-1,1′-biphenyl-3-amine (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> (425.0 mg, 79.7%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.08 (t, <i>J</i> = 7.8 Hz, 1H), 6.84 (s, 1H), 6.77 (d, <i>J</i> = 7.8 Hz, 1H), 6.67 (d, <i>J</i> = 2.2 Hz, 2H), 6.57 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 6.47 (t, <i>J</i> = 2.2 Hz, 1H), 5.14 (s, 2H), 3.85 (s, 3H), 3.79 (s, 6H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.6, 148.9, 143.3, 140.8, 129.2, 114.4, 113.3, 112.2, 104.6, 98.9, 55.1 ppm.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3′-Trifluoromethoxy-1,1′-biphenyl-3-amine (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> (674.9 mg, 91.7%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.60 (dt, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.54 (t, <i>J</i> = 7.8 Hz, 1H), 7.48 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.13 (t, <i>J</i> = 7.8 Hz, 1H), 6.89 (s, 1H), 6.81 (d, <i>J</i> = 7.8 Hz, 1H), 6.64 (d, <i>J</i> = 8.0 Hz, 1H), 5.23 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 148.8, 143.4, 139.1, 130.6, 129.5, 125.5, 120.1 (q, <i>J</i> = 254.7 Hz), 119.3, 118.7, 114.3, 113.8, 112.0, ppm.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4′-Trifluoromethoxy-1,1′-biphenyl-3-amine (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> (553.0 mg, 75.1%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.39 (d, <i>J</i> = 8.4 Hz, 2H), 7.11 (t, <i>J</i> = 7.8 Hz, 1H), 6.86 (s, 1H), 6.77 (d, <i>J</i> = 7.8 Hz, 1H), 6.62 (d, <i>J</i> = 7.8 Hz, 1H), 5.21 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 147.5, 140.3, 139.4, 129.5, 128.1, 121.2, 120.1 (q, <i>J</i> = 254.5 Hz), 114.3, 113.5, 112.1 ppm.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3′-Methylthio-1,1′-biphenyl-3-amine (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> (355.2 mg, 56.9%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.38–7.35 (m, 2H), 7.31 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.22 (dt, <i>J</i> = 7.6, 1.4 Hz, 1H), 7.09 (t, <i>J</i> = 7.8 Hz, 1H), 6.84 (t, <i>J</i> = 1.8 Hz, 1H), 6.77 (d, <i>J</i> = 7.6 Hz, 1H), 6.56 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 5.16 (s, 2H), 2.52 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.0, 141.7, 140.3, 138.5, 129.3, 129.2, 124.5, 123.6, 123.0, 114.3, 113.3, 112.0, 14.6 ppm.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4′-Methylthio-1,1′-biphenyl-3-amine (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> (456.0 mg, 73.1%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (t, <i>J</i> = 7.8 Hz, 1H), 6.83 (s, 1H), 6.76 (d, <i>J</i> = 7.8 Hz, 1H), 6.55 (d, <i>J</i> = 7.8 Hz, 1H), 5.14 (s, 2H), 3.35 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.0, 140.1, 137.5, 136.8, 129.3, 126.8, 126.2, 113.9, 113.0, 111.6, 14.6 ppm.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3′-Trifluoromethyl-1,1′-biphenyl-3-amine (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> (619.3 mg, 89.8%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.85–7.84 (m, 2H), 7.65–7.59 (m, 2H), 7.16 (t, <i>J</i> = 7.8 Hz, 1H), 6.99 (s, 1H), 6.84 (d, <i>J</i> = 7.8 Hz, 1H), 6.71 (d, <i>J</i> = 7.8 Hz, 1H), 5.27 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.3, 142.1, 139.3, 130.4, 129.9, 129.7, 129.6, 129.5, 125.6, 123.5 (t, <i>J</i> = 3.8 Hz), 122.9, 122.7 (t, <i>J</i> = 3.9 Hz), 114.5, 114.0, 112.3 ppm.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4′-Trifluoromethyl-1,1′-biphenyl-3-amine (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> (561.0 mg, 81.4%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.76 (s, 4H), 7.14 (dd, <i>J</i> = 8.0, 7.6 Hz, 1H), 6.90 (s, 1H), 6.82 (d, <i>J</i> = 7.6 Hz, 1H), 6.64 (d, <i>J</i> = 8.0 Hz, 1H), 5.25 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 145.0, 139.2, 129.6, 127.1, 125.6 (t, <i>J</i> = 3.8 Hz), 114.4, 114.0, 112.1 ppm.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3′-Cyano-1,1′-biphenyl-3-amine (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> (507.1 mg, 89.8%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.98 (t, <i>J</i> = 1.6 Hz, 1H), 7.89 (dt, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.78 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.63 (t, <i>J</i> = 7.8 Hz, 1H), 7.13 (t, <i>J</i> = 7.8 Hz, 1H), 6.87 (t, <i>J</i> = 1.6 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.62 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 5.22 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.2, 142.1, 138.6, 131.2, 130.6, 129.9, 129.8, 129.6, 118.8, 114.3, 113.9, 112.0, 111.8 ppm.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4′-Cyano-1,1′-biphenyl-3-amine (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> (438.8 mg, 77.7%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.88 (d, <i>J</i> = 8.2 Hz, 2H), 7.74 (d, <i>J</i> = 8.2 Hz, 2H), 7.14 (t, <i>J</i> = 7.8 Hz, 1H), 6.89 (s, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.64 (dd, <i>J</i> =7.8, 1.6 Hz, 1H), 5.26 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 149.3, 145.5, 138.9, 132.6, 129.6, 127.2, 118.9, 114.4, 114.3, 112.1, 109.5 ppm.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3′-Acetyl-1,1′-biphenyl-3-amine (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> (544.8 mg, 88.7%) was prepared following a similar procedure to compound <b>36</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11 (t, <i>J</i> = 1.6 Hz, 1H), 7.92 (d, <i>J</i> = 7.8 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7. 57 (t, <i>J</i> = 7.8 Hz, 1H), 7.14 (t, <i>J</i> = 7.8 Hz, 1H), 6.93 (t, <i>J</i> = 1.6 Hz, 1H), 6.84 (d, <i>J</i> = 7.8 Hz, 1H), 6.63 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 5.22 (s, 2H), 2.63 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 197.9, 149.2, 141.4, 139.9, 137.2, 131.0, 129.5, 129.1, 126.9, 125.8, 114.4, 113.5, 112.1, 26.8 ppm.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4′-Acetyl-1,1′-biphenyl-3-amine (<b>55</b>)</h3><div class="NLM_p last">Compound <b>55</b> (523.3 mg, 85.4%) was prepared following a similar procedure to compound <b>36</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.01 (d, <i>J</i> = 8.6 Hz, 2H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H), 7.25 (t, <i>J</i> = 7.8 Hz, 1H), 7.02 (d, <i>J</i> = 7.8 Hz, 1H), 6.93 (t, <i>J</i> = 1.8 Hz, 1H), 6.73 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 3.79 (s, 2H), 2.63 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 197.8, 146.9, 146.0, 141.0, 135.7, 129.8, 128.8, 127.1, 117.6, 114.9, 113.7, 26.6 ppm.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Ethyl (<i>E</i>)-3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)acrylate (<b>63</b>)</h3><div class="NLM_p last">To a solution of aldehyde <b>62</b> (1.68 g, 10.4 mmol) in toluene (150 mL) was added ethyl (triphenylphosphoranylidene)acetate (4.34 g, 12.4 mmol). After stirred overnight at rt, the reaction mixture was evaporated in vacuum followed by purification on silica gel column chromatography (petroleum ether/EtOAc = 2:1) to obtain compound <b>63</b> as a white solid (1.6 g, 66.7%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.33 (s, 1H), 8.10 (d, <i>J</i> = 16.2 Hz, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.52 (t, <i>J</i> = 7.6 Hz, 1H), 7.44 (d, <i>J</i> = 7.6 Hz, 1H), 6.80 (d, <i>J</i> = 16.2 Hz, 1H), 5.02 (s, 2H), 4.19 (q, <i>J</i> = 7.0 Hz, 2H), 1.26 (t, <i>J</i> = 7.0 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.3, 154.5, 143.0, 137.2, 131.1, 125.0, 123.0, 119.1, 69.6, 59.9, 14.1 ppm.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Ethyl 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)propanoate (<b>64</b>)</h3><div class="NLM_p last">To a solution of compound <b>63</b> (1.3 g, 5.6 mmol) in EtOH (120 mL) was added 10% Pd/C (592 mg). After stirred overnight under hydrogen atmosphere at rt, the reaction mixture was filtered and the filtrate was evaporated in vacuum. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 2:1) to obtain compound <b>64</b> as a white solid (1.2 g, 93.2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.98 (s, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 4.02 (q, <i>J</i> = 7.0 Hz, 2H), 3.30 (t, <i>J</i> = 7.8 Hz, 2H), 2.26 (t, <i>J</i> = 7.8 Hz, 2H), 1.14 (t, <i>J</i> = 7.0 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.2, 154.1, 144.6, 130.8, 126.7, 119.1, 69.7, 59.6, 35.4, 29.2, 14.0 ppm.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)propanoic Acid (<b>65</b>)</h3><div class="NLM_p last">To a solution of compound <b>64</b> (1.51 g, 6.45 mmol) in MeOH (66 mL) was added 1 M NaOH aq solution (33 mL). After stirred overnight at rt, the reaction mixture was acidified with conc. HCl to pH = 3. Then, the mixture was filtered to obtain compound <b>65</b> (1.23 g, 92.9%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.04 (s, 1H), 8.96 (s, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 2.99 (t, <i>J</i> = 7.8 Hz, 2H), 2.54 (t, <i>J</i> = 7.8 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.8, 154.1, 145.0, 130.8, 126.6, 119.0, 69.7, 35.5, 29.2 ppm; HRMS [electrospray ionization (ESI)]: [M + H]<sup>+</sup> C<sub>10</sub>H<sub>12</sub>BO<sub>4</sub> calcd 207.0829, found 207.0827; mp: 159–162 °C; HPLC: purity 99.1%, retention time 3.5 min.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-ethylpropanamide (<b>66</b>)</h3><div class="NLM_p last">Compound <b>65</b> (200 mg, 0.97 mmol) was dissolved in SOCl<sub>2</sub> (4 mL). After refluxed for 2 h, the mixture was evaporated in vacuo and the residue was dissolved in DCM (12 mL). To the mixture were added ethylamine hydrochloride (238 mg, 2.9 mmol) and TEA (324 mg, 3.2 mmol). After stirred at room temperature overnight, the mixture was evaporated in vacuo. The residue was purified by silica gel column chromatography (DCM/MeOH = 150:1) to obtain compound <b>66</b> as a white solid (81 mg, 35.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.97 (s, 1H), 7.73 (s, 1H), 7.34 (t, <i>J</i> = 7.6 Hz, 1H), 7.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.11 (d, <i>J</i> = 7.6 Hz, 1H), 4.95 (s, 2H), 3.05–2.97 (m, 4H), 2.36 (t, <i>J</i> = 7.6 Hz, 2H), 0.97 (t, <i>J</i> = 7.2 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.1, 154.0, 145.6, 130.6, 126.5, 118.7, 69.5, 37.2, 33.1, 29.6, 14.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>12</sub>H<sub>17</sub>BNO<sub>3</sub> calcd 234.1301, found 234.1304; mp: 121–125 °C; HPLC: purity 96.4%, retention time 7.5 min.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(<i>tert</i>-butyl)propanamide (<b>67</b>)</h3><div class="NLM_p last">Compound <b>67</b> (90 mg, 27.5%) was prepared following a similar procedure to compound <b>66</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96 (s, 1H), 7.35 (t, <i>J</i> = 7.6 Hz, 1H), 7.31 (s, 1H), 7.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.11 (d, <i>J</i> = 7.6 Hz, 1H), 4.95 (s, 2H), 2.97 (d, <i>J</i> = 7.6 Hz, 2H), 2.33 (t, <i>J</i> = 7.6 Hz, 2H), 1.22 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.1, 153.9, 145.8, 130.5, 126.5, 118.7, 69.5, 49.7, 37.9, 29.7, 28.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>14</sub>H<sub>21</sub>BNO<sub>3</sub> calcd 262.1614, found 262.1635; mp: 151–157 °C; HPLC: purity 96.0%, retention time 11.0 min.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-cyclohexylpropanamide (<b>68</b>)</h3><div class="NLM_p last">To a solution of compound <b>65</b> (60 mg, 0.29 mmol) in dry DCM (10 mL) were added aminocyclohexane (30 mg, 0.30 mmol) and EDCI (220 mg, 0.58 mmol). After stirred overnight at rt, the reaction mixture was evaporated in vacuum. The residue was purified by silica gel column chromatography (DCM/MeOH = 150:1) to obtain compound <b>68</b> as a white solid (32.7 mg, 39.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.99 (s, 1H), 7.61 (d, <i>J</i> = 7.8 Hz, 1H), 7.34 (t, <i>J</i> = 7.4 Hz, 1H), 7.19 (d, <i>J</i> = 7.4 Hz, 1H), 7.10 (d, <i>J</i> = 7.4 Hz, 1H), 4.95 (s, 2H), 3.53–3.46 (m, 1H), 2.98 (t, <i>J</i> = 7.6 Hz, 2H), 2.35 (t, <i>J</i> = 7.6 Hz, 2H), 1.68–1.62 (m, 4H), 1.53 (d, <i>J</i> = 11.9 Hz, 1H), 1.24–1.18 (m, 2H), 1.11–1.02 (m, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5, 154.0, 145.7, 130.6, 126.6, 118.8, 69.6, 47.2, 37.3, 32.4, 29.7, 25.2, 24.5 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>23</sub>BNO<sub>3</sub> calcd 288.1771, found 288.1779; mp: 221–224 °C; HPLC: purity 97.9%, retention time 11.0 min.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-phenylpropanamide (<b>69</b>)</h3><div class="NLM_p last">Compound <b>69</b> (192 mg, 70.5%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.82 (s, 1H), 8.99 (s, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 2H), 7.36 (t, <i>J</i> = 7.4 Hz, 1H), 7.27 (dd, <i>J</i> = 8.0, 7.4 Hz, 2H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 7.16 (d, <i>J</i> = 7.4 Hz, 1H), 7.01 (t, <i>J</i> = 7.4 Hz, 1H), 4.97 (s, 2H), 3.10 (t, <i>J</i> = 7.6 Hz, 2H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5, 154.1, 145.4, 139.2, 130.7, 128.5, 126.6, 122.8, 118.9, 118.8, 69.6, 38.1, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>17</sub>BNO<sub>3</sub> calcd 282.1301, found 282.1299; mp: 197–199 °C; HPLC: purity 95.6%, retention time 11.3 min.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-benzylpropanamide (<b>70</b>)</h3><div class="NLM_p last">Compound <b>70</b> (25.4 mg, 35.5%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.95 (s, 1H), 8.25 (t, <i>J</i> = 5.9 Hz, 1H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.28 (d, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.2 Hz, 2H), 7.15–7.11 (m, 3H), 4.95 (s, 2H), 4.24 (d, <i>J</i> = 5.9 Hz, 2H), 3.04 (t, <i>J</i> = 7.6 Hz, 2H), 2.47 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.4, 154.0, 145.5, 139.5, 130.7, 128.1, 127.0, 126.7, 126.5, 118.8, 69.6, 41.8, 37.1, 29.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>17</sub>H<sub>19</sub>BNO<sub>3</sub> calcd 296.1458, found 296.1462; mp: 158–162 °C; HPLC: purity 96.5%, retention time 10.1 min.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-phenethylpropanamide (<b>71</b>)</h3><div class="NLM_p last">Compound <b>71</b> (28.4 mg, 37.9%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96 (s, 1H), 7.85 (t, <i>J</i> = 5.6 Hz, 1H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.27 (t, <i>J</i> = 7.2 Hz, 2H), 7.21–7.18 (m, 2H), 7.15 (d, <i>J</i> = 7.2 Hz, 2H), 7.10 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 3.26–3.21 (m, 2H), 2.99 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.47 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.4, 154.0, 145.6, 139.4, 130.7, 128.5, 128.2, 126.5, 125.9, 118.8, 69.6, 37.2, 35.1, 29.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>18</sub>H<sub>21</sub>BNO<sub>3</sub> calcd 310.1614, found 310.1611; mp: 145–149 °C; HPLC: purity 99.4%, retention time 11.0 min.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(thiazol-2-yl)propanamide (<b>72</b>)</h3><div class="NLM_p last">Compound <b>72</b> (34.5 mg, 32.9%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.04 (s, 1H), 8.98 (s, 1H), 7.43 (d, <i>J</i> = 3.5 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 3.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.10 (t, <i>J</i> = 7.8 Hz, 2H), 2.76 (t, <i>J</i> = 7.8 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.4, 157.8, 154.0, 144.8, 137.4, 126.4, 119.0, 113.0, 69.6, 36.6, 28.9 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>13</sub>H<sub>14</sub>BN<sub>2</sub>O<sub>3</sub>S calcd 289.0818, found 289.0823; mp: 204–206 °C; HPLC: purity 98.8%, retention time 9.0 min.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-fluorophenyl)propanamide (<b>73</b>)</h3><div class="NLM_p last">Compound <b>73</b> (46.1 mg, 63.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.49–7.45 (m, 2H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.01 (t, <i>J</i> = 8.8 Hz, 2H), 5.05 (s, 2H), 3.16 (t, <i>J</i> = 7.6 Hz, 2H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.4, 154.1, 145.4, 135.6, 130.8, 126.6, 120.6 (d, <i>J</i> = 7.8 Hz), 119.0, 115.1 (d, <i>J</i> = 22.0 Hz), 69.7, 38.1, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BFNO<sub>3</sub> calcd 300.1207, found 300.1210; mp: 234–237 °C; HPLC: purity 98.0%, retention time 11.6 min.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-chlorophenyl)propanamide (<b>74</b>)</h3><div class="NLM_p last">Compound <b>74</b> (46.0 mg, 57.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.48 (d, <i>J</i> = 8.5 Hz, 2H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 8.5 Hz, 2H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 5.48 (s, 1H), 5.04 (s, 2H), 3.16 (t, <i>J</i> = 7.5 Hz, 2H), 2.64 (t, <i>J</i> = 7.5 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 154.0, 145.2, 138.0, 130.6, 128.4, 126.5, 120.4, 118.9, 69.6, 38.0, 29.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BClNO<sub>3</sub> calcd 316.0912, found 316.0909; mp: 216–219 °C; HPLC: purity 97.2%, retention time 13.0 min.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-bromophenyl)propanamide (<b>75</b>)</h3><div class="NLM_p last">Compound <b>75</b> (53.8 mg, 51.3%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.96 (s, 1H), 8.99 (s, 1H), 7.54 (d, <i>J</i> = 8.7 Hz, 2H), 7.45 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (t, <i>J</i> = 7.4 Hz, 1H), 7.20 (d, <i>J</i> = 7.4 Hz, 1H), 7.14 (d, <i>J</i> = 7.4 Hz, 1H), 4.96 (s, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.3, 138.5, 131.4, 130.7, 126.6, 120.8, 119.0, 114.4, 69.7, 38.1, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BBrNO<sub>3</sub> calcd 360.0407, found 360.0402; mp: 232–235 °C; HPLC: purity 95.7%, retention time 13.5 min.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-iodo-phenyl)propanamide (<b>76</b>)</h3><div class="NLM_p last">Compound <b>76</b> (32.6 mg, 27.5%) was prepared following a similar procedure to compound <b>68</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.59 (d, <i>J</i> = 8.6 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.31 (d, <i>J</i> = 8.6 Hz, 2H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 5.05 (s, 2H), 3.15 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 173.9, 155.7, 146.4, 139.9, 138.9, 132.3, 128.2, 123.1, 120.1, 72.2, 40.1, 31.5 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BINO<sub>3</sub> calcd 408.0268, found 408.0268; mp: 228–231 °C; HPLC: purity 95.6%, retention time 13.9 min.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-methylphenyl)propanamide (<b>77</b>)</h3><div class="NLM_p last">Compound <b>77</b> (49.5 mg, 57.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.73 (s, 1H), 8.99 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.07 (d, <i>J</i> = 8.2 Hz, 2H), 4.96 (s, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.62 (t, <i>J</i> = 7.6 Hz, 2H), 2.23 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.8, 154.6, 146.0, 137.2, 132.2, 131.3, 129.5, 127.1, 119.5, 119.4, 70.2, 38.7, 30.0, 20.9 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>17</sub>H<sub>19</sub>BNO<sub>3</sub> calcd 296.1458, found 296.1460; mp: 179–182 °C; HPLC: purity 96.2%, retention time 12.3 min.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-ethynylphenyl)propanamide (<b>78</b>)</h3><div class="NLM_p last">Compound <b>78</b> (14.5 mg, 12.2%) was prepared following a similar procedure to compound <b>68</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.00 (s, 1H), 9.00 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.39 (d, <i>J</i> = 8.5 Hz, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 4.06 (s, 1H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.3, 139.7, 132.2, 130.7, 126.6, 119.0, 118.7, 115.7, 83.5, 79.6, 69.7, 38.2, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>18</sub>H<sub>17</sub>BNO<sub>3</sub> calcd 306.1301, found 306.1305; mp: 193–196 °C; HPLC: purity 95.2%, retention time 11.5 min.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-<i>t</i>-butylphenyl)propanamide (<b>79</b>)</h3><div class="NLM_p last">Compound <b>79</b> (30.9 mg, 38.2%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.74 (s, 1H), 8.99 (s, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.28 (d, <i>J</i> = 8.6 Hz, 2H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.62 (t, <i>J</i> = 7.6 Hz, 2H), 1.25 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.3, 154.1, 145.5, 145.1, 136.6, 130.7, 126.6, 125.1, 118.9, 118.8, 69.6, 38.1, 33.9, 31.1, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>20</sub>H<sub>25</sub>BNO<sub>3</sub> calcd 338.1927, found 338.1927; mp: 145–147 °C; HPLC: purity 99.1%, retention time 15.2 min.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-methoxylphenyl)propanamide (<b>80</b>)</h3><div class="NLM_p last">Compound <b>80</b> (51.3 mg, 40.5%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.68 (s, 1H), 8.99 (s, 1H), 7.47 (d, <i>J</i> = 8.9 Hz, 2H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 6.85 (d, <i>J</i> = 8.9 Hz, 2H), 4.97 (s, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.3, 155.2, 154.3, 145.6, 132.4, 131.0, 126.8, 120.8, 119.2, 113.9, 69.8, 55.2, 38.2, 29.7 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>17</sub>H<sub>19</sub>BNO<sub>4</sub> calcd 312.1407, found 312.1403; mp: 200–203 °C; HPLC: purity 95.5%, retention time 10.9 min.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-(<i>t</i>-butoxycarbonylamino)phenyl)propanamide (<b>81</b>)</h3><div class="NLM_p last">Compound <b>81</b> (36.5 mg, 37.9%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.71 (s, 1H), 9.22 (s, 1H), 9.00 (s, 1H), 7.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.39–7.33 (m, 3H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 7.16 (d, <i>J</i> = 7.4 Hz, 1H), 4.97 (s, 2H), 3.09 (t, <i>J</i> = 7.2 Hz, 2H), 2.61 (t, <i>J</i> = 7.2 Hz, 2H), 1.47 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.2, 154.2, 152.9, 145.5, 134.7, 133.7, 130.8, 126.7, 119.6, 119.0, 118.5, 78.9, 69.7, 38.1, 29.5, 28.1 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>21</sub>H<sub>26</sub>BN<sub>2</sub>O<sub>5</sub> calcd 397.1935, found 397.1931; mp: >270 °C; HPLC: purity 99.6%, retention time 12.9 min.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-((<i>tert</i>-butoxycarbonyl)aminomethyl)-phenyl)propanamide (<b>82</b>)</h3><div class="NLM_p last">Compound <b>82</b> (338.2 mg, 84.9%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.78 (s, 1H), 8.98 (s, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.30 (t, <i>J</i> = 5.8 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.16–7.12 (m, 3H), 4.96 (s, 2H), 4.04 (d, <i>J</i> = 5.8 Hz, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.63 (t, <i>J</i> = 7.6 Hz, 2H), 1.38 (s, 9H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.3, 155.6, 154.1, 145.4, 137.7, 134.6, 130.7, 127.2, 126.6, 118.9, 77.6, 69.6, 42.9, 38.1, 29.4, 28.1 ppm; HRMS (ESI): [M + Na]<sup>+</sup> C<sub>22</sub>H<sub>27</sub>BN<sub>2</sub>NaO<sub>5</sub> calcd 433.1911, found 433.1911; mp: 171–174 °C; HPLC: purity 99.1%, retention time 12.7 min.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-ethoxycarbonylphenyl)propanamide (<b>83</b>)</h3><div class="NLM_p last">Compound <b>83</b> (90.3 mg, 26.3%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.19 (s, 1H), 9.02 (s, 1H), 7.88 (d, <i>J</i> = 8.7 Hz, 2H), 7.70 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 4.26 (q, <i>J</i> = 7.0 Hz, 2H), 3.10 (t, <i>J</i> = 7.6 Hz, 2H), 2.69 (t, <i>J</i> = 7.6 Hz, 2H), 1.29 (t, <i>J</i> = 7.0 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.2, 165.3, 154.2, 145.3, 143.5, 130.8, 130.2, 126.7, 123.9, 119.1, 118.3, 69.7, 60.4, 38.3, 29.3, 14.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>19</sub>H<sub>21</sub>BNO<sub>5</sub> calcd 354.1513, found 354.1515; mp: 155–157 °C; HPLC: purity 98.9%, retention time 11.9 min.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4-nitrophenyl)propanamide (<b>84</b>)</h3><div class="NLM_p last">Compound <b>84</b> (19.9 mg, 12.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.18 (d, <i>J</i> = 9.0 Hz, 2H), 7.76 (d, <i>J</i> = 9.0 Hz, 2H), 7.34 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 5.05 (s, 2H), 4.56 (s, 1H), 3.17 (t, <i>J</i> = 7.5 Hz, 2H), 2.75 (t, <i>J</i> = 7.5 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 174.3, 155.8, 146.3, 146.2, 144.6, 132.3, 128.3, 125.7, 120.4, 120.2, 72.2, 40.1, 32.8, 31.3, 23.7, 14.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BN<sub>2</sub>O<sub>5</sub> calcd 327.1152, found 327.1148; mp: 243–247 °C; HPLC: purity 98.5%, retention time 12.4 min.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3-bromophenyl)propanamide (<b>85</b>)</h3><div class="NLM_p last">Compound <b>85</b> (37.8 mg, 36.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.0 (s, 1H), 9.00 (s, 1H), 7.94 (s, 1H), 7.45 (d, <i>J</i> = 7.5 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.26–7.19 (m, 3H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.4, 154.7, 145.8, 141.3, 131.3, 131.1, 127.2, 126.0, 122.0, 121.8, 119.5, 118.2, 70.2, 38.7, 29.8 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BBrNO<sub>3</sub> calcd 360.0407, found 360.0405; mp: 188–192 °C; HPLC: purity 97.7%, retention time 13.3 min.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3-iodophenyl)propanamide (<b>86</b>)</h3><div class="NLM_p last">Compound <b>86</b> (44.0 mg, 37.1%) was prepared following a similar procedure to compound <b>68</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.91 (s, 1H), 8.98 (s, 1H), 8.08 (s, 1H), 7.49 (d, <i>J</i> = 8.0 Hz, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 7.08 (t, <i>J</i> = 8.0 Hz, 1H), 4.97 (s, 2H), 3.08 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.2, 140.5, 131.3, 130.7, 130.6, 127.1, 126.5, 118.9, 118.1, 94.4, 69.6, 38.1, 29.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>BINO<sub>3</sub> calcd 408.0268, found 408.0272; mp: 199–202 °C; HPLC: purity 96.7%, retention time 13.9 min.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3-<i>i</i>-propylphenyl)propanamide (<b>87</b>)</h3><div class="NLM_p last">Compound <b>87</b> (33.0 mg, 42.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.77 (s, 1H), 9.00 (s, 1H), 7.43–7.40 (m, 2H), 7.36 (t, <i>J</i> = 7.6 Hz, 1H), 7.20 (m, 3H), 6.89 (d, <i>J</i> = 7.6 Hz, 1H), 4.97 (s, 2H), 3.09 (t, <i>J</i> = 7.7 Hz, 2H), 2.85–2.78 (m, 1H), 2.63 (t, <i>J</i> = 7.7 Hz, 2H), 1.17 (d, <i>J</i> = 6.9 Hz, 6H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.4, 154.1, 148.8, 145.5, 139.2, 130.8, 128.4, 126.6, 121.0, 118.9, 116.9, 116.6, 69.7, 38.1, 33.4, 29.4, 23.8 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>19</sub>H<sub>23</sub>BNO<sub>3</sub> calcd 324.1771, found 324.1775; mp: 117–120 °C; HPLC: purity 99.4%, retention time 14.3 min.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3-ethynylphenyl)propanamide (<b>88</b>)</h3><div class="NLM_p last">Compound <b>88</b> (43.7 mg, 36.9%) was prepared following a similar procedure to compound <b>68</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.93 (s, 1H), 9.00 (s, 1H), 7.77 (s, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.29 (t, <i>J</i> = 7.8 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 4.97 (s, 2H), 4.16 (s, 1H), 3.09 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.3, 139.3, 130.7, 129.0, 126.5, 126.1, 121.8, 121.7, 119.5, 118.9, 83.3, 80.3, 69.6, 38.1, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>18</sub>H<sub>17</sub>BNO<sub>3</sub> calcd 306.1301, found 306.1306; mp: 177–179 °C; HPLC: purity 98.8%, retention time 12.4 min.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(2-methoxylphenyl)propanamide (<b>89</b>)</h3><div class="NLM_p last">Compound <b>89</b> (18.5 mg, 24.5%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.92 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.22–7.17 (m, 2H), 7.08 (dd, <i>J</i> = 8.0, 7.5 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 6.90 (dd, <i>J</i> = 7.8, 7.5 Hz, 1H), 5.06 (s, 2H), 3.84 (s, 3H), 3.16 (t, <i>J</i> = 7.8 Hz, 2H), 2.73 (t, <i>J</i> = 7.8 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 173.9, 155.8, 151.4, 146.4, 132.3, 128.2, 126.1, 123.3, 121.5, 120.2, 111.8, 72.2, 56.3, 40.3, 32.0 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>17</sub>H<sub>19</sub>BNO<sub>4</sub> calcd 312.1407, found 312.1412; mp: 158–162 °C; HPLC: purity 98.0%, retention time 12.0 min.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(2-ethynylphenyl)propanamide (<b>90</b>)</h3><div class="NLM_p last">Compound <b>90</b> (9.7 mg, 8.2%) was prepared following a similar procedure to compound <b>68</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 1H), 8.98 (s, 1H), 7.79 (d, <i>J</i> = 8.2 Hz, 1H), 7.45 (d, <i>J</i> = 7.6 Hz, 1H), 7.40–7.35 (m, 2H), 7.21 (t, <i>J</i> = 8.2 Hz, 2H), 7.12 (d, <i>J</i> = 7.6 Hz, 1H), 4.97 (s, 2H), 4.43 (s, 1H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.71 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.5, 155.0, 145.2, 139.4, 132.2, 131.5, 130.3, 127.4, 123.6, 119.8, 119.4, 110.8, 84.2, 79.3, 70.8, 40.5, 31.0 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>18</sub>H<sub>17</sub>BNO<sub>3</sub> calcd 306.1301, found 306.1296; mp: 182–185 °C; HPLC: purity 97.6%, retention time 12.5 min.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3-bromo-4-methylphenyl)propanamide (<b>91</b>)</h3><div class="NLM_p last">Compound <b>91</b> (51.2 mg, 47.0%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.91 (s, 1H), 9.00 (s, 1H), 7.94 (s, 1H), 7.38–7.34 (m, 2H), 7.24 (d, <i>J</i> = 8.2 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.96 (s, 2H), 3.08 (t, <i>J</i> = 7.6 Hz, 2H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H), 2.27 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 154.1, 145.3, 138.3, 131.2, 130.8, 130.7, 126.6, 123.6, 122.0, 119.0, 118.1, 69.7, 38.1, 29.3, 21.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>17</sub>H<sub>18</sub>BBrNO<sub>3</sub> calcd 374.0563, found 374.0564; mp: 174–177 °C; HPLC: purity 98.6%, retention time 14.3 min.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3,4-dimethoxylphenyl)propanamide (<b>92</b>)</h3><div class="NLM_p last">Compound <b>92</b> (27.4 mg, 33.1%) was prepared following a similar procedure to compound <b>68</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.36 (t, <i>J</i> = 7.5 Hz, 1H), 7.23–7.16 (m, 3H), 6.94 (d, <i>J</i> = 8.6 Hz, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 5.05 (s, 2H), 3.80 (s, 3H), 3.79 (s, 3H), 3.16 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 173.7, 155.7, 150.4, 147.2, 146.5, 133.6, 132.2, 128.3, 120.1, 113.8, 113.3, 106.9, 72.2, 56.8, 56.4, 40.0, 31.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>18</sub>H<sub>21</sub>BNO<sub>5</sub> calcd 342.1513, found 342.1512; mp: 201–204 °C; HPLC: purity 98.1%, retention time 10.1 min.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(2,4,6-trimethylphenyl)propanamide (<b>93</b>)</h3><div class="NLM_p last">Compound <b>93</b> (17.3 mg, 7.4%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.22–7.19 (m, 2H), 6.85 (s, 2H), 5.06 (s, 2H), 4.57 (s, 1H), 3.19 (t, <i>J</i> = 7.6 Hz, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H), 2.23 (s, 3H), 2.01 (s, 6H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 174.5, 155.8, 146.5, 138.0, 136.6, 133.0, 132.3, 129.6, 128.5, 120.2, 72.2, 38.9, 31.7, 21.0, 18.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>19</sub>H<sub>23</sub>BNO<sub>3</sub> calcd 324.1771, found 310.1776; mp: 262–266 °C; HPLC: purity 95.1%, retention time 10.5 min.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(naphthalene-1-yl)propanamide (<b>94</b>)</h3><div class="NLM_p last">Compound <b>94</b> (22.2 mg, 27.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.81 (s, 1H), 9.02 (s, 1H), 7.91 (d, <i>J</i> = 7.8 Hz, 1H), 7.84 (d, <i>J</i> = 8.2 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 1H), 7.62 (d, <i>J</i> = 7.4 Hz, 1H), 7.52–7.46 (m, 3H), 7.39 (t, <i>J</i> = 7.4 Hz, 1H), 7.25 (d, <i>J</i> = 7.6 Hz, 1H), 7.22 (d, <i>J</i> = 7.4 Hz, 1H), 4.99 (s, 2H), 3.17 (t, <i>J</i> = 7.5 Hz, 2H), 2.82 (t, <i>J</i> = 7.5 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.3, 154.2, 145.4, 133.6, 133.5, 130.8, 128.0, 127.8, 126.8, 125.9, 125.6, 125.5, 125.1, 122.8, 121.8, 119.0, 69.7, 37.8, 29.8 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>20</sub>H<sub>19</sub>BNO<sub>3</sub> calcd 332.1458, found 332.1456; mp: 172–175 °C; HPLC: purity 96.2%, retention time 11.8 min.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(naphthalene-2-yl)propanamide (<b>95</b>)</h3><div class="NLM_p last">Compound <b>95</b> (36.0 mg, 37.3%) was prepared following a similar procedure to compound <b>68</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.04 (s, 1H), 9.02 (s, 1H), 8.29 (s, 1H), 7.84–7.78 (m, 3H), 7.55 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.45 (t, <i>J</i> = 7.4 Hz, 1H), 7.40–7.35 (m, 2H), 7.20 (t, <i>J</i> = 7.6 Hz, 2H), 4.98 (s, 2H), 3.14 (t, <i>J</i> = 7.6 Hz, 2H), 2.72 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.4, 136.7, 133.3, 130.7, 129.5, 128.1, 127.3, 127.1, 126.6, 126.2, 124.3, 119.8, 118.9, 114.9, 69.6, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>20</sub>H<sub>19</sub>BNO<sub>3</sub> calcd 332.1458, found 332.1462; mp: 230–233 °C; HPLC: purity 95.2%, retention time 13.3 min.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(1,1′-biphenyl-2-yl)propanamide (<b>96</b>)</h3><div class="NLM_p last">Compound <b>96</b> (12.3 mg, 11.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.37–7.26 (m, 9H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 7.10 (t, <i>J</i> = 7.6 Hz, 1H), 5.05 (s, 2H), 3.05 (t, <i>J</i> = 7.6 Hz, 2H), 2.55 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 174.5, 155.7, 146.4, 140.4, 138.5, 135.5, 132.3, 131.5, 130.1, 129.5, 129.0, 128.5, 128.3, 127.6, 127.5, 120.2, 72.2, 39.5, 31.5 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>21</sub>BNO<sub>3</sub> calcd 358.1614, found 358.1620; mp: 161–164 °C; HPLC: purity 98.4%, retention time 13.4 min.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(1,1′-biphenyl-3-yl)propanamide (<b>97</b>)</h3><div class="NLM_p last">Compound <b>97</b> (52.4 mg, 50.4%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.94 (s, 1H), 9.01 (s, 1H), 7.90 (s, 1H), 7.60 (d, <i>J</i> = 7.5 Hz, 2H), 7.55 (d, <i>J</i> = 7.5 Hz, 1H), 7.47 (t, <i>J</i> = 7.5 Hz, 2H), 7.37 (t, <i>J</i> = 7.5 Hz, 3H), 7.30 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 154.1, 145.4, 140.6, 140.1, 139.7, 130.7, 129.2, 128.9, 127.4, 126.6, 126.5, 121.3, 118.9, 118.0, 117.2, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>21</sub>BNO<sub>3</sub> calcd 358.1614, found 358.1619; mp: 146–149 °C; HPLC: purity 98.8%, retention time 14.7 min.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(1,1′-biphenyl-4-yl)propanamide (<b>98</b>)</h3><div class="NLM_p last">Compound <b>98</b> (51.6 mg, 49.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.93 (s, 1H), 9.00 (s, 1H), 7.68–7.59 (m, 6H), 7.43 (t, <i>J</i> = 7.6 Hz, 2H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.32 (t, <i>J</i> = 7.2 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5, 154.1, 145.4, 139.7, 138.6, 134.5, 130.7, 128.8, 126.8, 126.7, 126.6, 126.1, 119.3, 118.9, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>21</sub>BNO<sub>3</sub> calcd 358.1614, found 358.1612; mp: 272–274 °C; HPLC: purity 95.0%, retention time 14.5 min.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-fluoro-1,1′-biphenyl-3-yl)propanamide (<b>99</b>)</h3><div class="NLM_p last">Compound <b>99</b> (58.8 mg, 53.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.96 (s, 1H), 9.02 (s, 1H), 7.92 (s, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.54–7.49 (m, 1H), 7.46–7.34 (m, 5H), 7.22–7.17 (m, 3H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.70 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 162.6 (d, <i>J</i> = 242.0 Hz), 154.1, 145.4, 142.6 (d, <i>J</i> = 7.7 Hz), 139.8, 139.2, 130.9 (d, <i>J</i> = 8.6 Hz), 130.8, 129.4, 126.6, 122.6, 121.4, 119.0, 118.6, 117.3, 114.3 (d, <i>J</i> = 20.9 Hz), 113.2 (d, <i>J</i> = 21.9 Hz), 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>20</sub>BFNO<sub>3</sub> calcd 376.1520, found 376.1514; mp: 140–143 °C; HPLC: purity 97.9%, retention time 14.6 min.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-fluoro-1,1′-biphenyl-3-yl)propanamide (<b>100</b>)</h3><div class="NLM_p last">Compound <b>100</b> (48.3 mg, 44.2%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.93 (s, 1H), 9.01 (s, 1H), 7.88 (s, 1H), 7.63 (dd, <i>J</i> = 8.6, 5.5 Hz, 2H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.37 (t, <i>J</i> = 7.6 Hz, 2H), 7.30 (t, <i>J</i> = 8.6 Hz, 3H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 4.97 (s, 2H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 154.1, 145.4, 139.7, 139.6, 130.7, 129.2, 128.5 (d, <i>J</i> = 8.1 Hz), 126.6, 121.2, 118.9, 118.0, 117.2, 115.6 (d, <i>J</i> = 21.3 Hz), 69.6, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>20</sub>BFNO<sub>3</sub> calcd 376.1520, found 376.1522; mp: 158–160 °C; HPLC: purity 97.7%, retention time 14.9 min.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-chloro-1,1′-biphenyl-3-yl)propanamide (<b>101</b>)</h3><div class="NLM_p last">Compound <b>101</b> (44.8 mg, 39.3%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.96 (s, 1H), 9.02 (s, 1H), 7.91 (s, 1H), 7.62 (s, 1H), 7.60–7.57 (m, 2H), 7.50 (t, <i>J</i> = 7.8 Hz, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.41–7.33 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.4, 142.3, 139.8, 139.0, 133.6, 130.8, 129.4, 127.3, 126.6, 126.2, 125.2, 121.4, 119.0, 118.6, 117.3, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>20</sub>BClNO<sub>3</sub> calcd 392.1225, found 392.1234; mp: 122–125 °C; HPLC: purity 98.8%, retention time 15.2 min.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-chloro-1,1′-biphenyl-3-yl)propanamide (<b>102</b>)</h3><div class="NLM_p last">Compound <b>102</b> (52.6 mg, 46.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.95 (s, 1H), 9.01 (s, 1H), 7.91 (s, 1H), 7.62 (d, <i>J</i> = 8.5 Hz, 2H), 7.57–7.52 (m, 3H), 7.40–7.35 (m, 2H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.4, 139.8, 139.2, 138.9, 132.3, 130.8, 129.3, 128.9, 128.3, 126.6, 121.2, 119.0, 118.3, 117.1, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>20</sub>BClNO<sub>3</sub> calcd 392.1225, found 392.1220; mp: 184–187 °C; HPLC: purity 97.2%, retention time 15.9 min.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>103</b>)</h3><div class="NLM_p last">Compound <b>103</b> (33.0 mg, 35.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.93 (s, 1H), 9.01 (s, 1H), 7.86 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.40–7.34 (m, 3H), 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.22–7.15 (m, 3H), 7.11 (s, 1H), 6.94 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 4.97 (s, 2H), 3.82 (s, 3H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 159.6, 154.1, 145.4, 141.6, 140.5, 139.7, 130.7, 129.9, 129.1, 126.6, 121.4, 118.9, 118.8, 118.1, 117.3, 113.0, 112.0, 69.7, 55.0, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 388.1720, found 388.1718; mp: 133–136 °C; HPLC: purity 99.2%, retention time 14.6 min.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>104</b>)</h3><div class="NLM_p last">Compound <b>104</b> (59.6 mg, 52.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.89 (s, 1H), 9.01 (s, 1H), 7.84 (s, 1H), 7.53 (d, <i>J</i> = 8.7 Hz, 2H), 7.50 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (d, <i>J</i> = 7.8 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 7.5 Hz, 1H), 7.03 (d, <i>J</i> = 8.7 Hz, 2H), 4.97 (s, 2H), 3.80 (s, 3H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 158.8, 154.1, 145.4, 140.2, 139.7, 132.4, 130.7, 129.1, 127.6, 126.6, 120.8, 118.9, 117.3, 116.8, 114.3, 69.7, 55.1, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 388.1720, found 388.1718; mp: 170–172 °C; HPLC: purity 99.6%, retention time 14.5 min.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′,5′-dimethoxy-1,1′-biphenyl-3-yl)propanamide (<b>105</b>)</h3><div class="NLM_p last">Compound <b>105</b> (35.3 mg, 29.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.92 (s, 1H), 9.01 (s, 1H), 7.82 (s, 1H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.39–7.29 (m, 3H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 6.70 (d, <i>J</i> = 2.2 Hz, 2H), 6.51 (t, <i>J</i> = 2.2 Hz, 1H), 4.97 (s, 2H), 3.80 (s, 6H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 160.8, 154.2, 145.4, 142.4, 140.6, 139.6, 130.8, 129.2, 126.7, 121.5, 119.0, 118.4, 117.4, 104.7, 99.3, 69.7, 55.2, 38.3, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>25</sub>BNO<sub>5</sub> calcd 418.1826, found 418.1826; mp: 161–164 °C; HPLC: purity 98.2%, retention time 14.4 min.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-trifluoromethoxy-1,1′-biphenyl-3-yl)propanamide (<b>106</b>)</h3><div class="NLM_p last">Compound <b>106</b> (66.5 mg, 51.8%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.98 (s, 1H), 9.02 (s, 1H), 7.91 (s, 1H), 7.67–7.59 (m, 3H), 7.53 (s, 1H), 7.42–7.35 (m, 4H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 148.8, 145.3, 142.4, 139.8, 138.8, 130.8, 130.7, 129.4, 126.5, 125.6, 121.4, 119.8, 118.9, 118.7, 117.3, 69.6, 38.2, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BF<sub>3</sub>NO<sub>4</sub> calcd 442.1437, found 442.1432; mp: 129–132 °C; HPLC: purity 97.4%, retention time 16.5 min.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-trifluoromethoxy-1,1′-biphenyl-3-yl)propanamide (<b>107</b>)</h3><div class="NLM_p last">Compound <b>107</b> (46.5 mg, 36.2%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.97 (s, 1H), 9.02 (s, 1H), 7.93 (s, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 2H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 7.39 (t, <i>J</i> = 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 7.5 Hz, 1H), 7.32 (d, <i>J</i> = 7.8 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.7 Hz, 2H), 2.69 (t, <i>J</i> = 7.7 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.4, 139.8, 139.4, 139.1, 130.8, 129.3, 128.4, 126.6, 121.4, 119.0, 118.4, 117.3, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BF<sub>3</sub>NO<sub>4</sub> calcd 442.1437, found 442.1438; mp: 174–177 °C; HPLC: purity 96.6%, retention time 16.5 min.</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-methylthio-1,1′-biphenyl-3-yl)propanamide (<b>108</b>)</h3><div class="NLM_p last">Compound <b>108</b> (42.8 mg, 36.4%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ 9.22 (s, 1H), 8.12 (s, 1H), 7.94 (s, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 1H), 7.49 (s, 1H), 7.40–7.32 (m, 5H), 7.29–7.26 (m, 1H), 7.22 (d, <i>J</i> = 7.5 Hz, 2H), 4.99 (s, 2H), 3.25 (t, <i>J</i> = 7.6 Hz, 2H), 2.78 (t, <i>J</i> = 7.6 Hz, 2H), 2.55 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ 172.9, 156.9, 147.8, 143.6, 143.0, 141.9, 141.8, 141.4, 132.9, 131.2, 131.1, 129.0, 127.2, 126.6, 125.5, 123.7, 121.0, 120.4, 119.7, 72.1, 41.2, 32.2, 16.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>3</sub>S calcd 404.1492, found 404.1497; mp: 152–154 °C; HPLC: purity 95.7%, retention time 14.3 min.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-methylthio-1,1′-biphenyl-3-yl)propanamide (<b>109</b>)</h3><div class="NLM_p last">Compound <b>109</b> (60.1 mg, 51.1%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.93 (s, 1H), 9.01 (s, 1H), 7.88 (s, 1H), 7.56–7.53 (m, 3H), 7.39–7.34 (m, 4H), 7.29 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H), 2.51 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.6, 154.1, 145.4, 139.9, 139.8, 137.5, 136.5, 130.7, 129.2, 126.9, 126.6, 126.3, 120.9, 118.9, 117.9, 116.8, 69.7, 38.2, 29.4, 14.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>3</sub>S calcd 404.1492, found 404.1491; mp: 158–162 °C; HPLC: purity 95.5%, retention time 15.5 min.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-trifluoromethyl-1,1′-biphenyl-3-yl)propanamide (<b>110</b>)</h3><div class="NLM_p last">Compound <b>110</b> (52.5 mg, 42.4%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.99 (s, 1H), 9.01 (s, 1H), 7.94–7.92 (m, 2H), 7.87 (s, 1H), 7.76–7.70 (m, 2H), 7.64 (dt, <i>J</i> = 7.0, 2.0 Hz, 1H), 7.44–7.40 (m, 2H), 7.37 (t, <i>J</i> = 7.4 Hz, 1H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.70 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.3, 141.1, 139.9, 138.9, 130.7, 130.6, 130.0, 129.4, 126.5, 125.4, 124.0 (d, <i>J</i> = 3.8 Hz), 122.8 (d, <i>J</i> = 4.1 Hz), 121.5, 118.9, 118.7, 117.3, 69.6, 38.2, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BF<sub>3</sub>NO<sub>3</sub> calcd 426.1488, found 426.1485; mp: 149–152 °C; HPLC: purity 98.7%, retention time 16.2 min.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-trifluoromethyl-1,1′-biphenyl-3-yl)propanamide (<b>111</b>)</h3><div class="NLM_p last">Compound <b>111</b> (56.5 mg, 45.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.00 (s, 1H), 9.02 (s, 1H), 7.99 (s, 1H), 7.83 (s, 4H), 7.60 (d, <i>J</i> = 7.6 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.69 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.6, 154.9, 146.2, 144.9, 140.7, 139.8, 131.6, 130.3, 128.1, 127.4, 126.6 (d, <i>J</i> = 3.6 Hz), 122.4, 119.8, 118.3, 70.5, 39.1, 30.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BF<sub>3</sub>NO<sub>3</sub> calcd 426.1488, found 426.1483; mp: 197–200 °C; HPLC: purity 98.6%, retention time 16.1 min.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-cyano-1,1′-biphenyl-3-yl)propanamide (<b>112</b>)</h3><div class="NLM_p last">Compound <b>112</b> (29.2 mg, 26.2%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.99 (s, 1H), 9.02 (s, 1H), 8.05 (s, 1H), 7.95–7.93 (m, 2H), 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (t, <i>J</i> = 7.8 Hz, 1H), 7.60 (d, <i>J</i> = 7.0 Hz, 1H), 7.44–7.35 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.4, 141.3, 139.9, 138.5, 131.4, 131.1, 130.8, 130.2, 130.1, 129.5, 126.6, 121.5, 119.0, 118.9, 118.7, 117.4, 112.0, 69.7, 38.2, 29.4 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BN<sub>2</sub>O<sub>3</sub> calcd 383.1567, found 383.1563; mp: 113–116 °C; HPLC: purity 98.1%, retention time 13.6 min.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-cyano-1,1′-biphenyl-3-yl)propanamide (<b>113</b>)</h3><div class="NLM_p last">Compound <b>113</b> (51.0 mg, 60.7%) was prepared following a similar procedure to compound <b>68</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.01 (s, 1H), 9.02 (s, 1H), 8.00 (s, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 2H), 7.80 (d, <i>J</i> = 8.3 Hz, 2H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.43 (t, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.7 Hz, 2H), 2.69 (t, <i>J</i> = 7.7 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.7, 154.1, 145.3, 144.6, 139.9, 138.6, 132.7, 130.7, 129.4, 127.3, 126.5, 121.5, 119.2, 118.9, 118.6, 117.4, 110.0, 69.6, 38.1, 29.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>20</sub>BN<sub>2</sub>O<sub>3</sub> calcd 383.1567, found 383.1571; mp: 181–184 °C; HPLC: purity 97.9%, retention time 13.3 min.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>114</b>)</h3><div class="NLM_p last">Compound <b>114</b> (71.2 mg, 30.6%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.99 (s, 1H), 9.02 (s, 1H), 8.13 (s, 1H), 7.97 (d, <i>J</i> = 7.7 Hz, 1H), 7.93 (s, 1H), 7.87 (d, <i>J</i> = 7.7 Hz, 1H), 7.65–7.61 (m, 2H), 7.43–7.35 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 197.9, 170.7, 154.1, 145.4, 140.5, 139.9, 139.7, 137.4, 131.2, 130.8, 129.4, 127.4, 126.6, 125.9, 121.4, 119.0, 118.5, 117.3, 69.7, 38.2, 29.4, 26.8 ppm; HRMS (ESI): [M + Na]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 422.1540, found 422.1541; mp: 122–126 °C; HPLC: purity 95.4%, retention time 13.3 min.</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>115</b>)</h3><div class="NLM_p last">Compound <b>115</b> (37.0 mg, 31.8%) was prepared following a similar procedure to compound <b>68</b> as a gray solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.98 (s, 1H), 9.01 (s, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 2H), 7.98 (s, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (d, <i>J</i> = 7.0 Hz, 1H), 7.44–7.35 (m, 3H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 4.97 (s, 2H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H), 2.61 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 197.4, 170.7, 154.1, 145.3, 144.4, 139.9, 139.3, 135.6, 130.7, 129.4, 128.9, 126.7, 126.6, 121.5, 118.9, 118.8, 117.4, 69.7, 38.2, 29.4, 26.7 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 400.1720, found 400.1722; mp: 167–171 °C; HPLC: purity 98.1%, retention time 13.4 min.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>116</b>)</h3><div class="NLM_p last">Compound <b>116</b> was prepared following a similar procedure to compound <b>103</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.98 (s, 1H), 9.09 (s, 1H), 7.86 (s, 1H), 7.66–7.53 (m, 2H), 7.39–7.30 (m, 5H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 7.10 (s, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 1H), 4.93 (s, 2H), 3.81 (s, 3H), 2.96 (t, <i>J</i> = 7.2 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.0, 160.2, 152.2, 142.1, 141.0, 140.1,140.0, 131.4, 131.0, 130.6, 130.5, 129.7, 122.1, 121.7, 119.4, 118.8, 117.9, 113.5, 112.6, 70.2, 55.6, 38.8, 31.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 388.1720, found 388.1712; mp: 153–155 °C; HPLC: purity 97.1%, retention time 17.7 min.</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-<i>N</i>-(3′,5′-dimethoxy-1,1′-biphenyl-3-yl)propanamide (<b>117</b>)</h3><div class="NLM_p last">Compound <b>117</b> was prepared following a similar procedure to compound <b>105</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.97 (s, 1H), 9.09 (s, 1H), 7.81 (s, 1H), 7.60 (s, 2H), 7.43–7.22 (m, 4H), 6.69 (s, 2H), 6.51 (s, 1H), 4.93 (s, 2H), 3.79 (s, 6H), 2.96 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.7, 161.2, 142.7, 141.0, 139.9, 139.6, 131.6, 130.5, 129.9, 122.5, 121.8, 119.3, 118.1, 105.2, 99.6, 70.3, 55.7, 31.1 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>25</sub>BNO<sub>5</sub> calcd 418.1826, found 418.1823; mp: 58–60 °C; HPLC: purity 97.8%, retention time 17.8 min.</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>118</b>)</h3><div class="NLM_p last">Compound <b>118</b> was prepared following a similar procedure to compound <b>115</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.05 (s, 1H), 9.11 (s, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 2H), 7.97 (s, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (s, 2H), 7.45–7.34 (m, 3H), 7.31 (d, <i>J</i> = 7.6 Hz, 1H), 4.93 (s, 2H), 2.97 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.60 (s, 3H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 198.1, 171.2, 152.2, 144.9, 140.2, 140.0, 139.9, 136.2, 131.4, 130.6, 130.0, 129.4, 127.3, 122.3, 121.7, 119.5, 118.0, 70.2, 38.8, 31.2, 27.2 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 400.1720, found 400.1715; mp: 199–201 °C; HPLC: purity 97.0%, retention time 16.6 min.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>119</b>)</h3><div class="NLM_p last">Compound <b>119</b> was prepared following a similar procedure to compound <b>103</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.98 (s, 1H), 9.05 (s, 1H), 7.85 (s, 1H), 7.63 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.41–7.27 (m, 4H), 7.23 (d, <i>J</i> = 7.6 Hz, 1H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.10 (t, <i>J</i> =2.4 Hz, 1H), 6.94 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 4.94 (s, 2H), 3.81 (s, 3H), 2.97 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.2 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.0, 160.2, 154.9, 144.5, 142.2, 141.1, 140.2, 130.9, 130.5, 129.8, 127.7, 122.1, 121.6, 119.4, 118.7, 117.9, 113.6, 112.6, 70.3, 55.6, 38.4, 31.5 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 388.1720, found 388.1713; mp: 128–130 °C; HPLC: purity 98.9%, retention time 17.5 min.</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)-<i>N</i>-(3′,5′-dimethoxy-1,1′-biphenyl-3-yl)propanamide (<b>120</b>)</h3><div class="NLM_p last">Compound <b>120</b> was prepared following a similar procedure to compound <b>105</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.00 (s, 1H), 9.08 (s, 1H), 7.81 (s, 1H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (t, <i>J</i> = 7.6 Hz, 1H), 7.33–7.26 (m, 2H), 7.23 (d, <i>J</i> = 7.6 Hz, 1H), 6.69 (d, <i>J</i> = 2.0 Hz, 2H), 6.50 (t, <i>J</i> = 2.0 Hz, 1H), 4.94 (s, 2H), 3.78 (s, 6H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H), 2.66 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.0, 161.3, 154.9, 144.5, 142.8, 141.1, 140.0, 130.9, 129.7,127.7, 122.2, 121.6, 118.9, 117.9, 105.2, 99.8, 70.3, 55.7, 38.4, 31.5 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>25</sub>BNO<sub>5</sub> calcd 418.1826, found 418.1818; mp: 59–61 °C; HPLC: purity 96.0%, retention time 17.6 min.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>121</b>)</h3><div class="NLM_p last">Compound <b>121</b> was prepared following a similar procedure to compound <b>115</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ9.97 (s, 1H), 9.11 (s, 1H), 7.80 (s, 1H), 7.58 (t, <i>J</i> = 8.0 Hz, 2H), 7.38–7.28 (m, 4H), 6.69 (d, <i>J</i> = 2.4 Hz, 2H), 6.50 (t, <i>J</i> = 2.2 Hz, 1H), 5.07 (s, 2H), 3.79 (s, 6H), 2.87 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 198.0, 171.0, 154.9, 145.0, 144.5, 140.4, 139.9, 136.2, 130.9, 130.0, 129.5, 127.7, 127.3, 122.2, 121.6, 119.5, 118.0, 70.3, 38.4, 31.5, 27.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 400.1720, found 400.1722; mp: 174–176 °C; HPLC: purity 97.5%, retention time 16.5 min.</div></div><div id="sec4_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-4-yl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>122</b>)</h3><div class="NLM_p last">Compound <b>122</b> was prepared following a similar procedure to compound <b>103</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.98 (s, 1H), 9.11 (s, 1H), 7.84 (s, 1H), 7.57 (d, <i>J</i> = 7.2 Hz, 2H), 7.42–7.25 (m, 5H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 6.94 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.07 (s, 2H), 3.81 (s, 3H), 2.87 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.9, 160.2, 152.8, 142.1, 141.1, 140.1, 134.8, 130.6, 130.5, 129.8, 128.8, 127.8, 122.1, 119.4, 118.4, 117.9, 113.6, 112.6, 69.6, 55.6, 36.8, 27.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 388.1720, found 388.1714; mp: 60–62 °C; HPLC: purity 98.7%, retention time 17.7 min.</div></div><div id="sec4_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-4-yl)-<i>N</i>-(3′,5′-dimethoxy-1,1′-biphenyl-3-yl)propanamide (<b>123</b>)</h3><div class="NLM_p last">Compound <b>123</b> was prepared following a similar procedure to compound <b>105</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.97 (s, 1H), 9.11 (s, 1H), 7.80 (s, 1H), 7.58 (t, <i>J</i> = 8.0 Hz, 2H), 7.38–7.28 (m, 4H), 6.69 (d, <i>J</i> = 2.4 Hz, 2H), 6.50 (t, <i>J</i> = 2.0 Hz, 1H), 5.07 (s, 2H), 3.79 (s, 6H), 2.87 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.0, 161.3, 152.8, 142.8, 141.1, 140.0, 134.8, 130.6, 129.7, 128.8, 127.8, 122.2, 118.9, 117.9, 105.2, 99.8, 69.6, 55.7, 36.8, 27.6 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>25</sub>BNO<sub>5</sub> calcd 418.1826, found 418.1819; mp: 58–60 °C; HPLC: purity 96.4%, retention time 17.8 min.</div></div><div id="sec4_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-4-yl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>124</b>)</h3><div class="NLM_p last">Compound <b>124</b> was prepared following a similar procedure to compound <b>115</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.04 (s, 1H), 9.12 (s, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 2H), 7.95 (s, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 2H), 7.60–7.55 (m, 2H), 7.44–7.4 (m, 2H), 7.35–7.26 (m, 2H), 5.08 (s, 2H), 2.87 (t, <i>J</i> = 7.2 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H), 2.60 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 198.8, 171.6, 152.7, 144.9, 139.9, 139.8, 136.1, 134.6, 130.8, 130.1 129.5, 128.8, 127.9, 127.3, 122.6, 119.7, 118.2, 69.6, 36.7, 27.5, 27.1 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>BNO<sub>4</sub> calcd 400.1720, found 400.1714; mp: 175–177 °C; HPLC: purity 95.8%, retention time 16.7 min.</div></div><div id="sec4_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> (<i>E</i>)-3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)acrylic Acid (<b>126</b>)</h3><div class="NLM_p last">Compound <b>126</b> (338.5 mg, 74.0%) was prepared following a similar procedure to compound <b>65</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.38 (s, 1H), 9.30 (s, 1H), 8.05 (d, <i>J</i> = 16.2 Hz, 1H), 7.78 (d, <i>J</i> = 7.6 Hz, 1H), 7.51 (t, <i>J</i> = 7.6 Hz, 1H), 7.43 (d, <i>J</i> = 7.6 Hz, 1H), 6.68 (d, <i>J</i> = 16.2 Hz, 1H), 5.02 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.7, 154.5, 142.6, 137.4, 131.2, 124.7, 122.8, 120.1, 69.7 ppm.</div></div><div id="sec4_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> 3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-<i>N</i>-phenylacrylamide (<b>127</b>)</h3><div class="NLM_p last">Compound <b>127</b> (26.5 mg, 32.3%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 9.26 (s, 1H), 8.09 (d, <i>J</i> = 15.8 Hz, 1H), 7.71–7.67 (m, 3H), 7.56 (t, <i>J</i> = 7.4 Hz, 1H), 7.42 (d, <i>J</i> = 7.4 Hz, 1H), 7.34 (d, <i>J</i> = 7.8 Hz, 2H), 7.07 (t, <i>J</i> = 7.4 Hz, 1H), 6.92 (d, <i>J</i> = 15.8 Hz, 1H), 5.03 (s, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 154.7, 139.3, 139.1, 138.1, 131.4, 128.9, 123.6, 123.5, 123.1, 122.5, 119.4, 69.8 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>16</sub>H<sub>15</sub>BNO<sub>3</sub> calcd 280.1145, found 280.1150; mp: 200–203 °C; HPLC: purity 99.4%, retention time 11.2 min.</div></div><div id="sec4_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> <i>N</i>-3-Diphenylpropanamide (<b>129</b>)</h3><div class="NLM_p last">Compound <b>129</b> (77.0 mg, 51.3%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.89 (s, 1H), 7.56 (d, <i>J</i> = 7.76 Hz, 2H), 7.30–7.24 (m, 6H), 7.18 (t, <i>J</i> = 6.8 Hz, 1H), 7.02 (t, <i>J</i> = 7.4 Hz, 1H), 2.91 (t, <i>J</i> = 7.7 Hz, 2H), 2.62 (t, <i>J</i> = 7.7 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.8, 141.7, 139.7, 129.1, 128.8, 128.7, 126.4, 123.5, 119.5, 38.4, 31.3 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>15</sub>H<sub>16</sub>NO calcd 226.1232, found 226.1230; mp: 91–94 °C; HPLC: purity 99.3%, retention time 10.9 min.</div></div><div id="sec4_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> <i>N</i>-(3′-Methoxy-1,1′-biphenyl-3-yl)-3-phenylpropanamide (<b>130</b>)</h3><div class="NLM_p last">Compound <b>130</b> (123.7 mg, 56.0%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.02 (s, 1H), 7.87 (s, 1H), 7.58 (d, <i>J</i> = 7.9 Hz, 1H), 7.40–7.35 (m, 2H), 7.33–7.25 (m, 5H), 7.20–7.15 (m, 2H), 7.11 (d, <i>J</i> = 2.0 Hz, 1H), 6.95 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 3.82 (s, 3H), 2.93 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5, 159.6, 141.6, 141.1, 140.5, 139.7, 130.0, 129.2, 128.3, 128.2, 125.9, 121.5, 118.9, 118.2, 117.3, 113.0, 112.1, 55.0, 37.9, 30.7 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>22</sub>H<sub>22</sub>NO<sub>2</sub> calcd 332.1651, found 332.1650; mp: 78–80 °C; HPLC: purity 99.4%, retention time 16.0 min.</div></div><div id="sec4_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> <i>N</i>-(3′,5′-Dimethoxy-1,1′-biphenyl-3-yl)-3-phenylpropanamide (<b>131</b>)</h3><div class="NLM_p last">Compound <b>131</b> (92 mg, 52.0%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.02 (s, 1H), 7.83 (s, 1H), 7.61 (d, <i>J</i> = 7.6 Hz, 1H), 7.38–7.25 (m, 6H), 7.18 (t, <i>J</i> = 6.4 Hz, 1H), 6.71 (s, 2H), 6.52 (s, 1H), 3.80 (s, 6H), 2.93 (t, <i>J</i> = 7.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.6 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.4, 160.8, 142.3, 141.1, 140.6, 139.6, 129.1, 128.2, 128.1, 125.9, 121.5, 118.3, 117.3, 104.7, 99.3, 55.2, 37.9, 30.7 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>24</sub>NO<sub>3</sub> calcd 362.1756, found 362.1743; mp: 94–96 °C; HPLC: purity 96.4%, retention time 18.0 min.</div></div><div id="sec4_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> <i>N</i>-(4′-Acetyl-1,1′-biphenyl-3-yl)-3-phenylpropanamide (<b>132</b>)</h3><div class="NLM_p last">Compound <b>132</b> (128.6 mg, 56.2%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.05 (d, <i>J</i> = 8.1 Hz, 2H), 7.99 (s, 1H), 7.75 (d, <i>J</i> = 8.1 Hz, 2H), 7.61 (d, <i>J</i> = 6.8 Hz, 1H), 7.45–7.39 (m, 2H), 7.31–7.25 (m, 4H), 7.18 (t, <i>J</i> = 6.8 Hz, 1H), 2.93 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.61 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 197.4, 170.6, 144.4, 141.1, 139.9, 139.4, 135.7, 129.5, 128.9, 128.3, 128.2, 126.7, 125.9, 121.7, 118.9, 117.4, 37.9, 30.7, 26.7 ppm; HRMS (ESI): [M + H]<sup>+</sup> C<sub>23</sub>H<sub>22</sub>NO<sub>2</sub> calcd 344.1651, found 344.1648; mp: 131–132 °C; HPLC: purity 99.6%, retention time 14.7 min.</div></div><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> (2-Bromo-3-((methoxymethoxy)methyl)phenyl)methanol (<b>133</b>)</h3><div class="NLM_p last">To a solution of compound <b>59</b> (15.0 g, 69 mmol) and DIPEA (10.5 g, 81 mmol) in dry THF (150 mL) was added MOMCl (6.2 g, 77 mmol) dropwise. After stirred at room temperature for 12 h, the reaction mixture was evaporated in vacuo. The residue was partitioned between DCM (100 mL) and H<sub>2</sub>O (100 mL). The separated aqueous phase was then extracted with DCM (100 mL × 3). Organic phase was combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was purified by silica gel column chromatography (DCM) to give compound <b>133</b> (5.6 g, 31.0%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.49–7.48 (m, 1H), 7.43–7.39 (m, 2H), 5.47 (t, <i>J</i> = 5.6 Hz, 1H), 4.71 (s, 2H), 4.59 (s, 2H), 4.53 (d, <i>J</i> = 5.6 Hz, 2H), 3.32 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 141.4, 137.0, 127.6, 127.2, 127.0, 121.5, 95.6, 68.3, 62.8, 54.9 ppm.</div></div><div id="sec4_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> 2-Bromo-3-((methoxymethoxy)methyl)benzaldehyde (<b>134</b>)</h3><div class="NLM_p last">To a solution of compound <b>133</b> (5.5 g, 21 mmol) in DCM (100 mL) was added pyridinium chlorochromate (9.1 g, 42 mmol) and Celite (9.1 g). After stirred at room temperature for 12 h, the reaction mixture was evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 100/1) to give compound <b>134</b> (4.5 g, 82.5%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.44 (s, 1H), 7.83 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.54 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 4.79 (s, 2H), 4.73 (s, 2H), 3.43 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 192.0, 139.0, 134.4, 133.7, 128.9, 127.6, 127.2, 96.2, 68.3, 55.6 ppm.</div></div><div id="sec4_100" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Ethyl (<i>E</i>)-3-(2-Bromo-3-((methoxymethoxy)methyl)phenyl)acrylate (<b>135</b>)</h3><div class="NLM_p last">Compound <b>135</b> (4.7 g, 82.2%) was prepared following a similar procedure to compound <b>63</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.12 (d, <i>J</i> = 16.0 Hz, 1H), 7.52 (d, <i>J</i> = 7.6 Hz, 2H), 7.33 (t, <i>J</i> = 7.6 Hz, 1H), 6.35 (d, <i>J</i> = 16.0 Hz, 1H), 4.78 (s, 2H), 4.69 (s, 2H), 4.27 (q, <i>J</i> = 7.2 Hz, 2H), 3.43 (s, 3H), 1.34 (t, <i>J</i> = 7.2 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 166.3, 143.3, 138.7, 135.1, 130.1, 127.4, 126.8, 125.3, 121.4, 96.2, 69.1, 60.7, 55.6, 14.3 ppm.</div></div><div id="sec4_101" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> Ethyl 3-(2-Bromo-3-((methoxymethoxy)methyl)phenyl)propanoate (<b>136</b>)</h3><div class="NLM_p last">To a solution of compound <b>135</b> (1.5 g, 4.6 mmol) in a mixture of MeOH (15 mL) and THF (15 mL) was added NaBH<sub>4</sub> (870 mg, 23 mmol) and NiCl<sub>2</sub>·6H<sub>2</sub>O (1.1 g, 4.6 mmol) at 0 °C. After stirred at 0 °C for 1 h, the reaction was quenched with H<sub>2</sub>O (100 mL) and then extracted with EtOAc (100 mL ×3). Organic phase was combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 20:1) to give compound <b>136</b> (0.5 g, 33%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.35 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 7.24 (t, <i>J</i> = 7.6 Hz, 1H), 7.20 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 4.77 (s, 2H), 4.67 (s, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 3.43 (s, 3H), 3.10 (t, <i>J</i> = 8.0 Hz, 2H), 2.64 (t, <i>J</i> = 8.0 Hz, 2H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz,CDCl<sub>3</sub>): δ 172.6, 140.3, 138.0, 129.5, 127.3, 127.2, 124.8, 96.1, 69.4, 60.5, 55.5, 34.1, 31.7, 14.2 ppm.</div></div><div id="sec4_102" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> Ethyl 3-(3-((Methoxymethoxy)methyl)-2-vinylphenyl)propanoate (<b>137</b>)</h3><div class="NLM_p last">To a solution of compound <b>136</b> (950 mg, 2.9 mmol) in DMF (20 mL) was added tributyl(vinyl)tin (1.1 g, 3.5 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (170 mg, 0.15 mmol) under N<sub>2</sub> atomosphere. After heated to 120 °C for 12 h, the reaction mixture was cooled to room temperature and diluted with H<sub>2</sub>O (100 mL). Then, the mixture was extracted with EtOAc (100 mL × 3). Organic phase was combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 20:1) to give compound <b>137</b> (0.7 g, 87.7%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33 (d, <i>J</i> = 7.6 Hz, 1H), 7.22 (t, <i>J</i> = 7.6 Hz, 1H), 7.16 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 6.80 (dd, <i>J</i> = 18.0, 11.6 Hz, 1H), 5.58 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 5.34 (dd, <i>J</i> = 18.0, 2.0 Hz, 1H), 4.71 (s, 2H), 4.59 (s, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 3.41 (s, 3H), 2.98 (t, <i>J</i> = 8.0 Hz, 2H), 2.54 (t, <i>J</i> = 8.0 Hz, 2H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 173.0, 138.5, 137.8, 135.5, 133.4, 128.4, 127.2, 127.1, 120.7, 95.9, 67.6, 60.4, 55.4, 35.1, 28.7, 14.2 ppm.</div></div><div id="sec4_103" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> 3-(3-((Methoxymethoxy)methyl)-2-vinylphenyl)propanoic Acid (<b>138</b>)</h3><div class="NLM_p last">Compound <b>138</b> (0.3 g, 71.0%) was prepared following a similar procedure to compound <b>65</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.15 (s, 1H), 7.29 (dd, <i>J</i> = 7.2, 2.0 Hz, 1H), 7.23–7.17 (m, 2H), 6.82 (dd, <i>J</i> = 18.0, 11.6 Hz, 1H), 5.57 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 5.31 (dd, <i>J</i> = 18.0, 2.0 Hz, 1H), 4.64 (s, 2H), 4.50 (s, 2H), 3.29 (s, 3H), 2.84 (t, <i>J</i> = 8.0 Hz, 2H), 2.45 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 138.0, 137.7, 135.5, 133.4, 128.4, 127.4, 127.3, 121.0, 95.9, 67.7, 55.4, 34.8, 28.4 ppm.</div></div><div id="sec4_104" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> 3-(3-((Methoxymethoxy)methyl)-2-vinylphenyl)-<i>N</i>-phenylpropanamide (<b>139</b>)</h3><div class="NLM_p last">Compound <b>139</b> (135 mg, 86.5%) was prepared following a similar procedure to compound <b>68</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (dd, <i>J</i> = 7.2, 2.0 Hz, 1H), 7.30 (t, <i>J</i> = 7.6 Hz, 2H), 7.24–7.19 (m, 2H), 7.11–7.07 (m, 2H), 6.82 (dd, <i>J</i> = 18.0, 11.6 Hz, 1H), 5.59 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 5.36 (dd, <i>J</i> = 18.0, 2.0 Hz, 1H), 4.71 (s, 2H), 4.59 (s, 2H), 3.41 (s, 3H), 3.09 (t, <i>J</i> = 8.0 Hz, 2H), 2.58 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 170.3, 138.5, 137.8, 137.7, 135.6, 133.5, 128.9, 128.6, 127.4, 127.3, 124.2, 120.9, 119.8, 95.9, 67.7, 55.4, 38.5, 29.2 ppm.</div></div><div id="sec4_105" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> <i>N</i>-(3′-Methoxy-1,1′-biphenyl-3-yl)-3-(3-((methoxymethoxy)methyl)-2-vinylphenyl)propanamide (<b>140</b>)</h3><div class="NLM_p last">Compound <b>140</b> (150 mg, 79.0%) was prepared following a similar procedure to compound <b>68</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.67 (s, 1H), 7.46 (d, <i>J</i> = 7.6 Hz, 1H), 7.37–7.31 (m, 5H), 7.27 (s, 1H), 7.21 (d, <i>J</i> = 6.8 Hz, 1H), 7.15 (d, <i>J</i> = 7.6 Hz, 1H), 7.10 (s, 1H), 6.89 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.82 (dd, <i>J</i> = 18.0, 11.6 Hz, 1H), 5.59 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 5.35 (dd, <i>J</i> = 18.0, 2.0 Hz, 1H), 4.70 (s, 2H), 4.59 (s, 2H), 3.85 (s, 3H), 3.41 (s, 3H), 3.11 (t, <i>J</i> = 8.0 Hz, 2H), 2.60 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 170.5, 159.8, 142.1, 141.9, 138.5, 138.1, 137.7, 135.6, 133.5, 129.7, 129.3, 128.6, 127.4, 127.3, 123.1, 120.9, 119.6, 118.8, 118.6, 112.9, 112.8, 95.9, 67.7, 55.4, 55.3, 38.5, 29.2 ppm.</div></div><div id="sec4_106" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> <i>N</i>-(4′-Acetyl-1,1′-biphenyl-3-yl)-3-(3-((methoxymethoxy)methyl)-2-vinylphenyl)propanamide (<b>141</b>)</h3><div class="NLM_p last">Compound <b>141</b> (160 mg, 70.0%) was prepared following a similar procedure to compound <b>68</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.02 (s, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (s, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.52 (d, <i>J</i> = 7.6 Hz, 1H), 7.37–7.33 (m, 3H), 7.20–7.15 (m, 2H), 6.80 (dd, <i>J</i> = 18.0, 11.6 Hz, 1H), 5.55 (d, <i>J</i> = 11.6 Hz, 1H), 5.32 (d, <i>J</i> = 18.0 Hz, 1H), 4.69 (s, 2H), 4.57 (s, 2H), 3.39 (s, 3H), 3.10 (t, <i>J</i> = 8.0 Hz, 2H), 2.63 (t, <i>J</i> = 8.0 Hz, 2H), 2.59 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 198.0, 170.9, 145.2, 140.4, 138.6, 138.4, 137.6, 135.7, 135.5, 133.3, 129.4, 128.8, 128.4, 127.2, 127.1, 127.0, 122.8, 120.7, 119.6, 118.6, 95.8, 67.6, 55.3, 38.2, 29.1, 26.6 ppm.</div></div><div id="sec4_107" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> 3-(2-Formyl-3-((methoxymethoxy)methyl)phenyl)-<i>N</i>-phenylpropanamide (<b>142</b>)</h3><div class="NLM_p last">To a solution of compound <b>139</b> (130 mg, 0.4 mmol) in a mixture of THF (4 mL) and H<sub>2</sub>O (1.8 mL) were added NaIO<sub>4</sub> (200 mg, 0.94 mmol) and K<sub>2</sub>OsO<sub>4</sub> (5 mg, 0.015 mmol). After stirred at room temperature for 12 h, the reaction mixture was evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 3:1) to give compound <b>142</b> (90 mg, 69.0%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.56 (s, 1H), 8.17 (s, 1H), 7.52 (d, <i>J</i> = 7.6 Hz, 2H), 7.45 (t, <i>J</i> = 7.6 Hz, 1H), 7.39 (d, <i>J</i> = 6.8 Hz, 1H), 7.30–7.26 (m, 3H), 7.07 (t, <i>J</i> = 7.6 Hz, 1H), 4.90 (s, 2H), 4.70 (s, 2H), 3.39 (s, 3H), 3.30 (t, <i>J</i> = 8.0 Hz, 2H), 2.62 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 193.5, 170.5, 143.5, 141.4, 138.0, 133.4, 131.6, 131.3, 128.8, 128.1, 124.0, 119.8, 95.9, 67.0, 55.6, 39.8, 30.2 ppm.</div></div><div id="sec4_108" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> 3-(2-Formyl-3-((methoxymethoxy)methyl)phenyl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>143</b>)</h3><div class="NLM_p last">Compound <b>143</b> (70 mg, 58.3%) was prepared following a similar procedure to compound <b>142</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.56 (s, 1H), 8.37 (s, 1H), 7.75 (s, 1H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.44–7.37 (m, 2H), 7.31–7.25 (m, 4H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.07 (t, <i>J</i> = 2.0 Hz, 1H), 6.87 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 4.88 (s, 2H), 4.69 (s, 2H), 3.82 (s, 3H), 3.37 (s, 3H), 3.31 (t, <i>J</i> = 8.0 Hz, 2H), 2.64 (t, <i>J</i> = 8.0 Hz, 2H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 193.5, 170.7, 159.7, 143.5, 142.1, 141.7, 141.3, 138.4, 133.4, 131.5, 131.3, 129.6, 129.1, 128.1, 122.8, 119.5, 118.8, 118.5, 112.7, 112.6, 95.9, 67.0, 55.6, 55.1, 39.7, 30.2 ppm.</div></div><div id="sec4_109" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> 3-(2-Formyl-3-((methoxymethoxy)methyl)phenyl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>144</b>)</h3><div class="NLM_p last">Compound <b>144</b> (95 mg, 67.6%) was prepared following a similar procedure to compound <b>142</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.59 (s, 1H), 8.16 (s, 1H), 8.01 (d, <i>J</i> = 8.4 Hz, 2H), 7.90 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.48 (t, <i>J</i> = 7.6 Hz, 1H), 7.43–7.39 (m, 2H), 7.36–7.32 (m, 2H), 4.92 (s, 2H), 4.71 (s, 2H), 3.40 (s, 3H), 3.33 (t, <i>J</i> = 8.0 Hz, 2H), 2.67 (t, <i>J</i> = 8.0 Hz, 2H), 2.63 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 193.7, 170.7, 145.3, 143.4, 141.7, 140.6, 138.7, 135.9, 133.6, 131.7, 131.6, 129.5, 128.8, 128.5, 127.3, 122.9, 119.4, 118.5, 96.0, 67.1, 55.7, 40.2, 30.7, 26.7 ppm.</div></div><div id="sec4_110" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> 3-(3-Hydroxy-1,3-dihydroisobenzofuran-4-yl)-<i>N</i>-phenylpropanamide (<b>145</b>)</h3><div class="NLM_p last">To a solution of compound <b>142</b> (90 mg, 0.28 mmol) in THF (2 mL) was added 4 M aqueous HCl (1 mL). After stirred at room temperature for 1 h, the reaction mixture was diluted in H<sub>2</sub>O (20 mL) and extracted with EtOAc (20 mL × 3). Organic phase was combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/EtOAc = 1:1) to give compound <b>145</b> (45 mg, 97.8%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.87 (s, 1H), 7.56 (d, <i>J</i> = 7.6 Hz, 1H), 7.31–7.27 (m, 3H), 7.15 (d, <i>J</i> = 7.6 Hz, 2H), 7.02 (t, <i>J</i> = 7.6 Hz, 1H), 6.76 (d, <i>J</i> = 1.2 Hz, 1H), 5.20 (d, <i>J</i> = 12.8 Hz, 1H), 5.01 (d, <i>J</i> = 12.8 Hz, 1H), 3.01–2.88 (m, 2H), 2.64–2.59 (m, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.2, 139.9, 139.1, 136.5, 135.9, 129.3, 128.6, 127.1, 122.9, 119.0, 118.8, 102.0, 71.6, 36.7, 26.8 ppm; HRMS (ESI): [M + Na]<sup>+</sup> C<sub>17</sub>H<sub>17</sub>NO<sub>3</sub>Na calcd 306.1106, found 306.1096; mp: 154–156 °C; HPLC: purity 97.8%, retention time 15.5 min.</div></div><div id="sec4_111" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> 3-(3-Hydroxy-1,3-dihydroisobenzofuran-4-yl)-<i>N</i>-(3′-methoxy-1,1′-biphenyl-3-yl)propanamide (<b>146</b>)</h3><div class="NLM_p last">Compound <b>146</b> (30 mg, 96.1%) was prepared following a similar procedure to compound <b>145</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.00 (s, 1H), 7.87 (t, <i>J</i> = 2.0 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.40–7.35 (m, 2H), 7.33–7.28 (m, 2H), 7.19–7.14 (m, 3H), 7.11 (t, <i>J</i> = 2.0 Hz, 1H), 6.93 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.70 (d, <i>J</i> = 7.2 Hz, 1H), 6.47 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 5.08 (d, <i>J</i> = 13.2 Hz, 1H), 4.86 (d, <i>J</i> = 13.2 Hz, 1H), 3.82 (s, 3H), 3.09–2.91 (m, 2H), 2.76–2.64 (m, 2H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5, 159.6, 141.6, 140.5, 139.6, 139.5, 138.3, 136.5, 129.9, 129.2, 128.8, 127.1, 121.5, 118.8, 118.7, 118.2, 117.3, 113.0, 112.0, 99.8, 70.6, 55.0, 36.9, 26.9 ppm; HRMS (ESI): [M + Na]<sup>+</sup> C<sub>24</sub>H<sub>23</sub>NO<sub>4</sub>Na calcd 412.1525, found 412.1512; mp: 134–136 °C; HPLC: purity 96.2%, retention time 17.5 min.</div></div><div id="sec4_112" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> 3-(3-Hydroxy-1,3-dihydroisobenzofuran-4-yl)-<i>N</i>-(4′-acetyl-1,1′-biphenyl-3-yl)propanamide (<b>147</b>)</h3><div class="NLM_p last">Compound <b>147</b> (50 mg, 65.3%) was prepared following a similar procedure to compound <b>145</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.17 (s, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 2H), 8.01 (s, 1H), 7.75 (d, <i>J</i> = 8.4 Hz, 2H), 7.63 (d, <i>J</i> = 6.8 Hz, 1H), 7.44–7.39 (m, 2H), 7.29 (t, <i>J</i> = 7.6 Hz, 1H), 7.19–7.14 (m, 2H), 6.72 (d, <i>J</i> = 7.2 Hz, 1H), 6.48 (dd, <i>J</i> = 7.2, 2.0 Hz, 1H), 5.08 (d, <i>J</i> = 12.8 Hz, 1H), 4.86 (d, <i>J</i> = 12.8 Hz, 1H), 3.09–2.91 (m, 2H), 2.77–2.66 (m, 2H), 2.62 (s, 3H) ppm; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 197.4, 170.6, 144.4, 139.9, 139.6, 139.3, 138.3, 136.5, 135.6, 129.4, 128.9, 128.8, 127.2, 126.7, 121.6, 118.9, 118.7, 117.4, 99.8, 70.6, 37.0, 26.9, 26.7 ppm; HRMS (ESI): [M + Na]<sup>+</sup> C<sub>25</sub>H<sub>23</sub>NO<sub>4</sub>Na calcd 424.1525, found 424.1512; mp: 136–138 °C; HPLC: purity 96.5%, retention time 16.6 min.</div></div><div id="sec4_113" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> Biology: Cell Culture</h3><div class="NLM_p last">All of the human cancer cell lines (MDA-MB231, SKOV3, HCT116, and H460) and human normal cell lines (WI-38) were obtained from the American Type Culture Collection. All of the three cancer cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) complete growth medium (high-glucose DMEM medium, supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 mg/mL streptomycin). WI-38 was cultured in minimum essential medium (MEM) complete growth medium (MEM, supplemented with 10% fetal bovine serum, and 1% nonessential amino acid). The cells were cultured in an incubator with 5% CO<sub>2</sub> at 37 °C under a humidified atmosphere.</div></div><div id="sec4_114" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> In Vitro Cell Viability Assessment</h3><div class="NLM_p last">3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were performed to evaluate the cell viability. Cells were seeded into 96-well plates for 24 h, treated with compounds at various concentrations for 72 h. Subsequently, 20 μL of MTT (5 mg/mL) was added to each well. After incubation for 4 h, MTT solution was removed and DMSO (150 μL) was added to each well. Optical density was determined at 550 nm on a plate reader (Thermo Varioskan Flash). Each compound was tested in triplicate wells for each concentration. Data were analyzed by GraphPad Prism 5.</div></div><div id="sec4_115" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> Annexin V–FITC/PI Apoptosis Assay</h3><div class="NLM_p last">SKOV3 cells were seeded into six-well plates, cultured overnight, and treated with compound <b>103</b> at indicated concentrations. After 48 h of treatment, the cells were harvested, washed with phosphate-buffered saline (PBS), and co-stained with annexin V–FITC and PI according to the kit manual. Cell apoptosis was detected with an FACS Calibur cytometer. Samples were analyzed by flow cytometry, and 10 000 events were counted each time.</div></div><div id="sec4_116" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> Western Blot Analysis</h3><div class="NLM_p last">H460 cells were seeded into six-well plates, cultured overnight, and treated with compound <b>103</b> at indicated concentrations. After 48 h of incubation, the cells were harvested and lysed by radioimmunoprecipitation assay lysis buffer. Protein concentrations were quantified by the method of bicinchoninic acid with bovine serum albumin as the standard. Equal amounts of total cellular protein extract were separated by electrophoresis on sodium dodecyl sulfate–polyacrylamide gels and transferred to nitrocellulose membranes. After blocking with 5% nonfat milk, the membrane was incubated with the desired primary antibody overnight at the following dilutions: anticleaved caspase-9 (1:200), anticleaved caspase-3 (1:200), anticleaved PARP (1:200), and anti-β-actin (1:2000). Subsequently, the membrane was incubated with appropriate fluorescent secondary antibody and scanned by Odyssey CLx infrared laser imaging system.</div></div><div id="sec4_117" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> Colony Formation Assay</h3><div class="NLM_p last">SKOV3 cells were seeded in six-well tissue culture plates with a density of 100 cells per well and maintained in regular culture media. After 24 h, the cells were treated with compounds <b>103</b> at indicated concentrations. The culture media with the compounds were changed every 72 h. At the end of 2 weeks, the wells were washed twice with PBS and 2 mL of 0.05% crystal violet staining buffer was added to each well and incubated for 30 min. The wells were then washed with PBS for 5 min three times and allowed to dry. Photographs were then taken, visible colonies were counted, and surviving fractions were calculated. Experiments were performed in triplicate, and the surviving fractions were analyzed with one-way ANOVA using GraphPad Prism 5 software package. The error bars represent standard deviation.</div></div><div id="sec4_118" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> In Vivo Tumor Growth Assessment</h3><div class="NLM_p last">Female BALB/c nude mice of age 5 weeks were purchased from Shanghai Lingchang and maintained in pathogen-free conditions. SKOV3 cells were harvested during log phase growth and resuspended in DMEM at 5 × 10<sup>7</sup> cells/mL. Each mouse was inoculated subcutaneously with 5 × 10<sup>6</sup> cells. When the volume of tumors reached approximately 50 mm<sup>3</sup>, the mice were divided into three groups (<i>n</i> = 6) randomly and treated intraperitoneally with compounds <b>103</b> and <b>115</b> at doses of 2 and 10 mg/kg or vehicle control (5% ethanol, 20% poly(ethylene glycol)400, and 75% ddH<sub>2</sub>O) once a day for 33 days. Tumor diameter and body weight were monitored once every 3 days by digital caliper and electronic balance, respectively. Tumor volume was calculated using the formula (<i>a</i> × <i>b</i><sup>2</sup>)/2, where <i>a</i> is the larger diameter and <i>b</i> is the smaller diameter of tumor. Eventually, the mice were sacrificed and tumors were dissected. The experiment was approved by the Animal Ethics Committee of Shanghai Jiao Tong University.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i142"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00736" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00736" class="ext-link">10.1021/acs.jmedchem.9b00736</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC traces of synthesized compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_001.pdf">jm9b00736_si_001.pdf (4.45 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_002.csv">jm9b00736_si_002.csv (14.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00736" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huchen Zhou</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5474-2320" title="Orcid link">http://orcid.org/0000-0002-5474-2320</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#731b10091b1c0633001907065d1617065d101d"><span class="__cf_email__" data-cfemail="fc949f86949389bc8f968889d2999889d29f92">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiong Zhang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinyi Zhang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiyun Hao</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weixiang Xin</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Yang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingyan Zhu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Microbial
Metabolism, School of Pharmacy, Shanghai
Jiao Tong University, 200240 Shanghai, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0328-5470" title="Orcid link">http://orcid.org/0000-0003-0328-5470</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.Z. and J.Z. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e8360-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i144">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge National Key Research and Development Program of China (2017YFA0505200), National Science Foundation of China (81222042 and 81573264), and E-Institutes of Shanghai Universities (EISU) Chemical Biology Division for the financial support of this work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per oral</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i146">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamczyk-Woźniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borys, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporzyński, A.</span></span> <span> </span><span class="NLM_article-title">Recent developments in the chemistry and biological applications of benzoxaboroles</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">5224</span>– <span class="NLM_lpage">5247</span>, <span class="refDoi"> DOI: 10.1021/cr500642d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500642d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=5224-5247&author=A.+Adamczyk-Wo%C5%BAniakauthor=K.+M.+Borysauthor=A.+Sporzy%C5%84ski&title=Recent+developments+in+the+chemistry+and+biological+applications+of+benzoxaboroles&doi=10.1021%2Fcr500642d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Developments in the Chemistry and Biological Applications of Benzoxaboroles</span></div><div class="casAuthors">Adamczyk-Wozniak, Agnieszka; Borys, Krzysztof M.; Sporzynski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5224-5247</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the prepn., reactivity, structures, physicochem. properties, and medicinal applications of benzoxaboroles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJxyFCt1j-c7Vg90H21EOLACvtfcHk0lhd6Y0yA1FXjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFWrtbc%253D&md5=790df9ee9b890643e8f0e6dec3c00b00</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr500642d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500642d%26sid%3Dliteratum%253Aachs%26aulast%3DAdamczyk-Wo%25C5%25BAniak%26aufirst%3DA.%26aulast%3DBorys%26aufirst%3DK.%2BM.%26aulast%3DSporzy%25C5%2584ski%26aufirst%3DA.%26atitle%3DRecent%2520developments%2520in%2520the%2520chemistry%2520and%2520biological%2520applications%2520of%2520benzoxaboroles%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D5224%26epage%3D5247%26doi%3D10.1021%2Fcr500642d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomsho, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span> <span> </span><span class="NLM_article-title">The unique chemistry of benzoxaboroles: current and emerging applications in biotechnology and therapeutic treatments</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4473</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmc.2014.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24864040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslyjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4462-4473&author=C.+Liuauthor=J.+W.+Tomshoauthor=S.+J.+Benkovic&title=The+unique+chemistry+of+benzoxaboroles%3A+current+and+emerging+applications+in+biotechnology+and+therapeutic+treatments&doi=10.1016%2Fj.bmc.2014.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The unique chemistry of benzoxaboroles: Current and emerging applications in biotechnology and therapeutic treatments</span></div><div class="casAuthors">Liu, C. Tony; Tomsho, John W.; Benkovic, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4462-4473</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Benzoxaboroles have garnered much attention in recent years due to their diverse applications in bio-sensing technol., material science, and therapeutic intervention.  Part of the reason arises from the benzoxaboroles' unique chem. properties, esp. in comparison to their acyclic boronic acid counterparts.  Furthermore, the low bio-toxicity combined with the high target specificity assocd. with benzoxaboroles make them very attractive as therapeutic agents.  Herein, we provide an updated summary on the current knowledge of the fundamental chem. reactivity of benzoxaboroles, followed by highlighting their major applications reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpniR1y-qZ9BrVg90H21EOLACvtfcHk0lhd6Y0yA1FXjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslyjtb8%253D&md5=ce3d7e137a60a8dcc9309f34b74459b5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DTomsho%26aufirst%3DJ.%2BW.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520unique%2520chemistry%2520of%2520benzoxaboroles%253A%2520current%2520and%2520emerging%2520applications%2520in%2520biotechnology%2520and%2520therapeutic%2520treatments%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4462%26epage%3D4473%26doi%3D10.1016%2Fj.bmc.2014.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">The synthesis of benzoxaboroles and their applications in medicinal chemistry</span>. <i>Sci. China Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1381</span>, <span class="refDoi"> DOI: 10.1007/s11426-013-4981-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1007%2Fs11426-013-4981-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOisrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1372-1381&author=J.+Zhangauthor=M.+Zhuauthor=Y.+Linauthor=H.+Zhou&title=The+synthesis+of+benzoxaboroles+and+their+applications+in+medicinal+chemistry&doi=10.1007%2Fs11426-013-4981-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of benzoxaboroles and their applications in medicinal chemistry</span></div><div class="casAuthors">Zhang, Jiong; Zhu, Ming Yan; Lin, Yi Nan; Zhou, Hu Chen</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1372-1381</span>CODEN:
                <span class="NLM_cas:coden">SCCCCS</span>;
        ISSN:<span class="NLM_cas:issn">1869-1870</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">A review.  Benzoxaboroles, as a versatile scaffold, play important roles in org. synthesis, mol. recognition and supramol. chem.  It is also a privileged structure in medicinal chem. due to its desirable physicochem. and drug-like properties.  Recently, benzoxaboroles were widely applied as antifungal, antibacterial, antiviral, antiparasite, and antiinflammatory agents.  This review covers the properties, synthetic methods and applications of benzoxaboroles in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKpFLz0p2J7Vg90H21EOLACvtfcHk0lhKurnSKPrtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOisrjL&md5=818a5b5bc6169ad282a3ba0a534c5f69</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11426-013-4981-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-013-4981-y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DThe%2520synthesis%2520of%2520benzoxaboroles%2520and%2520their%2520applications%2520in%2520medicinal%2520chemistry%26jtitle%3DSci.%2520China%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1372%26epage%3D1381%26doi%3D10.1007%2Fs11426-013-4981-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bross, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brower, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobburu, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goheer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lostritto, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinn, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbois, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Approval summary for bortezomib for injection in the treatment of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3954</span>– <span class="NLM_lpage">3964</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-03-0781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1158%2F1078-0432.CCR-03-0781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=15217925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFWmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3954-3964&author=P.+F.+Brossauthor=R.+Kaneauthor=A.+T.+Farrellauthor=S.+Abrahamauthor=K.+Bensonauthor=M.+E.+Browerauthor=S.+Bradleyauthor=J.+V.+Gobburuauthor=A.+Goheerauthor=S.-L.+Leeauthor=J.+Leightonauthor=C.+Y.+Liangauthor=R.+T.+Lostrittoauthor=W.+D.+McGuinnauthor=D.+E.+Morseauthor=A.+Rahmanauthor=L.+A.+Rosarioauthor=S.+L.+Verboisauthor=G.+Williamsauthor=Y.+C.+Wangauthor=R.+Pazdur&title=Approval+summary+for+bortezomib+for+injection+in+the+treatment+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-03-0781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma</span></div><div class="casAuthors">Bross, Peter F.; Kane, Robert; Farrell, Ann T.; Abraham, Sophia; Benson, Kimberly; Brower, Margaret E.; Bradley, Sean; Gobburu, Jogarao V.; Goheer, Anwar; Lee, Shwu-Luan; Leighton, John; Liang, Cheng Yi; Lostritto, Richard T.; McGuinn, William D.; Morse, David E.; Rahman, Atiqur; Rosario, Lilliam A.; Verbois, S. Leigh; Williams, Grant; Wang, Yong-Cheng; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3954-3964</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Purpose: Multiple myeloma is a malignant plasma cell disorder accounting for about 10% of hematol. malignancies.  Despite treatment advances, including hepatopoietic stem-cell transplantation to facilitate administration of high-dose cytotoxic chemotherapy, the median survival remains approx. 3 yr and long-term remissions are rare.  Bortezomib (Velcade, formerly known as PS-341; Millennium Pharmaceuticals, Cambridge MA) is a dipeptide boronic acid that inhibits the 20S proteasome involved in the degrdn. of intracellular proteins, including those affecting cell cycle regulation in mammalian cells.  Described herein are the analyses by the United States Food and Drug Administration (FDA) of clin. and nonclin. data submitted in the New Drug Application.  Chem. manufg. and controls, animal toxicol., and biopharmaceutical data are described.  The results of Phase I and Phase II clin. studies in patients with multiple myeloma are summarized.  The marketing approval and postmarketing commitments are discussed.  Results: Toxicol. studies in the rat and monkey identified hematol., lymphoid, cardiac, renal, gastrointestinal, and ndurol. toxicities of bortezomib.  A steep dose-toxicity effect was noted at doses ≥0.9 mg/m2.  Administration of doses >3.0 mg/m2 to monkeys resulted in cardiovascular collapse and death 12-14 h postdose.  Histopathol. evidence of axonal and myelin degeneration of dorsal root ganglia, peripheral nerves, and spinal cord were obsd. i monkeys and rodents; concurrent clin. observations included tremors and decreased activity.  Pharmacokinetic studies in patients with advanced malignancies demonstrated that the mean elimination half-life after the bortezomib dose varied from 9 to 15 h at doses ranging from 1.45 to 2.00 mg/m2.  The drug is metabolized by cytochrome P 450-3A4, -2D6, -2C19, -2C9, and -1A2.  Three Phase I studies were performed in a total of 123 patients with advanced malignancies.  Dose-limiting toxicity included diarrhea and sensory neurotoxicity.  No dose-limiting hematol. toxicity was reported.  Safety and efficacy were evaluated in an open-label, Phase II study of 202 patients with multiple myeloma who had received at least two prior therapies and had demonstrated disease progression on their most recent therapy.  A smaller dose finding study of 54 patients provided addnl. supportive information.  Bortezomib was administered by i.v. bolus on days 1, 4, 8, an 11 in a 21-day cycle for up to eight cycles.  The initial dose was 1.3 mg/m2 except for 28 patients in the dose-finding study who received a 1.0 mg/m2 dose.  The primary study end point in this single-arm trial was response rate, easily measured and thought to correlate with clin. benefit in patients with myeloma.  One hundred eight-eight patients who met the inclusion criteria were included in the FDA efficacy anal. population.  Complete responses (CRs) were obsd. in 5 patients and partial responses (PRs) in 47 patients for an overall response (OR) rate (OR = CR + PR) of 28%.  The dose finding study of 54 patients showed a higher response rate for patients given 1.3 mg/m2 compared with 1.0 mg/m2 twice weekly for two of the 3-wk schedule, but the study was too small for statistical dose-response comparisons.  The most commonly reported adverse events were asthenic conditions (including fatigue, malaise, and weakness) in 65%, nausea (64%), diarrhea (51%), appetite decreased (including anorexia; 43%), constipation (43%), thrombocytopenia (43%), peripheral neuropathy (37%, including peripheral sensory neuropathy and peripheral neuropathy aggravated), pyrexia (36%), vomiting (36%), and anemia (32%).  Conclusions: The FDA granted marketing approved in Millennium Pharmaceuticals on May 13, 2003 for bortezomib for use as a single agent for the treatment of multiple myeloma in patients who have received at least two prior therapies and have demonstrated disease progression on the last therapy.  Accelerated approval was based on a surrogate end point of response rate rather than clin. benefit, such as an improvement in survival.  The recommended dose of bortezomib is 1.3 mg/m2 administered twice weekly for 2 wk (days 1, 4, 8 , and 11) followed by a 10-day rest period (days 12-21).  Accelerated approval was based on the results of two Phase II studies in a total of 256 patients and addnl. Phase I safety information.  Mandated Phase IV study commitments to characterize clin. efficacy and safety more precisely are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9U7azd4GPrVg90H21EOLACvtfcHk0lhKurnSKPrtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFWmtLk%253D&md5=b2d07d88fb384b92b1691bf2f9900044</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0781%26sid%3Dliteratum%253Aachs%26aulast%3DBross%26aufirst%3DP.%2BF.%26aulast%3DKane%26aufirst%3DR.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DBenson%26aufirst%3DK.%26aulast%3DBrower%26aufirst%3DM.%2BE.%26aulast%3DBradley%26aufirst%3DS.%26aulast%3DGobburu%26aufirst%3DJ.%2BV.%26aulast%3DGoheer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-L.%26aulast%3DLeighton%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%2BY.%26aulast%3DLostritto%26aufirst%3DR.%2BT.%26aulast%3DMcGuinn%26aufirst%3DW.%2BD.%26aulast%3DMorse%26aufirst%3DD.%2BE.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DRosario%26aufirst%3DL.%2BA.%26aulast%3DVerbois%26aufirst%3DS.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520summary%2520for%2520bortezomib%2520for%2520injection%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3954%26epage%3D3964%26doi%3D10.1158%2F1078-0432.CCR-03-0781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torssell, K.</span></span> <span> </span><span class="NLM_article-title">Arylboronic acids. III. Bromination of tolylboronic acids according to Wohl-Ziegler</span>. <i>Ark. Kemi.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADyaG1cXot1Chuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1957&pages=507-511&author=K.+Torssell&title=Arylboronic+acids.+III.+Bromination+of+tolylboronic+acids+according+to+Wohl-Ziegler"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Arylboronic acids. III. Bromination of tolylboronic acids according to Wohl-Ziegler</span></div><div class="casAuthors">Torssell, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Arkiv foer Kemi</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507-11</span>CODEN:
                <span class="NLM_cas:coden">ARKEAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-6128</span>.
    </div><div class="casAbstract">Tolylboronic acids reacted with 1 or 2 mols. of N-bromosuccinimide (I) to form ω-bromo or ω,ω-dibromo derivs., resp.  Hydrolysis of the bromo compds. gave hydroxymethyl-, and formylphenylboronic acids.  I (6.8 g.) and about 0.1 g. Bz2O2 were added to 5 g. p-MeC6H4B(OH)2 (II) in 190 ml. CCl4, the mixt. refluxed 1 hr. on a water bath with exclusion of moisture, and the succinimide filtered off, giving p-BrCH2C6H4B(OH)2 (III), m. 165-8° (from CCl4), 90% yield.  Prepd. similarly were the m-isomer, m. 214-16° (CCl4), and the ο-isomer (IV), m. 148° (CCl4).  IV (0.4 g.) heated in 6 ml. H2O 10 min. gave 0.1 g. white ο ο-HOCH2C6H4B(OH)2 anhydride, m. 97-8°.  Reaction of III with boiling H2O probably gave p-HOCH2C6H4B(OH)2, but it could not be isolated; however, some p-OHCC6H4B(OH)2 (V) was isolated.  The products from the attempted prepns. of p-H2NC6H4B(OH)2 and of p-Et2NC6H4B(OH)2 could not be isolated in pure form. p-Br2C6H3B(OH)2 (VI), decomp. 160-70° (CCl4 or PhMe), was prepd. as for III, with only half as much II used.  Similarly obtained were 69% m-isomer, decomp. 160-5° (Me-NO2), and 56% ο-isomer, m. 163° (cyclohexane).  VI (0.5 g.) heated 10 min. in 5 ml. H2O satd. with SO2 and the mixt. cooled gave 0.16 g. V, sinters 230-40° to a glassy mass (H2O).  Prepd. likewise were ο-OHCC6H4B(OH)2, m. 123° (MeNO2), and 47% m-isomer, m. 112° with loss of H2O, m. 180° (H2O).  Derivs. of V prepd. were the red p-nitro-phenylhydrazone, decomp. approx. 280° (70% MeOH), and the white thiosemicarbazone, decomp. 204-5° (3:1 H2O-EtOH).  Attempts to prep. ο-HO2CC6H4B(OH)2 were unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjyYyQpe_M7Vg90H21EOLACvtfcHk0lhKurnSKPrtnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXot1Chuw%253D%253D&md5=da2777214f487f8073a6ce1dcb2174f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorssell%26aufirst%3DK.%26atitle%3DArylboronic%2520acids.%2520III.%2520Bromination%2520of%2520tolylboronic%2520acids%2520according%2520to%2520Wohl-Ziegler%26jtitle%3DArk.%2520Kemi.%26date%3D1957%26volume%3D10%26spage%3D507%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennarz, W. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1021/ja01537a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01537a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADyaG1cXmtV2lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=835-838&author=H.+R.+Snyderauthor=A.+J.+Reedyauthor=W.+J.+Lennarz&title=Synthesis+of+aromatic+boronic+acids.+Aldehydo+boronic+acids+and+a+boronic+acid+analog+of+tyrosine&doi=10.1021%2Fja01537a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine</span></div><div class="casAuthors">Snyder, H. R.; Reedy, Albert J.; Lennarz, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">835-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">ο-MeC6H4B(OH)2 (I) (5 g.) and 100 cc. CCl4 treated with stirring with about 5 cc. soln. of 6 g. dry Br in 50 cc. CCl4 while being illuminated with a 200-w. light bulb, the mixt. treated after an induction period of 5-15 min. with the remainder of the Br soln. in portions of about 5 cc. during about 15 min. and evapd., and the residue recrystd. from CHCl3 yielded 7.4 g. ο-BrCH2C6H4B(OH)2 (II), m. 139-46°.  p-MeC6H4B(OH)2 (III) (5 g.) gave similarly 7.2 g. p-BrCH2C6H4B(OH)2 (IV), m. 138-44°.  III (5 g.), 150 cc. dry CHCl3, 650 mg. Bz2O2, and 6.5 g. N-bromosuccinimide (V) refluxed 3 hrs. while being illuminated with a 200-w. light bulb, the mixt. refluxed 1 hr. with 7 g. hexamethylenetetramine in 75 cc. dry CHCl3, the hot soln. decanted, the residue extd. with 40 cc. HCl of pH 4, the aq. soln. freed of a few drops CHCl3, refluxed 1 hr., poured into a beaker, treated immediately with 10 cc. concd. HCl, and cooled, and the cryst. product recrystd. from H2O yielded 1.5 g. p-OHCC6H4B(OH)2 (VI).0.5H2O, m. 230-40°, which dried 24 hrs. at room temp. and 1 mm. gave VI; a sample dried 1 hr. at 80°/1 mm. gave the anhydride.  I (1 g.), 40 cc. dry CCl4, 2.6 g. V, and 260 mg. Bz2O2 refluxed 2.5 hrs. while being illuminated by a 200-w. bulb, filtered, and extd. with 15% aq. KOH, the alk. ext. acidified after 15 min., kept 2 hrs., and extd. with Et2O, and the ext. evapd. gave 370 mg. ο-OHCC6H4B(OH)2 (VII), m. 118-20°.  VI (500 mg.), 200 mg. MeNO2, and 4 cc. EtOH treated slowly below 10° with 274 mg. NaOH in 4 cc. H2O, stirred 15 min. at 10°, clarified with aq. NaOH, cooled to 5°, and added to 2 cc. concd. HCl in 3 cc. H2O at 0° yielded 455 mg. p-O2NCH:CHC6H4B(OH)2, light yellow, m. 289-90° (decompn.) (33% EtOH).  VII was recovered unchanged from a similar run.  VI (1 g.), 15 cc. Me2CO, 5 cc. H2O, and 5 cc. 10% aq. NaOH kept below 30° by cooling with tap water and then 4 hrs. at room temp. and filtered, the residue dissolved in 10 cc. H2O and acidified, the ppt. filtered, and the residues recrystd. from aq. EtOH gave 1.05 g. p-AcCH:CHC6H4B(OH)2, m. 205-12°.  VII was recovered unchanged from a similar run.  VI (1 g.), 3.5 g. KCN, and 7 cc. H2O treated slowly at 10° with 0.57 cc. concd. H2SO4 in 1.73 cc. H2O, filtered, acidified with 10% HCl, kept 10 min. at 10°, and the product isolated with Et2O gave p-NC(HO)CHC6H4B(OH)2, which softened at about 65° and appeared to undergo several changes before completely m. 104°.  VI treated with N2H4.H2O gave the azine of VI, m. 295° (aq. HCONMe2).  VI oxidized with KMnO4 at room temp. yielded 86% p-HO2CC6H4B(OH)2, m. 219-20°.  VI in EtOH hydrogenated over PtO2 gave a gelatinous solid which could not be purified.  VI treated with 10 or 20% aq. NaOH at room temp. to reflux temp. from 45 min. to 12 hrs. was recovered unchanged; similar results were obtained in the attempted benzoin condensation during 40-90 min. and in the attempted condensations with BzH, p-Me2NC6H4CHO, and p-O2NC6H4CHO.  VII (600 mg.) refluxed 2 hrs. with 5 cc. deoxygenated 20% aq. NaOH under N yielded 300 mg. BzOH.  VII (500 mg.) and 360 mg. NH2OH.HCl in 20 cc. hot H2O adjusted with NaOH to pH 7, refluxed 15 min., cooled, acidified with concd. HCl, and refrigerated 2 days gave 420 mg. p-HON:CHC6H4B(OH)2, m. 150-5°.  I (5 g.) treated in CCl4 in the usual manner with 6 g. Br and extd. with 15% aq. KOH, the ext. kept 1 hr. at room temp., acidified with 15% HCl, and filtered, the filtrate concd. to 50 cc., and the product isolated with Et2O gave 3.5 g. ο-C6H4.CH2.O.BOH (VIII), m. 96-8° (H2O).  I (25 g.), 32.5 g. V, 3.25 g. Bz2O2, and 350 cc. dry CHCl3 refluxed 3 hrs., treated with 30 g. hexamethylenetetramine in 200 cc. CHCl3, refluxed 15 min., and decanted, the residue dissolved in 100 cc. aq. HCl of pH 4, and the aq. soln. refluxed 1 hr. gave 5.2 g. IX, m. 308-9° (HCONMe2).  IX in 10% HCl treated with NaNO2 effervesced and gave VIII.  AcNHCH(CO2Et)2 (28.8 g.) added to 3.16 g. Na in 300 cc. abs. EtOH with stirring, the mixt. treated with stirring with 19.7 g. VI, refluxed 11 hrs. with stirring, cooled to room temp., treated with 12 cc. 3N HCl, and filtered, the filtrate evapd., and the residual semisolid crystd. from about 600 cc. 33% EtOH yielded 21.7 g. p-(EtO2C)2C(NHAc)CH2C6H4B(OH)2 (X), m. 220-3°.  X (21.7 g.) and 180 cc. 5% aq. NaOH refluxed 3.75 hrs. with stirring, cooled, treated slowly with 90 cc. 3NN HCl, refluxed 1 hr., and evapd. in vacuo, and the residue crystd. from the min. amt. of H2O yielded 13.5 g. p-HO2CCH(NHAc)C6H4B(OH)2 (XI), m. 168-70°.  XI (13.5 g.) and 16 g. NaOH in 250 cc. H2O refluxed 9 hrs. with stirring, acidified with 25 cc. concd. HCl, adjusted to pH 6.2 with NH4OH, concd. to 100 cc. in vacuo, and refrigerated overnight yielded 8.3 g. p-HO2CCH(NH2)CH2C6H4B(OH)2 (XII), m. 285-90° (decompn.).  XII (0.1-0.2 g.) treated with 3 cc. N HCl and slowly evapd. to dryness yielded XII.HCl, m. 200-3°.  XII (0.5 g.) in 20 cc. 5% aq. NaOH refluxed 48 hrs. in a Cu flask, filtered hot, adjusted to pH 3 with HCl and then to pH 5.7 with NH4OH, and filtered, the filtrate evapd. to near dryness in vacuo, the residue treated with 10 cc. H2O, and the remaining solid filtered off gave a mixt., m. 235-40°, of XII and PhCH2CH(NH2)CO2H which chromatographed with 4:1:5 BuOH-AcOH-H2O (descending) showed the Rf values 0.46 and 0.69, resp.  XII in excess aq. NaOH titrated with 0.1N HCl gave a titration curve similar in shape to that of a normal amino acid.  The boronic acid function has a pKa of the same magnitude as the ammonium ion; on the basic side of the titration curve 2 equivs. acid were required for neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo50pif1I7F2bVg90H21EOLACvtfcHk0lg8eXHUUIq_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXmtV2lsw%253D%253D&md5=95318dbe3031236608bed3b91c3bdf2a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja01537a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01537a021%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BR.%26aulast%3DReedy%26aufirst%3DA.%2BJ.%26aulast%3DLennarz%26aufirst%3DW.%2BJ.%26atitle%3DSynthesis%2520of%2520aromatic%2520boronic%2520acids.%2520Aldehydo%2520boronic%2520acids%2520and%2520a%2520boronic%2520acid%2520analog%2520of%2520tyrosine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D835%26epage%3D838%26doi%3D10.1021%2Fja01537a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of Onychomycosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4447</span>– <span class="NLM_lpage">4450</span>, <span class="refDoi"> DOI: 10.1021/jm0603724</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603724" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt12lsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4447-4450&author=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=T.+Akamaauthor=A.+Lauauthor=H.+Zhouauthor=V.+Hernandezauthor=W.+M.+Maoauthor=M.+R.+K.+Alleyauthor=V.+Sandersauthor=J.+J.+Plattner&title=Discovery+of+a+new+boron-containing+antifungal+agent%2C+5-fluoro-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaborole+%28AN2690%29%2C+for+the+potential+treatment+of+Onychomycosis&doi=10.1021%2Fjm0603724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis</span></div><div class="casAuthors">Baker, Stephen J.; Zhang, Yong-Kang; Akama, Tsutomu; Lau, Agnes; Zhou, Huchen; Hernandez, Vincent; Mao, Weimin; Alley, M. R. K.; Sanders, Virginia; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4447-4450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-contg. small mol., AN2690 (I), which is currently in clin. trials for onychomycosis topical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCA9knQ5nc7Vg90H21EOLACvtfcHk0lg8eXHUUIq_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt12lsro%253D&md5=c21119d24d45861fefe07d802d9a786e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0603724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603724%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DMao%26aufirst%3DW.%2BM.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520new%2520boron-containing%2520antifungal%2520agent%252C%25205-fluoro-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaborole%2520%2528AN2690%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520Onychomycosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4447%26epage%3D4450%26doi%3D10.1021%2Fjm0603724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaremchuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinis, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1126/science.1142189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1126%2Fscience.1142189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=17588934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1759-1761&author=F.+L.+Rockauthor=W.+Maoauthor=A.+Yaremchukauthor=M.+Tukaloauthor=T.+Crepinauthor=H.+Zhouauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=T.+Akamaauthor=S.+J.+Bakerauthor=J.+J.+Plattnerauthor=L.+Shapiroauthor=S.+A.+Martinisauthor=S.+J.+Benkovicauthor=S.+Cusackauthor=M.+R.+K.+Alley&title=An+antifungal+agent+inhibits+an+aminoacyl-tRNA+synthetase+by+trapping+tRNA+in+the+editing+site&doi=10.1126%2Fscience.1142189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span></div><div class="casAuthors">Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5832</span>),
    <span class="NLM_cas:pages">1759-1761</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aminoacyl-tRNA synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets.  We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNALeu-AN2690 adduct in the editing site of the enzyme.  Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine.  The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNALeu and consequentially blocking protein synthesis.  This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcTqC8iispbVg90H21EOLACvtfcHk0lg8eXHUUIq_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D&md5=0da444baf3c2f6e0768fe19febcaee6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142189%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DYaremchuk%26aufirst%3DA.%26aulast%3DTukalo%26aufirst%3DM.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DShapiro%26aufirst%3DL.%26aulast%3DMartinis%26aufirst%3DS.%2BA.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DAn%2520antifungal%2520agent%2520inhibits%2520an%2520aminoacyl-tRNA%2520synthetase%2520by%2520trapping%2520tRNA%2520in%2520the%2520editing%2520site%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1759%26epage%3D1761%26doi%3D10.1126%2Fscience.1142189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=19303290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2129-2132&author=T.+Akamaauthor=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=H.+Zhouauthor=V.+Sandersauthor=Y.+Freundauthor=R.+Kimuraauthor=K.+R.+Maplesauthor=J.+J.+Plattner&title=Discovery+and+structure-activity+study+of+a+novel+benzoxaborole+anti-inflammatory+agent+%28AN2728%29+for+the+potential+topical+treatment+of+psoriasis+and+atopic+dermatitis&doi=10.1016%2Fj.bmcl.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span></div><div class="casAuthors">Akama, Tsutomu; Baker, Stephen J.; Zhang, Yong-Kang; Hernandez, Vincent; Zhou, Huchen; Sanders, Virginia; Freund, Yvonne; Kimura, Richard; Maples, Kirk R.; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2129-2132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release.  5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo.  This compd. is now in clin. development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdD-T7O2W57Vg90H21EOLACvtfcHk0lgS3P1_Pe7DDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D&md5=a526278d0506fc5916432cf20c6ff5e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-activity%2520study%2520of%2520a%2520novel%2520benzoxaborole%2520anti-inflammatory%2520agent%2520%2528AN2728%2529%2520for%2520the%2520potential%2520topical%2520treatment%2520of%2520psoriasis%2520and%2520atopic%2520dermatitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2129%26epage%3D2132%26doi%3D10.1016%2Fj.bmcl.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukac, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span> <span> </span><span class="NLM_article-title">Clinical and veterinary trypanocidal benzoxaboroles target CPSF3</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9616</span>– <span class="NLM_lpage">9621</span>, <span class="refDoi"> DOI: 10.1073/pnas.1807915115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1073%2Fpnas.1807915115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=30185555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=9616-9621&author=R.+J.+Wallauthor=E.+Ricoauthor=I.+Lukacauthor=F.+Zuccottoauthor=S.+Elgauthor=I.+H.+Gilbertauthor=Y.+Freundauthor=M.+R.+K.+Alleyauthor=M.+C.+Fieldauthor=S.+Wyllieauthor=D.+Horn&title=Clinical+and+veterinary+trypanocidal+benzoxaboroles+target+CPSF3&doi=10.1073%2Fpnas.1807915115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and veterinary trypanocidal benzoxaboroles target CPSF3</span></div><div class="casAuthors">Wall, Richard J.; Rico, Eva; Lukac, Iva; Zuccotto, Fabio; Elg, Sara; Gilbert, Ian H.; Freund, Yvonne; Alley, M. R. K.; Field, Mark C.; Wyllie, Susan; Horn, David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">9616-9621</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">African trypanosomes cause lethal and neglected tropical diseases, known as sleeping sickness in humans and nagana in animals.  Current therapies are limited, but fortunately, promising therapies are in advanced clin. and veterinary development, including acoziborole (AN5568 or SCYX-7158) and AN11736, resp.  These benzoxaboroles will likely be key to the World Health Organization's target of disease control by 2030.  Their mode of action was previously unknown.  We have developed a high-coverage overexpression library and use it here to explore drug mode of action in Trypanosoma brucei.  Initially, an inhibitor with a known target was used to select for drug resistance and to test massive parallel library screening and genome-wide mapping; this effectively identified the known target and validated the approach.  Subsequently, the overexpression screening approach was used to identify the target of the benzoxaboroles, Cleavage and Polyadenylation Specificity Factor 3 (CPSF3, Tb927.4.1340).  We validated the CPSF3 endonuclease as the target, using independent overexpression strains.  Knockdown provided genetic validation of CPSF3 as essential, and GFP tagging confirmed the expected nuclear localization.  Mol. docking and CRISPR-Cas9-based editing demonstrated how acoziborole can specifically block the active site and mRNA processing by parasite, but not host CPSF3.  Thus, our findings provide both genetic and chem. validation for CPSF3 as an important drug target in trypanosomes and reveal inhibition of mRNA maturation as the mode of action of the trypanocidal benzoxaboroles.  Understanding the mechanism of action of benzoxaborole-based therapies can assist development of improved therapies, as well as the prediction and monitoring of resistance, if or when it arises.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yjPx5rJD7LVg90H21EOLACvtfcHk0lgS3P1_Pe7DDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhu7zL&md5=aaa91988ec41afbc6add5d664b1e5a29</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1807915115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1807915115%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DRico%26aufirst%3DE.%26aulast%3DLukac%26aufirst%3DI.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DElg%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DHorn%26aufirst%3DD.%26atitle%3DClinical%2520and%2520veterinary%2520trypanocidal%2520benzoxaboroles%2520target%2520CPSF3%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D9616%26epage%3D9621%26doi%3D10.1073%2Fpnas.1807915115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (<i>S</i>)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3<i>H</i>)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+Perez-Herranauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+potent+and+specific+M.+tuberculosis+leucyl-tRNA+synthetase+inhibitor%3A+%28S%29-3-%28aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0lgxkRZV1dytgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520specific%2520M.%2520tuberculosis%2520leucyl-tRNA%2520synthetase%2520inhibitor%253A%2520%2528S%2529-3-%2528aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eason, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaravino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erve, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. part 5. lead optimization of novel amide pyrazinyloxy benzoxaboroles and identification of a preclinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5889-5908&author=Y.+K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easonauthor=R.+T.+Jacobsauthor=D.+Guoauthor=Y.+R.+Freundauthor=P.+Berryauthor=V.+Ciaravinoauthor=J.+C.+Erveauthor=P.+J.+Rosenthalauthor=B.+Campoauthor=F.+Gamoauthor=L.+Sanzauthor=J.+Cao&title=Benzoxaborole+antimalarial+agents.+part+5.+lead+optimization+of+novel+amide+pyrazinyloxy+benzoxaboroles+and+identification+of+a+preclinical+candidate&doi=10.1021%2Facs.jmedchem.7b00621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Jacobs, Robert T.; Guo, Denghui; Freund, Yvonne R.; Berry, Pamela; Ciaravino, Vic; Erve, John C. L.; Rosenthal, Philip J.; Campo, Brice; Gamo, Francisco-Javier; Sanz, Laura M.; Cao, Jianxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5889-5908</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a mol. with satisfactory antimalarial activity, physicochem. properties, pharmacokinetic profile, in vivo efficacy, and safety profile.  This optimization effort discovered 46, which met our target candidate profile.  Compd. 46 had excellent activity against cultured Plasmodium falciparum, and in vivo against P. falciparum and P. berghei in infected mice.  It exhibited good PK properties in mice, rats, and dogs.  It was highly active against the other 11 P. falciparum strains, which are mostly resistant to chloroquine and pyrimethamine.  The rapid parasite in vitro redn. and in vivo parasite clearance profile of 46 were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials.  It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg.  The combined properties of this novel benzoxaborole support its progression to preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojoCeksZcUZrVg90H21EOLACvtfcHk0lgxkRZV1dytgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7bO&md5=2b3aee2afe14e6eee0b8dd24f02e8433</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00621%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEason%26aufirst%3DE.%2BE.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DFreund%26aufirst%3DY.%2BR.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DCiaravino%26aufirst%3DV.%26aulast%3DErve%26aufirst%3DJ.%2BC.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DGamo%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520part%25205.%2520lead%2520optimization%2520of%2520novel%2520amide%2520pyrazinyloxy%2520benzoxaboroles%2520and%2520identification%2520of%2520a%2520preclinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5889%26epage%3D5908%26doi%3D10.1021%2Facs.jmedchem.7b00621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against <i>Trypanosoma brucei</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.ejmech.2014.04.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24826816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=59-75&author=P.+Wuauthor=J.+Zhangauthor=Q.+Mengauthor=B.+Nareauthor=R.+T.+Jacobsauthor=H.+Zhou&title=Novel+pyrrolobenzoxaboroles%3A+design%2C+synthesis%2C+and+biological+evaluation+against+Trypanosoma+brucei&doi=10.1016%2Fj.ejmech.2014.04.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei</span></div><div class="casAuthors">Wu, Puhua; Zhang, Jiong; Meng, Qingqing; Nare, Bakela; Jacobs, Robert T.; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-75</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis is a fatal parasitic infection caused by the protozoan Trypanosoma brucei.  The development of novel antitrypanosomal agents is urgently needed.  Here authors report the synthesis and structure-activity relationship of a new class of benzoxaboroles as antitrypanosomal agents.  These compds. showed antiparasitic IC50 values ranging from 4.02 to 0.03 μg/mL and satisfactory cytotoxicity profile.  Three of the lead compds. were demonstrated to cure the parasitic infection in a murine acute infection model.  The structure-activity relationship of the pyrrolobenzoxaboroles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQOnvv25q8bVg90H21EOLACvtfcHk0lgDZm4NeXKfxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltb8%253D&md5=07aa0344d601ef45da9ae409363f3eae</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.079%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DNovel%2520pyrrolobenzoxaboroles%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520against%2520Trypanosoma%2520brucei%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D59%26epage%3D75%26doi%3D10.1016%2Fj.ejmech.2014.04.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent benzoxaborole-based anti-pneumococcal agent</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">2475</span> <span class="refDoi"> DOI: 10.1038/srep02475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fsrep02475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=23959225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC3sbhtFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&author=Q.+Huauthor=R.+Liuauthor=Z.+Fangauthor=J.+Zhangauthor=Y.+Dingauthor=M.+Tanauthor=M.+Wangauthor=W.+Panauthor=H.+Zhouauthor=E.+Wang&title=Discovery+of+a+potent+benzoxaborole-based+anti-pneumococcal+agent&doi=10.1038%2Fsrep02475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase</span></div><div class="casAuthors">Hu Qing-Hua; Liu Ru-Juan; Fang Zhi-Peng; Zhang Jiong; Ding Ying-Ying; Tan Min; Wang Meng; Pan Wei; Zhou Hu-Chen; Wang En-Duo</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2475</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Streptococcus pneumoniae causes bacterial pneumonia with high mortality and morbidity.  The emergency of multidrug-resistant bacteria threatens the treatment of the disease.  Leucyl-tRNA synthetase (LeuRS) plays an essential role in cellular translation and is an attractive drug target for antimicrobial development.  Here we report the compound ZCL039, a benzoxaborole-based derivative of AN2690, as a potent anti-pneumococcal agent that inhibits S. pneumoniae LeuRS (SpLeuRS) activity.  We show using kinetic, biochemical analyses combined with the crystal structure of ZCL039-AMP in complex with the separated SpLeuRS editing domain, that ZCL039 binds to the LeuRS editing active site which requires the presence of tRNA(Leu), and employs an uncompetitive inhibition mechanism.  Further docking models establish that ZCL039 clashes with the eukaryal/archaeal specific insertion I4ae helix within editing domains.  These findings demonstrate the potential of benzoxaboroles as effective LeuRS inhibitors for pneumococcus infection therapy, and provide future structure-guided drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFg4yvXGLu5u98rul4nhSdfW6udTcc2eb3bOccUiCGYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbhtFKqtg%253D%253D&md5=6378664efa8609e30e2bade33e3aa469</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsrep02475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep02475%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520benzoxaborole-based%2520anti-pneumococcal%2520agent%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26doi%3D10.1038%2Fsrep02475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1021/jm2012408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3553-3557&author=Z.+Qiaoauthor=Q.+Wangauthor=F.+Zhangauthor=Z.+Wangauthor=T.+Bowlingauthor=B.+Nareauthor=R.+T.+Jacobsauthor=J.+Zhangauthor=D.+Dingauthor=Y.+Liuauthor=H.+Zhou&title=Chalcone-benzoxaborole+hybrid+molecules+as+potent+antitrypanosomal+agents&doi=10.1021%2Fjm2012408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-Benzoxaborole Hybrid Molecules as Potent Antitrypanosomal Agents</span></div><div class="casAuthors">Qiao, Zhitao; Wang, Qi; Zhang, Fenglong; Wang, Zhongli; Bowling, Tana; Nare, Bakela; Jacobs, Robert T.; Zhang, Jiong; Ding, Dazhong; Liu, Yangang; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3553-3557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the novel chalcone-benzoxaborole hybrids and their structure-activity relationship againstTrypanosoma brucei parasites.  The 4-NH2 deriv. 29 and 3-OMe deriv. 43 were found to have excellent potency.  The synergistic 4-NH2-3-OMe compd. 49 showed an IC50 of 0.010 μg/mL and resulted in 100% survival and zero parasitemia in a murine infection model, which represents one of the most potent compds. discovered to date from the benzoxaborole class that inhibit T. brucei growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3nXM7LHIG8LVg90H21EOLACvtfcHk0lgDZm4NeXKfxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVagurc%253D&md5=626a1fb63f3749953b64c9acca267d3f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2012408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012408%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DChalcone-benzoxaborole%2520hybrid%2520molecules%2520as%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3553%26epage%3D3557%26doi%3D10.1021%2Fjm2012408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of <i>Trypanosoma brucei</i> leucyl-tRNA synthetase inhibitors as antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1276</span>– <span class="NLM_lpage">1287</span>, <span class="refDoi"> DOI: 10.1021/jm101225g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101225g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1276-1287&author=D.+Dingauthor=Q.+Mengauthor=G.+Gaoauthor=Y.+Zhaoauthor=Q.+Wangauthor=B.+Nareauthor=R.+Jacobsauthor=F.+Rockauthor=M.+R.+K.+Alleyauthor=J.+J.+Plattnerauthor=G.+Q.+Chenauthor=D.+Liauthor=H.+Zhou&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+Trypanosoma+brucei+leucyl-tRNA+synthetase+inhibitors+as+antitrypanosomal+agents&doi=10.1021%2Fjm101225g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents</span></div><div class="casAuthors">Ding, Dazhong; Meng, Qingqing; Gao, Guangwei; Zhao, Yaxue; Wang, Qing; Nare, Bakela; Jacobs, Robert; Rock, Fernando; Alley, Michael R. K.; Plattner, Jacob J.; Chen, Guoqiang; Li, Dawei; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1276-1287</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">African trypanosomiasis, caused by the protozoal pathogen Trypanosoma brucei (T. brucei), is one of the most neglected tropical diseases that are in great need of new drugs.  The design and synthesis of T. brucei leucyl-tRNA synthetase (TbLeuRS) inhibitors and their structure-activity relation is reported.  Benzoxaborole was used as the core structure and C(6) was modified to achieve improved affinity based on docking results that showed further binding space at this position.  Indeed, compds. with C(7) substitutions showed diminished activity due to clash with the eukaryote specific I4ae helix while substitutions at C(6) gave enhanced affinity.  TbLeuRS inhibitors with IC50 ≥1.6 μM were discovered, and the structure-activity relation is discussed.  The most potent enzyme inhibitors also showed excellent T. brucei parasite growth inhibition activity.  This is the 1st time that TbLeuRS inhibitors are reported, and probably leucyl-tRNA synthetase (LeuRS) is a potential target for antiparasitic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGQVCRyjEerVg90H21EOLACvtfcHk0ljVR90rK6Q39w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeju7g%253D&md5=e72df282e5806c3fa66dc38d412cf0fd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101225g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101225g%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DRock%26aufirst%3DF.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DG.%2BQ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520Trypanosoma%2520brucei%2520leucyl-tRNA%2520synthetase%2520inhibitors%2520as%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1276%26epage%3D1287%26doi%3D10.1021%2Fjm101225g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Ding, D.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Zhang, Y.-K.</span>; <span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Boron-Containing Small Molecules as Antiprotozoal Agents</span>. <span class="NLM_patent">WO2011/022337 A1</span>, Feb 24, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+Zhou&author=D.+Ding&author=Y.+Zhou&author=Y.-K.+Zhang&author=J.+J.+Plattner&title=Boron-Containing+Small+Molecules+as+Antiprotozoal+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DBoron-Containing%2520Small%2520Molecules%2520as%2520Antiprotozoal%2520Agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvest, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2054</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2011.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=21353550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2048-2054&author=X.+Liauthor=S.+Zhangauthor=Y.+K.+Zhangauthor=Y.+Liuauthor=Z.+Charlesauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=W.+M.+Kazmierskiauthor=M.+S.+Duanauthor=R.+M.+Grimesauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.+J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=Z.+J.+Niauthor=W.+X.+Zouauthor=J.+Wright&title=Synthesis+and+SAR+of+acyclic+HCV+NS3+protease+inhibitors+with+novel+P4-benzoxaborole+moieties&doi=10.1016%2Fj.bmcl.2011.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties</span></div><div class="casAuthors">Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang; Kazmierski, Wieslaw M.; Duan, Maosheng; Grimes, Richard M.; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Ni, Zhi-Jie; Zou, Wuxin; Wright, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2048-2054</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acyclic P4-2,1-benzoxaboroles I (5a-j; X = 6-OCO, 6-NHCO, 6-CO, 6-CH2NHCO, 7-NHCO, 4-NHCO, 6-bond; Y = H, Cl, F; R = H, Me) were prepd. and evaluated as a new series of HCV NS3 protease inhibitors.  Structure-activity relationships were investigated, leading to the identification of compds. 5g and 17 with low nanomolar potency in the enzymic and cell-based replicon assay.  The linker-truncated compd. 5j (X = 6-bond, R = Y = H) was found to exhibit improved absorption and oral bioavailability in rats, suggesting that further redn. of mol. wt. and polar surface area could result in improved drug-like properties of this novel series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRXjiaRgnNMLVg90H21EOLACvtfcHk0ljVR90rK6Q39w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCktr8%253D&md5=54ff9010e0afd00ae45dceda0b40e7c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCharles%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DDuan%26aufirst%3DM.%2BS.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%2BX.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520acyclic%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520novel%2520P4-benzoxaborole%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2048%26epage%3D2054%26doi%3D10.1016%2Fj.bmcl.2011.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=19303290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2129-2132&author=T.+Akamaauthor=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=H.+Zhouauthor=V.+Sandersauthor=Y.+Freundauthor=R.+Kimuraauthor=K.+R.+Maplesauthor=J.+J.+Plattner&title=Discovery+and+structure-activity+study+of+a+novel+benzoxaborole+anti-inflammatory+agent+%28AN2728%29+for+the+potential+topical+treatment+of+psoriasis+and+atopic+dermatitis&doi=10.1016%2Fj.bmcl.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span></div><div class="casAuthors">Akama, Tsutomu; Baker, Stephen J.; Zhang, Yong-Kang; Hernandez, Vincent; Zhou, Huchen; Sanders, Virginia; Freund, Yvonne; Kimura, Richard; Maples, Kirk R.; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2129-2132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release.  5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo.  This compd. is now in clin. development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdD-T7O2W57Vg90H21EOLACvtfcHk0ljVR90rK6Q39w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D&md5=a526278d0506fc5916432cf20c6ff5e5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-activity%2520study%2520of%2520a%2520novel%2520benzoxaborole%2520anti-inflammatory%2520agent%2520%2528AN2728%2529%2520for%2520the%2520potential%2520topical%2520treatment%2520of%2520psoriasis%2520and%2520atopic%2520dermatitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2129%26epage%3D2132%26doi%3D10.1016%2Fj.bmcl.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baade, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics in China, 2015</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.3322/caac.21338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.3322%2Fcaac.21338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=26808342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC28njvVykug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=115-132&author=W.+Chenauthor=R.+Zhengauthor=P.+D.+Baadeauthor=S.+Zhangauthor=H.+Zengauthor=F.+Brayauthor=A.+Jemalauthor=X.+Q.+Yuauthor=J.+He&title=Cancer+statistics+in+China%2C+2015&doi=10.3322%2Fcaac.21338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics in China, 2015</span></div><div class="casAuthors">Chen Wanqing; Zheng Rongshou; Baade Peter D; Zhang Siwei; Zeng Hongmei; Bray Freddie; Jemal Ahmedin; Yu Xue Qin; Yu Xue Qin; He Jie</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem.  Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year.  With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015.  Data from 22 registries were used for trend analyses (2000-2011).  The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death.  Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death.  Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively).  For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females.  In contrast, the mortality rates since 2006 have decreased significantly for both males (-1.4% per year; P < .05) and females (-1.1% per year; P < .05).  Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkZeZPQ7Kk7ntlzo9xastyfW6udTcc2eaPEaQixsNF_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njvVykug%253D%253D&md5=2affa5f8beab6f885ccd830cbb249707</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21338%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DBaade%26aufirst%3DP.%2BD.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DBray%26aufirst%3DF.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DX.%2BQ.%26aulast%3DHe%26aufirst%3DJ.%26atitle%3DCancer%2520statistics%2520in%2520China%252C%25202015%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D115%26epage%3D132%26doi%3D10.3322%2Fcaac.21338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2015</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.3322%2Fcaac.21254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=25559415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=5-29&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2015&doi=10.3322%2Fcaac.21254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2015</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015.  During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women.  The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.  However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%).  For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress.  Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7d8BN92t5_sNIRw0GKUoEfW6udTcc2eaPEaQixsNF_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D&md5=9b569d8b3f5e9da465900f1c428a9218</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21254%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202015%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2015%26volume%3D65%26spage%3D5%26epage%3D29%26doi%3D10.3322%2Fcaac.21254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaeybroeck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, P. G.</span></span> <span> </span><span class="NLM_article-title">Cancer drug resistance: an evolving paradigm</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1038/nrc3599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fnrc3599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24060863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=714-726&author=C.+Holohanauthor=S.+Van+Schaeybroeckauthor=D.+B.+Longleyauthor=P.+G.+Johnston&title=Cancer+drug+resistance%3A+an+evolving+paradigm&doi=10.1038%2Fnrc3599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer drug resistance: an evolving paradigm</span></div><div class="casAuthors">Holohan, Caitriona; Van Schaeybroeck, Sandra; Longley, Daniel B.; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">714-726</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research.  The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific mol. targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death.  With the increasing arsenal of anticancer agents, improving preclin. models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clin. assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrykBEUSgvv7Vg90H21EOLACvtfcHk0lgt6Dy7m4ZEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE&md5=b497a823bbd968904ce1591b918d0679</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrc3599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3599%26sid%3Dliteratum%253Aachs%26aulast%3DHolohan%26aufirst%3DC.%26aulast%3DVan%2BSchaeybroeck%26aufirst%3DS.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DCancer%2520drug%2520resistance%253A%2520an%2520evolving%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D714%26epage%3D726%26doi%3D10.1038%2Fnrc3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuczynski, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerbel, R. S.</span></span> <span> </span><span class="NLM_article-title">Drug rechallenge and treatment beyond progression-implications for drug resistance</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2013.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fnrclinonc.2013.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=23999218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWqtrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=571-587&author=E.+A.+Kuczynskiauthor=D.+J.+Sargentauthor=A.+Grotheyauthor=R.+S.+Kerbel&title=Drug+rechallenge+and+treatment+beyond+progression-implications+for+drug+resistance&doi=10.1038%2Fnrclinonc.2013.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Drug rechallenge and treatment beyond progression-implications for drug resistance</span></div><div class="casAuthors">Kuczynski, Elizabeth A.; Sargent, Daniel J.; Grothey, Axel; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">571-587</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The established dogma in oncol. for managing recurrent or refractory disease dictates that therapy is changed at disease progression, because the cancer is assumed to have become drug-resistant.  Drug resistance, whether pre-existing or acquired, is largely thought to be a stable and heritable process; thus, reuse of therapeutic agents that have failed is generally contraindicated.  Over the past few decades, clin. evidence has suggested a role for unstable, non-heritable mechanisms of acquired drug resistance pertaining to chemotherapy and targeted agents.  There are many examples of circumstances where patients respond to reintroduction of the same therapy (drug rechallenge) after a drug holiday following disease relapse or progression during therapy.  Addnl., albeit limited, evidence suggests that, in certain circumstances, continuing a therapy beyond disease progression can also have antitumor activity.  In this Review, we describe the anticancer agents used in these treatment strategies and discuss the potential mechanisms explaining the apparent tumor re-sensitization with reintroduced or continued therapy.  The extensive no. of malignancies and drugs that challenge the custom of permanently switching to different drugs at each line of therapy warrants a more in-depth examn. of the definitions of disease progression and drug resistance and the resulting implications for patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGVmbq8ucsa7Vg90H21EOLACvtfcHk0lii3e6Ig15lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWqtrzJ&md5=513ca799d7cabdd8208b0c4ae9507753</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2013.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2013.158%26sid%3Dliteratum%253Aachs%26aulast%3DKuczynski%26aufirst%3DE.%2BA.%26aulast%3DSargent%26aufirst%3DD.%2BJ.%26aulast%3DGrothey%26aufirst%3DA.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DDrug%2520rechallenge%2520and%2520treatment%2520beyond%2520progression-implications%2520for%2520drug%2520resistance%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D10%26spage%3D571%26epage%3D587%26doi%3D10.1038%2Fnrclinonc.2013.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sravan
Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsello, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereddy, V. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel benzoxaboroles as potential antimicrobial and anticancer agents</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1002/jhet.1777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1002%2Fjhet.1777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOju7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=814-820&author=J.+Sravan%0AKumarauthor=M.+A.+Alamauthor=S.+Gurrapuauthor=G.+Nelsonauthor=M.+Williamsauthor=M.+A.+Corselloauthor=J.+L.+Johnsonauthor=S.+C.+Jonnalagaddaauthor=V.+R.+Mereddy&title=Synthesis+and+biological+evaluation+of+novel+benzoxaboroles+as+potential+antimicrobial+and+anticancer+agents&doi=10.1002%2Fjhet.1777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Benzoxaboroles as Potential Antimicrobial and Anticancer Agents</span></div><div class="casAuthors">Sravan Kumar, J.; Alam, M. A.; Gurrapu, Shirisha; Nelson, Grady; Williams, Michael; Corsello, Michael A.; Johnson, Joseph L.; Jonnalagadda, Subash C.; Mereddy, Venkatram R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">1943-5193</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Several novel benzoxaborole derivs. were synthesized starting from 2-formylphenylboronic acid utilizing Baylis-Hillman reaction, Barbier allylation, Passerini reaction, and aldol reaction protocols as the key step.  All the synthesized benzoxaboroles have been evaluated for their antibacterial, antifungal, and anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmNCNFVMQU7Vg90H21EOLACvtfcHk0lii3e6Ig15lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOju7bN&md5=b008fb1c41ec2ff40f9e9ccadab93fa2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjhet.1777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.1777%26sid%3Dliteratum%253Aachs%26aulast%3DSravan%2BKumar%26aufirst%3DJ.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DGurrapu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DCorsello%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26aulast%3DJonnalagadda%26aufirst%3DS.%2BC.%26aulast%3DMereddy%26aufirst%3DV.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520benzoxaboroles%2520as%2520potential%2520antimicrobial%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2013%26volume%3D50%26spage%3D814%26epage%3D820%26doi%3D10.1002%2Fjhet.1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel benzoxaborole-containing phenylalanine analogues</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4924</span>– <span class="NLM_lpage">4926</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.tetlet.2011.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=4924-4926&author=X.+F.+Liauthor=J.+J.+Plattnerauthor=V.+Hernandezauthor=C.+Z.+Dingauthor=W.+Wuauthor=Y.+Yangauthor=M.+S.+Xu&title=Synthesis+of+novel+benzoxaborole-containing+phenylalanine+analogues&doi=10.1016%2Fj.tetlet.2011.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel benzoxaborole-containing phenylalanine analogues</span></div><div class="casAuthors">Li, Xianfeng; Plattner, Jacob J.; Hernandez, Vincent; Ding, Charles Z.; Wu, Wei; Yang, Yang; Xu, Musheng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">4924-4926</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of novel benzoxaborole-contg. phenylalanine analogs has been developed.  The key steps involve the prepn. of appropriate precursors from the readily available amino acids and the formation of benzoxaborole ring directly in the corresponding amino acid fragment.  The resulting compds. show improved water soly. at physiol. pH, suggesting their potential use as boron delivery agents for boron neutron capture therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CFGGBQUvw7Vg90H21EOLACvtfcHk0lii3e6Ig15lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtb3F&md5=900abe32054bc9cb28ae54fd083f0974</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BF.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%2520novel%2520benzoxaborole-containing%2520phenylalanine%2520analogues%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D4924%26epage%3D4926%26doi%3D10.1016%2Fj.tetlet.2011.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Chalcone-benzoxaborole hybrids as novel anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5801</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2016.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=28327308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5797-5801&author=J.+Zhangauthor=F.+Yangauthor=Z.+Qiaoauthor=M.+Zhuauthor=H.+Zhou&title=Chalcone-benzoxaborole+hybrids+as+novel+anticancer+agents&doi=10.1016%2Fj.bmcl.2016.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-benzoxaborole hybrids as novel anticancer agents</span></div><div class="casAuthors">Zhang, Jiong; Yang, Fei; Qiao, Zhitao; Zhu, Mingyan; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5797-5801</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we report the synthesis of a series of chalcone-benzoxaborole hybrid mols. and the evaluation of their anticancer activity.  Their anticancer potency and toxicity were tested on three human cancer cell lines and two normal cell lines.  The 4-fluoro compd. 15 was found to be the most potent compd. with an IC50 value of 1.4 μM on SKOV3 cells.  The 4-iodo compd. 18 and 3-methyloxy-4-amino compd. 47 showed good potency on SKOV3 cells while exhibiting low toxicity on normal cells.  This work extended the application of benzoxaboroles to the field of anticancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQt3p0JOBnCLVg90H21EOLACvtfcHk0lgLioy86rpbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnsbvM&md5=eccffe08b7b7b2bd001ef379cda06fef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DChalcone-benzoxaborole%2520hybrids%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5797%26epage%3D5801%26doi%3D10.1016%2Fj.bmcl.2016.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Convenient and versatile synthesis of formyl-substituted benzoxaboroles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">8738</span>– <span class="NLM_lpage">8744</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2009.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.tet.2009.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=8738-8744&author=L.+Yeauthor=D.+Dingauthor=Y.+Fengauthor=D.+Xieauthor=P.+Wuauthor=H.+Guoauthor=Q.+Mengauthor=H.+Zhou&title=Convenient+and+versatile+synthesis+of+formyl-substituted+benzoxaboroles&doi=10.1016%2Fj.tet.2009.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient and versatile synthesis of formyl-substituted benzoxaboroles</span></div><div class="casAuthors">Ye, Long; Ding, Dazhong; Feng, Yiqing; Xie, Dongsheng; Wu, Puhua; Guo, Hui; Meng, Qingqing; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8738-8744</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite of the medicinal significance of benzoxaboroles, with the newly discovered clin. compd. AN2690 as an example, the synthetic method for rapid diversification of this novel scaffold is lacking.  To this end, a versatile and scalable synthesis of formyl-substituted benzoxaboroles is described here.  A key step is the mono-oxidn. of the two hydroxyls in 7-hydroxymethyl-1-hydroxy-1,3-dihydro-2,1-benzoxaborole by taking advantage of the stable oxaborole ring in non-coordinating solvents, which was devised based on the study of the intramol. coordination and exchange properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTlwtJ_jhnQLVg90H21EOLACvtfcHk0lgLioy86rpbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakt7zN&md5=2ed6ca54eb1f2cfc48ecfc94e56d1165</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DConvenient%2520and%2520versatile%2520synthesis%2520of%2520formyl-substituted%2520benzoxaboroles%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D8738%26epage%3D8744%26doi%3D10.1016%2Fj.tet.2009.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. part 2: discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2011.12.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=22243961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1299-1307&author=Y.+K.+Zhangauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=E.+Easomauthor=Y.+Zhouauthor=L.+Yeauthor=H.+Zhouauthor=D.+Watersonauthor=F.+Gamoauthor=L.+Sanzauthor=M.+Geauthor=Z.+Liauthor=L.+Liauthor=H.+Wangauthor=H.+Cui&title=Benzoxaborole+antimalarial+agents.+part+2%3A+discovery+of+fluoro-substituted+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1016%2Fj.bmcl.2011.12.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Freund, Yvonne R.; Easom, Eric E.; Zhou, Yasheen; Ye, Long; Zhou, Huchen; Waterson, David; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Zhiya; Li, Lingchao; Wang, Hailong; Cui, Han</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1299-1307</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New boron-contg. benzoxaborole compds. were designed and synthesized for a continuing structure-activity relation (SAR) study to assess the antimalarial activity changes derived from side-chain structural variation, substituent modification on the benzene ring and removal of boron from five-membered oxaborole ring.  This SAR study demonstrated that boron is required for the antimalarial activity, and discovered that three of the newly prepd. fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles have excellent potencies (IC50 0.026-0.209 μM) against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqR7ILmo50S7Vg90H21EOLACvtfcHk0lgLioy86rpbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D&md5=1b1dfbd62c694f926255c6edb7016b0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.096%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DGamo%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DH.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520part%25202%253A%2520discovery%2520of%2520fluoro-substituted%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1299%26epage%3D1307%26doi%3D10.1016%2Fj.bmcl.2011.12.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibotla, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solano, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, S. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of functionalized aminobenzoboroxoles as potential anti-cancer agents</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>798</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2015.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.jorganchem.2015.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFehsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=798&publication_year=2015&pages=125-131&author=P.+Sumanauthor=B.+P.+Patelauthor=A.+V.+Kasibotlaauthor=L.+N.+Solanoauthor=S.+C.+Jonnalagadda&title=Synthesis+and+evaluation+of+functionalized+aminobenzoboroxoles+as+potential+anti-cancer+agents&doi=10.1016%2Fj.jorganchem.2015.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of functionalized aminobenzoboroxoles as potential anti-cancer agents</span></div><div class="casAuthors">Suman, Pathi; Patel, Bhawankumar P.; Kasibotla, Agasthya V.; Solano, Lucas N.; Jonnalagadda, Subash C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">798</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">125-131</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several aminobenzoboroxole derivs. have been prepd. starting from o-boronobenzaldehyde employing reductive amination protocol.  The corresponding aminobenzoboroxole derivs. have been further functionalized as N-nitrosoaminobenzoboroxoles as well as N-benzoboroxolylureas.  These derivs. have been evaluated for their anti-cancer activity on human pancreatic cancer MIAPaCa-2 and human breast cancer MDA-MB-231 cell lines. 2015 Elsevier Ltd.  All rights reserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzdeGQBYfEsLVg90H21EOLACvtfcHk0lgLioy86rpbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFehsrjJ&md5=b1f391f82ec18f65e6323b7f616b0dd7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2015.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2015.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DSuman%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DB.%2BP.%26aulast%3DKasibotla%26aufirst%3DA.%2BV.%26aulast%3DSolano%26aufirst%3DL.%2BN.%26aulast%3DJonnalagadda%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520functionalized%2520aminobenzoboroxoles%2520as%2520potential%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2015%26volume%3D798%26spage%3D125%26epage%3D131%26doi%3D10.1016%2Fj.jorganchem.2015.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Psurski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupicka-Slowik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamczyk-Wozniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wietrzyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporzynski, A.</span></span> <span> </span><span class="NLM_article-title">Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology-phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1007/s10637-018-0611-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1007%2Fs10637-018-0611-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=29779163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=35-46&author=M.+Psurskiauthor=A.+Lupicka-Slowikauthor=A.+Adamczyk-Wozniakauthor=J.+Wietrzykauthor=A.+Sporzynski&title=Discovering+simple+phenylboronic+acid+and+benzoxaborole+derivatives+for+experimental+oncology-phase+cycle-specific+inducers+of+apoptosis+in+A2780+ovarian+cancer+cells&doi=10.1007%2Fs10637-018-0611-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology - phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells</span></div><div class="casAuthors">Psurski, Mateusz; Lupicka-Slowik, Agnieszka; Adamczyk-Wozniak, Agnieszka; Wietrzyk, Joanna; Sporzynski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objective The aim of the study was to evaluate the antiproliferative potential of simple phenylboronic acid and benzoxaborole derivs. as well as to provide preliminary insight into their mode of action in cancer cells in vitro.  Methods The antiproliferative activity was assessed in five diverse cancer cell lines via the SRB method (sulforhodamine B) or MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method after 72 h of treatment.  Further studies of the mechanism of action consisted of the influence of the compds. on cell cycle progression and apoptosis induction, which was assessed by flow cytometry, caspase-3 enzymic activity, fluorescence microscopy and western blot anal.  Results A clear structure-activity relationship was obsd. for both groups of compds. with several representatives evaluated as highly active antiproliferative agents with low micromolar IC72h50 values. 2-Fluoro-6-formylphenylboronic acid (18) and 3-morpholino-5-fluorobenzoxaborole (27) exhibited strong cell cycle arrest induction in G2/M assocd. with caspase-3 activation in an A2780 ovarian cancer cell line.  These events were accompanied by a mitotic catastrophe cell morphol. and an increased percentage of aneuploid and tetraploid cells.  Further expts. indicated that the compds. were phase cycle-specific agents since cells co-treated with hydroxyurea were less sensitive.  The obsd. cell cycle arrest resulted from significant p21 accumulation and was assocd. neither with cyclin B1 nor β-tubulin degrdn.  Conclusion Phenylboronic acid and benzoxaborole derivs. were found to be highly promising antiproliferative and proapoptotic compds. with a cell cycle-specific mode of action.  The presented data support their candidacy for further studies as a novel class of potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZxTHMmIC3zrVg90H21EOLACvtfcHk0lgVBdXqmJ8d0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVShtrY%253D&md5=644f65a5cd14d0fdb77ecd611c801084</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0611-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0611-z%26sid%3Dliteratum%253Aachs%26aulast%3DPsurski%26aufirst%3DM.%26aulast%3DLupicka-Slowik%26aufirst%3DA.%26aulast%3DAdamczyk-Wozniak%26aufirst%3DA.%26aulast%3DWietrzyk%26aufirst%3DJ.%26aulast%3DSporzynski%26aufirst%3DA.%26atitle%3DDiscovering%2520simple%2520phenylboronic%2520acid%2520and%2520benzoxaborole%2520derivatives%2520for%2520experimental%2520oncology-phase%2520cycle-specific%2520inducers%2520of%2520apoptosis%2520in%2520A2780%2520ovarian%2520cancer%2520cells%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D35%26epage%3D46%26doi%3D10.1007%2Fs10637-018-0611-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole as a new chemotype for carbonic anhydrase inhibition</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">11983</span>– <span class="NLM_lpage">11986</span>, <span class="refDoi"> DOI: 10.1039/C6CC06399C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1039%2FC6CC06399C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=27722534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sis7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=11983-11986&author=V.+Alterioauthor=R.+Cadoniauthor=D.+Espositoauthor=D.+Vulloauthor=A.+D.+Fioreauthor=S.+M.+Montiauthor=A.+Caporaleauthor=M.+Ruvoauthor=M.+Sechiauthor=P.+Dumyauthor=C.+T.+Supuranauthor=G.+D.+Simoneauthor=J.+Y.+Winum&title=Benzoxaborole+as+a+new+chemotype+for+carbonic+anhydrase+inhibition&doi=10.1039%2FC6CC06399C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole as a new chemotype for carbonic anhydrase inhibition</span></div><div class="casAuthors">Alterio, Vincenzo; Cadoni, Roberta; Esposito, Davide; Vullo, Daniela; Di Fiore, Anna; Monti, Simona Maria; Caporale, Andrea; Ruvo, Menotti; Sechi, Mario; Dumy, Pascal; Supuran, Claudiu T.; De Simone, Giuseppina; Winum, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">80</span>),
    <span class="NLM_cas:pages">11983-11986</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the synthesis of a series of benzoxaborole derivs., their inhibitory properties against some carbonic anhydrases (CAs), recognized as important drug targets, and the characterization of the binding mode of these mols. by the CA active site.  The data provide the 1st exptl. evidence that benzoxaboroles can be efficiently used as CA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_khysGipBbVg90H21EOLACvtfcHk0lgVBdXqmJ8d0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sis7zJ&md5=e07f69485cbda00926c92e2972d85439</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FC6CC06399C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC06399C%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DCadoni%26aufirst%3DR.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DFiore%26aufirst%3DA.%2BD.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DCaporale%26aufirst%3DA.%26aulast%3DRuvo%26aufirst%3DM.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDumy%26aufirst%3DP.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DSimone%26aufirst%3DG.%2BD.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DBenzoxaborole%2520as%2520a%2520new%2520chemotype%2520for%2520carbonic%2520anhydrase%2520inhibition%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D11983%26epage%3D11986%26doi%3D10.1039%2FC6CC06399C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nocentini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1473379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1080%2F13543776.2018.1473379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=29727210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=493-504&author=A.+Nocentiniauthor=C.+T.+Supuranauthor=J.+Y.+Winum&title=Benzoxaborole+compounds+for+therapeutic+uses%3A+a+patent+review+%282010-2018%29&doi=10.1080%2F13543776.2018.1473379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018)</span></div><div class="casAuthors">Nocentini, Alessio; Supuran, Claudiu T.; Winum, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Benzoxaborole is a versatile boron-heterocyclic scaffold which has found in the last 10 years a broad spectrum of applications in medicinal chem., due to its physicochem. and drug-like properties.  Use of benzoxaborole moiety in the design of compds. led to the discovery of new classes of anti-bacterial, anti-fungal, anti-protozoal, anti-viral as well as anti-inflammatory agents with interesting drug development perspectives.  This article reviews the patent literature as well as chem. literature during the period 2010-2018 where in several benzoxaborole derivs. with therapeutic options were reported.  Two benzoxaborole derivs. are already clin. used for the treatment of onychomycosis (tavaborole) and atopic dermatitis (crisaborole), with several others in various phases of clin. trials.  By inhibiting enzymes essential in the life cycle of fungal, protozoan, bacterial and viral pathogens, it is probable that other compds. may soon enter the armamentarium of anti-infective agents.  On the other hand, phosphodiesterase 4 seems to be the human target responsible of the anti-inflammatory action of some benzoxaboroles.  The chem. versatility, peculiar mechanism of action related to the electron deficient nature of the boron atom, and ease of prepn. make benzoxaboroles a highly interesting field for the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSG_ztCy7KlrVg90H21EOLACvtfcHk0lgVBdXqmJ8d0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlSjt7o%253D&md5=07549982342b406a7e036d20dfe6aa4a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1473379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1473379%26sid%3Dliteratum%253Aachs%26aulast%3DNocentini%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DBenzoxaborole%2520compounds%2520for%2520therapeutic%2520uses%253A%2520a%2520patent%2520review%2520%25282010-2018%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D493%26epage%3D504%26doi%3D10.1080%2F13543776.2018.1473379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Er-Jun Hao, Gong-Xin Li, Yu-Ru Liang, Ming-Sheng Xie, Dong-Chao Wang, Xiao-Han Jiang, Jia-Yi Cheng, Zhi-Xian Shi, Yang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Ming Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2077-2109. <a href="https://doi.org/10.1021/acs.jmedchem.0c01717" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01717%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BActivity%252BEvaluation%252Bof%252BNovel%252BAcyclic%252BNucleosides%252Bas%252BPotential%252BAnticancer%252BAgents%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DHao%26aufirst%3DEr-Jun%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30092020%26date%3D04022021%26volume%3D64%26issue%3D4%26spage%3D2077%26epage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Muthalagu Vetrichelvan, Souvik Rakshit, Sathishkumar Chandrasekaran, Karthikeyan Chinnakalai, Chetan Padmakar Darne, Dyamanna Doddalingappa, Indasi Gopikumar, Anuradha Gupta, Arun Kumar Gupta, Ananta Karmakar, Thirumalai Lakshminarasimhan, David K. Leahy, Senthil Palani, Vignesh Radhakrishnan, Richard Rampulla, Antony Savarimuthu, Varadharajan Subramanian, Upender Velaparthi, Jayakumar Warrier, Martin D. Eastgate, Robert M. Borzilleri, Arvind Mathur, <span class="NLM_string-name hlFld-ContribAuthor">Rajappa Vaidyanathan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Scalable Synthesis of the Small Molecule TGFβR1 Inhibitor BMS-986260. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (7)
                                     , 1310-1320. <a href="https://doi.org/10.1021/acs.oprd.0c00232" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00232%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BScalable%252BSynthesis%252Bof%252Bthe%252BSmall%252BMolecule%252BTGF%2525CE%2525B2R1%252BInhibitor%252BBMS-986260%26aulast%3DVetrichelvan%26aufirst%3DMuthalagu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17052020%26date%3D02072020%26volume%3D24%26issue%3D7%26spage%3D1310%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinglin Li, Shanchao Wu, Guoqiang Dong, Shuqiang Chen, Zonglin Ma, Dan Liu, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 439-444. <a href="https://doi.org/10.1021/acsmedchemlett.9b00513" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00513%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNatural%252BProduct%252BEvodiamine%252Bwith%252BBorate%252BTrigger%252BUnit%25253A%252BDiscovery%252Bof%252BPotent%252BAntitumor%252BAgents%252Bagainst%252BColon%252BCancer%26aulast%3DLi%26aufirst%3DXinglin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06112019%26date%3D28022020%26date%3D04032020%26date%3D28022020%26volume%3D11%26issue%3D4%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Cai  Xiao</span>, <span class="hlFld-ContribAuthor ">Xiao-Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Ji  Deng</span>, <span class="hlFld-ContribAuthor ">Yu-Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Kai-Rong  Zhu</span>, <span class="hlFld-ContribAuthor ">Gen  Li</span>, <span class="hlFld-ContribAuthor ">Jun-Lin  Yu</span>, <span class="hlFld-ContribAuthor ">Jürgen  Brem</span>, <span class="hlFld-ContribAuthor ">Fener  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (62)
                                     , 7709-7712. <a href="https://doi.org/10.1039/D1CC03026D" title="DOI URL">https://doi.org/10.1039/D1CC03026D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC03026D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC03026D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DDesign%252Band%252Benantioselective%252Bsynthesis%252Bof%252B3-%252528%2525CE%2525B1-acrylic%252Bacid%252529%252Bbenzoxaboroles%252Bto%252Bcombat%252Bcarbapenemase%252Bresistance%26aulast%3DXiao%26aufirst%3DYou-Cai%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D62%26spage%3D7709%26epage%3D7712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijun  Yang</span>, <span class="hlFld-ContribAuthor ">Huiyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Finney</span>. </span><span class="cited-content_cbyCitation_article-title">A lysosome-targeted probe for the real-time detection of hypobromous acid in living human cancer cells. </span><span class="cited-content_cbyCitation_journal-name">The Analyst</span><span> <strong>2021,</strong> <em>146 </em>
                                    (8)
                                     , 2484-2489. <a href="https://doi.org/10.1039/D1AN00147G" title="DOI URL">https://doi.org/10.1039/D1AN00147G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1AN00147G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1AN00147G%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Analyst%26atitle%3DA%252Blysosome-targeted%252Bprobe%252Bfor%252Bthe%252Breal-time%252Bdetection%252Bof%252Bhypobromous%252Bacid%252Bin%252Bliving%252Bhuman%252Bcancer%252Bcells%26aulast%3DWang%26aufirst%3DYali%26date%3D2021%26date%3D2021%26volume%3D146%26issue%3D8%26spage%3D2484%26epage%3D2489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the medicinal chemistry of single boron atom-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>73 </em><a href="https://doi.org/10.1016/j.apsb.2021.01.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bsingle%252Bboron%252Batom-containing%252Bcompounds%26aulast%3DSong%26aufirst%3DShu%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Alan  Aitken</span>, <span class="hlFld-ContribAuthor ">Dheirya K.  Sonecha</span>. </span><span class="cited-content_cbyCitation_article-title">Five-membered Rings With Two Adjacent Heteroatoms With at Least One Boron. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00111-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00111-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00111-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00111-6%26sid%3Dliteratum%253Aachs%26atitle%3DFive-membered%252BRings%252BWith%252BTwo%252BAdjacent%252BHeteroatoms%252BWith%252Bat%252BLeast%252BOne%252BBoron%26aulast%3DAitken%26aufirst%3DR.%2BAlan%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asha  Ganesher</span>, <span class="hlFld-ContribAuthor ">Priyank  Chaturvedi</span>, <span class="hlFld-ContribAuthor ">Rohit  Sahai</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Meena</span>, <span class="hlFld-ContribAuthor ">Kalyan  Mitra</span>, <span class="hlFld-ContribAuthor ">Dipak  Datta</span>, <span class="hlFld-ContribAuthor ">Gautam  Panda</span>. </span><span class="cited-content_cbyCitation_article-title">New Spisulosine Derivative promotes robust autophagic response to cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 112011. <a href="https://doi.org/10.1016/j.ejmech.2019.112011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.112011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.112011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.112011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BSpisulosine%252BDerivative%252Bpromotes%252Brobust%252Bautophagic%252Bresponse%252Bto%252Bcancer%252Bcells%26aulast%3DGanesher%26aufirst%3DAsha%26date%3D2020%26volume%3D188%26spage%3D112011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Hardy</span>, <span class="hlFld-ContribAuthor ">Marianne  Engeser</span>, <span class="hlFld-ContribAuthor ">Arne  Lützen</span>. </span><span class="cited-content_cbyCitation_article-title">A heterobimetallic tetrahedron from a linear platinum(II)-bis(acetylide) metalloligand. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 2701-2708. <a href="https://doi.org/10.3762/bjoc.16.220" title="DOI URL">https://doi.org/10.3762/bjoc.16.220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.220%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252Bheterobimetallic%252Btetrahedron%252Bfrom%252Ba%252Blinear%252Bplatinum%252528II%252529-bis%252528acetylide%252529%252Bmetalloligand%26aulast%3DHardy%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D2701%26epage%3D2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of bortezomib, tavaborole, crisaborole, and compounds <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Amine Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, tetrahydrofuran (THF); (b) trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, THF, TEA; (c) KOH, MeOH; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, sat. aqueous (aq) Na<sub>2</sub>CO<sub>3</sub>, EtOH, toluene.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-Propanamide Benzoxaboroles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KMnO<sub>4</sub>, <i>t</i>-BuOH, H<sub>2</sub>O; (b) SOCl<sub>2</sub>; (c) MeOH, Et<sub>3</sub>N; (d) LiBH<sub>4</sub>, MeOH, THF; (e) dihydropyran, <i>p</i>-TsOH–H<sub>2</sub>O, dimethylformamide (DMF); (f) <i>n</i>-BuLi, B(<i>i-</i>PrO)<sub>3</sub>, THF; (g) 6 M HCl, MeOH; (h) pyridinium chlorochromate (PCC), Celite, dichloromethane (DCM); (i) ethyl (triphenylphosphoranylidene)acetate, toluene; (j) Pd/C, H<sub>2</sub>, EtOH; (k) NaOH, MeOH, H<sub>2</sub>O; (l) RNH<sub>2</sub>, EDCI, DCM.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogue Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, MeOH, H<sub>2</sub>O; (b) RNH<sub>2</sub>, EDCI, DCM; (c) methoxymethyl chloride (MOMCl), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), THF; (d) PCC, Celite, DCM; (e) ethyl (triphenylphosphoranylidene)acetate, toluene; (f) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O; (g) tributyl(vinyl)tin, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF; (h) NaIO<sub>4</sub>, K<sub>2</sub>OsO<sub>4</sub>, THF, H<sub>2</sub>O; (i) 4 M aqueous HCl, THF.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Induction of apoptosis on SKOV3 cells by compound <b>103</b>: flow cytometry analysis of apoptotic SKOV3 cells induced by compound <b>103</b> at different concentrations. Cells were treated with vehicle or compound <b>103</b> at 1.0, 3.0, and 10 μM for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of biological markers for apoptosis induction by compound <b>103</b> on H460 cells for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibitory effects of compound <b>103</b> on colony formation of SKOV3 cells. (A) Cells were treated with compound <b>103</b> at various concentrations. Digital image was taken and all visible colonies were counted. (B) Data were normalized to untreated control. The error bars represent standard deviations from triplicates. The statistical significance was obtained with one-way analysis of variance (ANOVA) (<i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/medium/jm-2019-00736d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo anticancer activity of compounds <b>103</b> and <b>115</b> on SKOV3 xenograft mouse model. Female nude BALB/c mice were administered by intraperitoneal injection with vehicle, compounds <b>103</b> and <b>115</b>, at a dosage of 2 and 10 mg/kg, respectively (<i>n</i> = 6 each group), once a day for 33 days. Average tumor volume (A, B), average body weight (C, D), and average tumor weight (E, F) were measured every 3 days. Data are expressed as the mean ± standard error (<i>n</i> = 6). * indicates <i>P</i> < 0.05 and ** indicates <i>P</i> < 0.01 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00736/20190719/images/large/jm-2019-00736d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00736&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i146">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamczyk-Woźniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borys, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporzyński, A.</span></span> <span> </span><span class="NLM_article-title">Recent developments in the chemistry and biological applications of benzoxaboroles</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">5224</span>– <span class="NLM_lpage">5247</span>, <span class="refDoi"> DOI: 10.1021/cr500642d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500642d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=5224-5247&author=A.+Adamczyk-Wo%C5%BAniakauthor=K.+M.+Borysauthor=A.+Sporzy%C5%84ski&title=Recent+developments+in+the+chemistry+and+biological+applications+of+benzoxaboroles&doi=10.1021%2Fcr500642d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Developments in the Chemistry and Biological Applications of Benzoxaboroles</span></div><div class="casAuthors">Adamczyk-Wozniak, Agnieszka; Borys, Krzysztof M.; Sporzynski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5224-5247</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the prepn., reactivity, structures, physicochem. properties, and medicinal applications of benzoxaboroles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJxyFCt1j-c7Vg90H21EOLACvtfcHk0li2G-76Olb4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFWrtbc%253D&md5=790df9ee9b890643e8f0e6dec3c00b00</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr500642d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500642d%26sid%3Dliteratum%253Aachs%26aulast%3DAdamczyk-Wo%25C5%25BAniak%26aufirst%3DA.%26aulast%3DBorys%26aufirst%3DK.%2BM.%26aulast%3DSporzy%25C5%2584ski%26aufirst%3DA.%26atitle%3DRecent%2520developments%2520in%2520the%2520chemistry%2520and%2520biological%2520applications%2520of%2520benzoxaboroles%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D5224%26epage%3D5247%26doi%3D10.1021%2Fcr500642d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomsho, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span> <span> </span><span class="NLM_article-title">The unique chemistry of benzoxaboroles: current and emerging applications in biotechnology and therapeutic treatments</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4473</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmc.2014.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24864040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslyjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4462-4473&author=C.+Liuauthor=J.+W.+Tomshoauthor=S.+J.+Benkovic&title=The+unique+chemistry+of+benzoxaboroles%3A+current+and+emerging+applications+in+biotechnology+and+therapeutic+treatments&doi=10.1016%2Fj.bmc.2014.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The unique chemistry of benzoxaboroles: Current and emerging applications in biotechnology and therapeutic treatments</span></div><div class="casAuthors">Liu, C. Tony; Tomsho, John W.; Benkovic, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4462-4473</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Benzoxaboroles have garnered much attention in recent years due to their diverse applications in bio-sensing technol., material science, and therapeutic intervention.  Part of the reason arises from the benzoxaboroles' unique chem. properties, esp. in comparison to their acyclic boronic acid counterparts.  Furthermore, the low bio-toxicity combined with the high target specificity assocd. with benzoxaboroles make them very attractive as therapeutic agents.  Herein, we provide an updated summary on the current knowledge of the fundamental chem. reactivity of benzoxaboroles, followed by highlighting their major applications reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpniR1y-qZ9BrVg90H21EOLACvtfcHk0li2G-76Olb4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslyjtb8%253D&md5=ce3d7e137a60a8dcc9309f34b74459b5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DTomsho%26aufirst%3DJ.%2BW.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520unique%2520chemistry%2520of%2520benzoxaboroles%253A%2520current%2520and%2520emerging%2520applications%2520in%2520biotechnology%2520and%2520therapeutic%2520treatments%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4462%26epage%3D4473%26doi%3D10.1016%2Fj.bmc.2014.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">The synthesis of benzoxaboroles and their applications in medicinal chemistry</span>. <i>Sci. China Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1381</span>, <span class="refDoi"> DOI: 10.1007/s11426-013-4981-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1007%2Fs11426-013-4981-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOisrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1372-1381&author=J.+Zhangauthor=M.+Zhuauthor=Y.+Linauthor=H.+Zhou&title=The+synthesis+of+benzoxaboroles+and+their+applications+in+medicinal+chemistry&doi=10.1007%2Fs11426-013-4981-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of benzoxaboroles and their applications in medicinal chemistry</span></div><div class="casAuthors">Zhang, Jiong; Zhu, Ming Yan; Lin, Yi Nan; Zhou, Hu Chen</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1372-1381</span>CODEN:
                <span class="NLM_cas:coden">SCCCCS</span>;
        ISSN:<span class="NLM_cas:issn">1869-1870</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">A review.  Benzoxaboroles, as a versatile scaffold, play important roles in org. synthesis, mol. recognition and supramol. chem.  It is also a privileged structure in medicinal chem. due to its desirable physicochem. and drug-like properties.  Recently, benzoxaboroles were widely applied as antifungal, antibacterial, antiviral, antiparasite, and antiinflammatory agents.  This review covers the properties, synthetic methods and applications of benzoxaboroles in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKpFLz0p2J7Vg90H21EOLACvtfcHk0lh8VQ_nd_FbVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOisrjL&md5=818a5b5bc6169ad282a3ba0a534c5f69</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11426-013-4981-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-013-4981-y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DThe%2520synthesis%2520of%2520benzoxaboroles%2520and%2520their%2520applications%2520in%2520medicinal%2520chemistry%26jtitle%3DSci.%2520China%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1372%26epage%3D1381%26doi%3D10.1007%2Fs11426-013-4981-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bross, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brower, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobburu, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goheer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lostritto, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinn, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbois, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Approval summary for bortezomib for injection in the treatment of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3954</span>– <span class="NLM_lpage">3964</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-03-0781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1158%2F1078-0432.CCR-03-0781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=15217925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFWmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3954-3964&author=P.+F.+Brossauthor=R.+Kaneauthor=A.+T.+Farrellauthor=S.+Abrahamauthor=K.+Bensonauthor=M.+E.+Browerauthor=S.+Bradleyauthor=J.+V.+Gobburuauthor=A.+Goheerauthor=S.-L.+Leeauthor=J.+Leightonauthor=C.+Y.+Liangauthor=R.+T.+Lostrittoauthor=W.+D.+McGuinnauthor=D.+E.+Morseauthor=A.+Rahmanauthor=L.+A.+Rosarioauthor=S.+L.+Verboisauthor=G.+Williamsauthor=Y.+C.+Wangauthor=R.+Pazdur&title=Approval+summary+for+bortezomib+for+injection+in+the+treatment+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-03-0781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma</span></div><div class="casAuthors">Bross, Peter F.; Kane, Robert; Farrell, Ann T.; Abraham, Sophia; Benson, Kimberly; Brower, Margaret E.; Bradley, Sean; Gobburu, Jogarao V.; Goheer, Anwar; Lee, Shwu-Luan; Leighton, John; Liang, Cheng Yi; Lostritto, Richard T.; McGuinn, William D.; Morse, David E.; Rahman, Atiqur; Rosario, Lilliam A.; Verbois, S. Leigh; Williams, Grant; Wang, Yong-Cheng; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3954-3964</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Purpose: Multiple myeloma is a malignant plasma cell disorder accounting for about 10% of hematol. malignancies.  Despite treatment advances, including hepatopoietic stem-cell transplantation to facilitate administration of high-dose cytotoxic chemotherapy, the median survival remains approx. 3 yr and long-term remissions are rare.  Bortezomib (Velcade, formerly known as PS-341; Millennium Pharmaceuticals, Cambridge MA) is a dipeptide boronic acid that inhibits the 20S proteasome involved in the degrdn. of intracellular proteins, including those affecting cell cycle regulation in mammalian cells.  Described herein are the analyses by the United States Food and Drug Administration (FDA) of clin. and nonclin. data submitted in the New Drug Application.  Chem. manufg. and controls, animal toxicol., and biopharmaceutical data are described.  The results of Phase I and Phase II clin. studies in patients with multiple myeloma are summarized.  The marketing approval and postmarketing commitments are discussed.  Results: Toxicol. studies in the rat and monkey identified hematol., lymphoid, cardiac, renal, gastrointestinal, and ndurol. toxicities of bortezomib.  A steep dose-toxicity effect was noted at doses ≥0.9 mg/m2.  Administration of doses >3.0 mg/m2 to monkeys resulted in cardiovascular collapse and death 12-14 h postdose.  Histopathol. evidence of axonal and myelin degeneration of dorsal root ganglia, peripheral nerves, and spinal cord were obsd. i monkeys and rodents; concurrent clin. observations included tremors and decreased activity.  Pharmacokinetic studies in patients with advanced malignancies demonstrated that the mean elimination half-life after the bortezomib dose varied from 9 to 15 h at doses ranging from 1.45 to 2.00 mg/m2.  The drug is metabolized by cytochrome P 450-3A4, -2D6, -2C19, -2C9, and -1A2.  Three Phase I studies were performed in a total of 123 patients with advanced malignancies.  Dose-limiting toxicity included diarrhea and sensory neurotoxicity.  No dose-limiting hematol. toxicity was reported.  Safety and efficacy were evaluated in an open-label, Phase II study of 202 patients with multiple myeloma who had received at least two prior therapies and had demonstrated disease progression on their most recent therapy.  A smaller dose finding study of 54 patients provided addnl. supportive information.  Bortezomib was administered by i.v. bolus on days 1, 4, 8, an 11 in a 21-day cycle for up to eight cycles.  The initial dose was 1.3 mg/m2 except for 28 patients in the dose-finding study who received a 1.0 mg/m2 dose.  The primary study end point in this single-arm trial was response rate, easily measured and thought to correlate with clin. benefit in patients with myeloma.  One hundred eight-eight patients who met the inclusion criteria were included in the FDA efficacy anal. population.  Complete responses (CRs) were obsd. in 5 patients and partial responses (PRs) in 47 patients for an overall response (OR) rate (OR = CR + PR) of 28%.  The dose finding study of 54 patients showed a higher response rate for patients given 1.3 mg/m2 compared with 1.0 mg/m2 twice weekly for two of the 3-wk schedule, but the study was too small for statistical dose-response comparisons.  The most commonly reported adverse events were asthenic conditions (including fatigue, malaise, and weakness) in 65%, nausea (64%), diarrhea (51%), appetite decreased (including anorexia; 43%), constipation (43%), thrombocytopenia (43%), peripheral neuropathy (37%, including peripheral sensory neuropathy and peripheral neuropathy aggravated), pyrexia (36%), vomiting (36%), and anemia (32%).  Conclusions: The FDA granted marketing approved in Millennium Pharmaceuticals on May 13, 2003 for bortezomib for use as a single agent for the treatment of multiple myeloma in patients who have received at least two prior therapies and have demonstrated disease progression on the last therapy.  Accelerated approval was based on a surrogate end point of response rate rather than clin. benefit, such as an improvement in survival.  The recommended dose of bortezomib is 1.3 mg/m2 administered twice weekly for 2 wk (days 1, 4, 8 , and 11) followed by a 10-day rest period (days 12-21).  Accelerated approval was based on the results of two Phase II studies in a total of 256 patients and addnl. Phase I safety information.  Mandated Phase IV study commitments to characterize clin. efficacy and safety more precisely are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9U7azd4GPrVg90H21EOLACvtfcHk0lh8VQ_nd_FbVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFWmtLk%253D&md5=b2d07d88fb384b92b1691bf2f9900044</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0781%26sid%3Dliteratum%253Aachs%26aulast%3DBross%26aufirst%3DP.%2BF.%26aulast%3DKane%26aufirst%3DR.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DBenson%26aufirst%3DK.%26aulast%3DBrower%26aufirst%3DM.%2BE.%26aulast%3DBradley%26aufirst%3DS.%26aulast%3DGobburu%26aufirst%3DJ.%2BV.%26aulast%3DGoheer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-L.%26aulast%3DLeighton%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%2BY.%26aulast%3DLostritto%26aufirst%3DR.%2BT.%26aulast%3DMcGuinn%26aufirst%3DW.%2BD.%26aulast%3DMorse%26aufirst%3DD.%2BE.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DRosario%26aufirst%3DL.%2BA.%26aulast%3DVerbois%26aufirst%3DS.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520summary%2520for%2520bortezomib%2520for%2520injection%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3954%26epage%3D3964%26doi%3D10.1158%2F1078-0432.CCR-03-0781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torssell, K.</span></span> <span> </span><span class="NLM_article-title">Arylboronic acids. III. Bromination of tolylboronic acids according to Wohl-Ziegler</span>. <i>Ark. Kemi.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADyaG1cXot1Chuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1957&pages=507-511&author=K.+Torssell&title=Arylboronic+acids.+III.+Bromination+of+tolylboronic+acids+according+to+Wohl-Ziegler"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Arylboronic acids. III. Bromination of tolylboronic acids according to Wohl-Ziegler</span></div><div class="casAuthors">Torssell, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Arkiv foer Kemi</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507-11</span>CODEN:
                <span class="NLM_cas:coden">ARKEAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-6128</span>.
    </div><div class="casAbstract">Tolylboronic acids reacted with 1 or 2 mols. of N-bromosuccinimide (I) to form ω-bromo or ω,ω-dibromo derivs., resp.  Hydrolysis of the bromo compds. gave hydroxymethyl-, and formylphenylboronic acids.  I (6.8 g.) and about 0.1 g. Bz2O2 were added to 5 g. p-MeC6H4B(OH)2 (II) in 190 ml. CCl4, the mixt. refluxed 1 hr. on a water bath with exclusion of moisture, and the succinimide filtered off, giving p-BrCH2C6H4B(OH)2 (III), m. 165-8° (from CCl4), 90% yield.  Prepd. similarly were the m-isomer, m. 214-16° (CCl4), and the ο-isomer (IV), m. 148° (CCl4).  IV (0.4 g.) heated in 6 ml. H2O 10 min. gave 0.1 g. white ο ο-HOCH2C6H4B(OH)2 anhydride, m. 97-8°.  Reaction of III with boiling H2O probably gave p-HOCH2C6H4B(OH)2, but it could not be isolated; however, some p-OHCC6H4B(OH)2 (V) was isolated.  The products from the attempted prepns. of p-H2NC6H4B(OH)2 and of p-Et2NC6H4B(OH)2 could not be isolated in pure form. p-Br2C6H3B(OH)2 (VI), decomp. 160-70° (CCl4 or PhMe), was prepd. as for III, with only half as much II used.  Similarly obtained were 69% m-isomer, decomp. 160-5° (Me-NO2), and 56% ο-isomer, m. 163° (cyclohexane).  VI (0.5 g.) heated 10 min. in 5 ml. H2O satd. with SO2 and the mixt. cooled gave 0.16 g. V, sinters 230-40° to a glassy mass (H2O).  Prepd. likewise were ο-OHCC6H4B(OH)2, m. 123° (MeNO2), and 47% m-isomer, m. 112° with loss of H2O, m. 180° (H2O).  Derivs. of V prepd. were the red p-nitro-phenylhydrazone, decomp. approx. 280° (70% MeOH), and the white thiosemicarbazone, decomp. 204-5° (3:1 H2O-EtOH).  Attempts to prep. ο-HO2CC6H4B(OH)2 were unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjyYyQpe_M7Vg90H21EOLACvtfcHk0lhpc2UFVW0kjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXot1Chuw%253D%253D&md5=da2777214f487f8073a6ce1dcb2174f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorssell%26aufirst%3DK.%26atitle%3DArylboronic%2520acids.%2520III.%2520Bromination%2520of%2520tolylboronic%2520acids%2520according%2520to%2520Wohl-Ziegler%26jtitle%3DArk.%2520Kemi.%26date%3D1957%26volume%3D10%26spage%3D507%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennarz, W. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1021/ja01537a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01537a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADyaG1cXmtV2lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=835-838&author=H.+R.+Snyderauthor=A.+J.+Reedyauthor=W.+J.+Lennarz&title=Synthesis+of+aromatic+boronic+acids.+Aldehydo+boronic+acids+and+a+boronic+acid+analog+of+tyrosine&doi=10.1021%2Fja01537a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine</span></div><div class="casAuthors">Snyder, H. R.; Reedy, Albert J.; Lennarz, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">835-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">ο-MeC6H4B(OH)2 (I) (5 g.) and 100 cc. CCl4 treated with stirring with about 5 cc. soln. of 6 g. dry Br in 50 cc. CCl4 while being illuminated with a 200-w. light bulb, the mixt. treated after an induction period of 5-15 min. with the remainder of the Br soln. in portions of about 5 cc. during about 15 min. and evapd., and the residue recrystd. from CHCl3 yielded 7.4 g. ο-BrCH2C6H4B(OH)2 (II), m. 139-46°.  p-MeC6H4B(OH)2 (III) (5 g.) gave similarly 7.2 g. p-BrCH2C6H4B(OH)2 (IV), m. 138-44°.  III (5 g.), 150 cc. dry CHCl3, 650 mg. Bz2O2, and 6.5 g. N-bromosuccinimide (V) refluxed 3 hrs. while being illuminated with a 200-w. light bulb, the mixt. refluxed 1 hr. with 7 g. hexamethylenetetramine in 75 cc. dry CHCl3, the hot soln. decanted, the residue extd. with 40 cc. HCl of pH 4, the aq. soln. freed of a few drops CHCl3, refluxed 1 hr., poured into a beaker, treated immediately with 10 cc. concd. HCl, and cooled, and the cryst. product recrystd. from H2O yielded 1.5 g. p-OHCC6H4B(OH)2 (VI).0.5H2O, m. 230-40°, which dried 24 hrs. at room temp. and 1 mm. gave VI; a sample dried 1 hr. at 80°/1 mm. gave the anhydride.  I (1 g.), 40 cc. dry CCl4, 2.6 g. V, and 260 mg. Bz2O2 refluxed 2.5 hrs. while being illuminated by a 200-w. bulb, filtered, and extd. with 15% aq. KOH, the alk. ext. acidified after 15 min., kept 2 hrs., and extd. with Et2O, and the ext. evapd. gave 370 mg. ο-OHCC6H4B(OH)2 (VII), m. 118-20°.  VI (500 mg.), 200 mg. MeNO2, and 4 cc. EtOH treated slowly below 10° with 274 mg. NaOH in 4 cc. H2O, stirred 15 min. at 10°, clarified with aq. NaOH, cooled to 5°, and added to 2 cc. concd. HCl in 3 cc. H2O at 0° yielded 455 mg. p-O2NCH:CHC6H4B(OH)2, light yellow, m. 289-90° (decompn.) (33% EtOH).  VII was recovered unchanged from a similar run.  VI (1 g.), 15 cc. Me2CO, 5 cc. H2O, and 5 cc. 10% aq. NaOH kept below 30° by cooling with tap water and then 4 hrs. at room temp. and filtered, the residue dissolved in 10 cc. H2O and acidified, the ppt. filtered, and the residues recrystd. from aq. EtOH gave 1.05 g. p-AcCH:CHC6H4B(OH)2, m. 205-12°.  VII was recovered unchanged from a similar run.  VI (1 g.), 3.5 g. KCN, and 7 cc. H2O treated slowly at 10° with 0.57 cc. concd. H2SO4 in 1.73 cc. H2O, filtered, acidified with 10% HCl, kept 10 min. at 10°, and the product isolated with Et2O gave p-NC(HO)CHC6H4B(OH)2, which softened at about 65° and appeared to undergo several changes before completely m. 104°.  VI treated with N2H4.H2O gave the azine of VI, m. 295° (aq. HCONMe2).  VI oxidized with KMnO4 at room temp. yielded 86% p-HO2CC6H4B(OH)2, m. 219-20°.  VI in EtOH hydrogenated over PtO2 gave a gelatinous solid which could not be purified.  VI treated with 10 or 20% aq. NaOH at room temp. to reflux temp. from 45 min. to 12 hrs. was recovered unchanged; similar results were obtained in the attempted benzoin condensation during 40-90 min. and in the attempted condensations with BzH, p-Me2NC6H4CHO, and p-O2NC6H4CHO.  VII (600 mg.) refluxed 2 hrs. with 5 cc. deoxygenated 20% aq. NaOH under N yielded 300 mg. BzOH.  VII (500 mg.) and 360 mg. NH2OH.HCl in 20 cc. hot H2O adjusted with NaOH to pH 7, refluxed 15 min., cooled, acidified with concd. HCl, and refrigerated 2 days gave 420 mg. p-HON:CHC6H4B(OH)2, m. 150-5°.  I (5 g.) treated in CCl4 in the usual manner with 6 g. Br and extd. with 15% aq. KOH, the ext. kept 1 hr. at room temp., acidified with 15% HCl, and filtered, the filtrate concd. to 50 cc., and the product isolated with Et2O gave 3.5 g. ο-C6H4.CH2.O.BOH (VIII), m. 96-8° (H2O).  I (25 g.), 32.5 g. V, 3.25 g. Bz2O2, and 350 cc. dry CHCl3 refluxed 3 hrs., treated with 30 g. hexamethylenetetramine in 200 cc. CHCl3, refluxed 15 min., and decanted, the residue dissolved in 100 cc. aq. HCl of pH 4, and the aq. soln. refluxed 1 hr. gave 5.2 g. IX, m. 308-9° (HCONMe2).  IX in 10% HCl treated with NaNO2 effervesced and gave VIII.  AcNHCH(CO2Et)2 (28.8 g.) added to 3.16 g. Na in 300 cc. abs. EtOH with stirring, the mixt. treated with stirring with 19.7 g. VI, refluxed 11 hrs. with stirring, cooled to room temp., treated with 12 cc. 3N HCl, and filtered, the filtrate evapd., and the residual semisolid crystd. from about 600 cc. 33% EtOH yielded 21.7 g. p-(EtO2C)2C(NHAc)CH2C6H4B(OH)2 (X), m. 220-3°.  X (21.7 g.) and 180 cc. 5% aq. NaOH refluxed 3.75 hrs. with stirring, cooled, treated slowly with 90 cc. 3NN HCl, refluxed 1 hr., and evapd. in vacuo, and the residue crystd. from the min. amt. of H2O yielded 13.5 g. p-HO2CCH(NHAc)C6H4B(OH)2 (XI), m. 168-70°.  XI (13.5 g.) and 16 g. NaOH in 250 cc. H2O refluxed 9 hrs. with stirring, acidified with 25 cc. concd. HCl, adjusted to pH 6.2 with NH4OH, concd. to 100 cc. in vacuo, and refrigerated overnight yielded 8.3 g. p-HO2CCH(NH2)CH2C6H4B(OH)2 (XII), m. 285-90° (decompn.).  XII (0.1-0.2 g.) treated with 3 cc. N HCl and slowly evapd. to dryness yielded XII.HCl, m. 200-3°.  XII (0.5 g.) in 20 cc. 5% aq. NaOH refluxed 48 hrs. in a Cu flask, filtered hot, adjusted to pH 3 with HCl and then to pH 5.7 with NH4OH, and filtered, the filtrate evapd. to near dryness in vacuo, the residue treated with 10 cc. H2O, and the remaining solid filtered off gave a mixt., m. 235-40°, of XII and PhCH2CH(NH2)CO2H which chromatographed with 4:1:5 BuOH-AcOH-H2O (descending) showed the Rf values 0.46 and 0.69, resp.  XII in excess aq. NaOH titrated with 0.1N HCl gave a titration curve similar in shape to that of a normal amino acid.  The boronic acid function has a pKa of the same magnitude as the ammonium ion; on the basic side of the titration curve 2 equivs. acid were required for neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo50pif1I7F2bVg90H21EOLACvtfcHk0lhpc2UFVW0kjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXmtV2lsw%253D%253D&md5=95318dbe3031236608bed3b91c3bdf2a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja01537a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01537a021%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BR.%26aulast%3DReedy%26aufirst%3DA.%2BJ.%26aulast%3DLennarz%26aufirst%3DW.%2BJ.%26atitle%3DSynthesis%2520of%2520aromatic%2520boronic%2520acids.%2520Aldehydo%2520boronic%2520acids%2520and%2520a%2520boronic%2520acid%2520analog%2520of%2520tyrosine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D835%26epage%3D838%26doi%3D10.1021%2Fja01537a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of Onychomycosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4447</span>– <span class="NLM_lpage">4450</span>, <span class="refDoi"> DOI: 10.1021/jm0603724</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603724" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt12lsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4447-4450&author=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=T.+Akamaauthor=A.+Lauauthor=H.+Zhouauthor=V.+Hernandezauthor=W.+M.+Maoauthor=M.+R.+K.+Alleyauthor=V.+Sandersauthor=J.+J.+Plattner&title=Discovery+of+a+new+boron-containing+antifungal+agent%2C+5-fluoro-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaborole+%28AN2690%29%2C+for+the+potential+treatment+of+Onychomycosis&doi=10.1021%2Fjm0603724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis</span></div><div class="casAuthors">Baker, Stephen J.; Zhang, Yong-Kang; Akama, Tsutomu; Lau, Agnes; Zhou, Huchen; Hernandez, Vincent; Mao, Weimin; Alley, M. R. K.; Sanders, Virginia; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4447-4450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-contg. small mol., AN2690 (I), which is currently in clin. trials for onychomycosis topical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCA9knQ5nc7Vg90H21EOLACvtfcHk0lhpc2UFVW0kjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt12lsro%253D&md5=c21119d24d45861fefe07d802d9a786e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0603724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603724%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DMao%26aufirst%3DW.%2BM.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520new%2520boron-containing%2520antifungal%2520agent%252C%25205-fluoro-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaborole%2520%2528AN2690%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520Onychomycosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4447%26epage%3D4450%26doi%3D10.1021%2Fjm0603724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaremchuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinis, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1126/science.1142189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1126%2Fscience.1142189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=17588934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1759-1761&author=F.+L.+Rockauthor=W.+Maoauthor=A.+Yaremchukauthor=M.+Tukaloauthor=T.+Crepinauthor=H.+Zhouauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=T.+Akamaauthor=S.+J.+Bakerauthor=J.+J.+Plattnerauthor=L.+Shapiroauthor=S.+A.+Martinisauthor=S.+J.+Benkovicauthor=S.+Cusackauthor=M.+R.+K.+Alley&title=An+antifungal+agent+inhibits+an+aminoacyl-tRNA+synthetase+by+trapping+tRNA+in+the+editing+site&doi=10.1126%2Fscience.1142189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span></div><div class="casAuthors">Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5832</span>),
    <span class="NLM_cas:pages">1759-1761</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aminoacyl-tRNA synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets.  We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNALeu-AN2690 adduct in the editing site of the enzyme.  Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine.  The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNALeu and consequentially blocking protein synthesis.  This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcTqC8iispbVg90H21EOLACvtfcHk0liMQ3VeqAnv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D&md5=0da444baf3c2f6e0768fe19febcaee6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142189%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DYaremchuk%26aufirst%3DA.%26aulast%3DTukalo%26aufirst%3DM.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DShapiro%26aufirst%3DL.%26aulast%3DMartinis%26aufirst%3DS.%2BA.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DAn%2520antifungal%2520agent%2520inhibits%2520an%2520aminoacyl-tRNA%2520synthetase%2520by%2520trapping%2520tRNA%2520in%2520the%2520editing%2520site%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1759%26epage%3D1761%26doi%3D10.1126%2Fscience.1142189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=19303290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2129-2132&author=T.+Akamaauthor=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=H.+Zhouauthor=V.+Sandersauthor=Y.+Freundauthor=R.+Kimuraauthor=K.+R.+Maplesauthor=J.+J.+Plattner&title=Discovery+and+structure-activity+study+of+a+novel+benzoxaborole+anti-inflammatory+agent+%28AN2728%29+for+the+potential+topical+treatment+of+psoriasis+and+atopic+dermatitis&doi=10.1016%2Fj.bmcl.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span></div><div class="casAuthors">Akama, Tsutomu; Baker, Stephen J.; Zhang, Yong-Kang; Hernandez, Vincent; Zhou, Huchen; Sanders, Virginia; Freund, Yvonne; Kimura, Richard; Maples, Kirk R.; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2129-2132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release.  5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo.  This compd. is now in clin. development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdD-T7O2W57Vg90H21EOLACvtfcHk0liMQ3VeqAnv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D&md5=a526278d0506fc5916432cf20c6ff5e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-activity%2520study%2520of%2520a%2520novel%2520benzoxaborole%2520anti-inflammatory%2520agent%2520%2528AN2728%2529%2520for%2520the%2520potential%2520topical%2520treatment%2520of%2520psoriasis%2520and%2520atopic%2520dermatitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2129%26epage%3D2132%26doi%3D10.1016%2Fj.bmcl.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukac, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span> <span> </span><span class="NLM_article-title">Clinical and veterinary trypanocidal benzoxaboroles target CPSF3</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9616</span>– <span class="NLM_lpage">9621</span>, <span class="refDoi"> DOI: 10.1073/pnas.1807915115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1073%2Fpnas.1807915115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=30185555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=9616-9621&author=R.+J.+Wallauthor=E.+Ricoauthor=I.+Lukacauthor=F.+Zuccottoauthor=S.+Elgauthor=I.+H.+Gilbertauthor=Y.+Freundauthor=M.+R.+K.+Alleyauthor=M.+C.+Fieldauthor=S.+Wyllieauthor=D.+Horn&title=Clinical+and+veterinary+trypanocidal+benzoxaboroles+target+CPSF3&doi=10.1073%2Fpnas.1807915115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and veterinary trypanocidal benzoxaboroles target CPSF3</span></div><div class="casAuthors">Wall, Richard J.; Rico, Eva; Lukac, Iva; Zuccotto, Fabio; Elg, Sara; Gilbert, Ian H.; Freund, Yvonne; Alley, M. R. K.; Field, Mark C.; Wyllie, Susan; Horn, David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">9616-9621</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">African trypanosomes cause lethal and neglected tropical diseases, known as sleeping sickness in humans and nagana in animals.  Current therapies are limited, but fortunately, promising therapies are in advanced clin. and veterinary development, including acoziborole (AN5568 or SCYX-7158) and AN11736, resp.  These benzoxaboroles will likely be key to the World Health Organization's target of disease control by 2030.  Their mode of action was previously unknown.  We have developed a high-coverage overexpression library and use it here to explore drug mode of action in Trypanosoma brucei.  Initially, an inhibitor with a known target was used to select for drug resistance and to test massive parallel library screening and genome-wide mapping; this effectively identified the known target and validated the approach.  Subsequently, the overexpression screening approach was used to identify the target of the benzoxaboroles, Cleavage and Polyadenylation Specificity Factor 3 (CPSF3, Tb927.4.1340).  We validated the CPSF3 endonuclease as the target, using independent overexpression strains.  Knockdown provided genetic validation of CPSF3 as essential, and GFP tagging confirmed the expected nuclear localization.  Mol. docking and CRISPR-Cas9-based editing demonstrated how acoziborole can specifically block the active site and mRNA processing by parasite, but not host CPSF3.  Thus, our findings provide both genetic and chem. validation for CPSF3 as an important drug target in trypanosomes and reveal inhibition of mRNA maturation as the mode of action of the trypanocidal benzoxaboroles.  Understanding the mechanism of action of benzoxaborole-based therapies can assist development of improved therapies, as well as the prediction and monitoring of resistance, if or when it arises.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yjPx5rJD7LVg90H21EOLACvtfcHk0liMQ3VeqAnv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhu7zL&md5=aaa91988ec41afbc6add5d664b1e5a29</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1807915115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1807915115%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DRico%26aufirst%3DE.%26aulast%3DLukac%26aufirst%3DI.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DElg%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DHorn%26aufirst%3DD.%26atitle%3DClinical%2520and%2520veterinary%2520trypanocidal%2520benzoxaboroles%2520target%2520CPSF3%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D9616%26epage%3D9621%26doi%3D10.1073%2Fpnas.1807915115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (<i>S</i>)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3<i>H</i>)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+Perez-Herranauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+potent+and+specific+M.+tuberculosis+leucyl-tRNA+synthetase+inhibitor%3A+%28S%29-3-%28aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0ljjDrDQ0IRAfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520specific%2520M.%2520tuberculosis%2520leucyl-tRNA%2520synthetase%2520inhibitor%253A%2520%2528S%2529-3-%2528aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eason, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaravino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erve, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. part 5. lead optimization of novel amide pyrazinyloxy benzoxaboroles and identification of a preclinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5889-5908&author=Y.+K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easonauthor=R.+T.+Jacobsauthor=D.+Guoauthor=Y.+R.+Freundauthor=P.+Berryauthor=V.+Ciaravinoauthor=J.+C.+Erveauthor=P.+J.+Rosenthalauthor=B.+Campoauthor=F.+Gamoauthor=L.+Sanzauthor=J.+Cao&title=Benzoxaborole+antimalarial+agents.+part+5.+lead+optimization+of+novel+amide+pyrazinyloxy+benzoxaboroles+and+identification+of+a+preclinical+candidate&doi=10.1021%2Facs.jmedchem.7b00621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Jacobs, Robert T.; Guo, Denghui; Freund, Yvonne R.; Berry, Pamela; Ciaravino, Vic; Erve, John C. L.; Rosenthal, Philip J.; Campo, Brice; Gamo, Francisco-Javier; Sanz, Laura M.; Cao, Jianxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5889-5908</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a mol. with satisfactory antimalarial activity, physicochem. properties, pharmacokinetic profile, in vivo efficacy, and safety profile.  This optimization effort discovered 46, which met our target candidate profile.  Compd. 46 had excellent activity against cultured Plasmodium falciparum, and in vivo against P. falciparum and P. berghei in infected mice.  It exhibited good PK properties in mice, rats, and dogs.  It was highly active against the other 11 P. falciparum strains, which are mostly resistant to chloroquine and pyrimethamine.  The rapid parasite in vitro redn. and in vivo parasite clearance profile of 46 were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials.  It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg.  The combined properties of this novel benzoxaborole support its progression to preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojoCeksZcUZrVg90H21EOLACvtfcHk0ljjDrDQ0IRAfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7bO&md5=2b3aee2afe14e6eee0b8dd24f02e8433</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00621%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEason%26aufirst%3DE.%2BE.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DFreund%26aufirst%3DY.%2BR.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DCiaravino%26aufirst%3DV.%26aulast%3DErve%26aufirst%3DJ.%2BC.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DGamo%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520part%25205.%2520lead%2520optimization%2520of%2520novel%2520amide%2520pyrazinyloxy%2520benzoxaboroles%2520and%2520identification%2520of%2520a%2520preclinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5889%26epage%3D5908%26doi%3D10.1021%2Facs.jmedchem.7b00621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against <i>Trypanosoma brucei</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.ejmech.2014.04.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24826816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=59-75&author=P.+Wuauthor=J.+Zhangauthor=Q.+Mengauthor=B.+Nareauthor=R.+T.+Jacobsauthor=H.+Zhou&title=Novel+pyrrolobenzoxaboroles%3A+design%2C+synthesis%2C+and+biological+evaluation+against+Trypanosoma+brucei&doi=10.1016%2Fj.ejmech.2014.04.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei</span></div><div class="casAuthors">Wu, Puhua; Zhang, Jiong; Meng, Qingqing; Nare, Bakela; Jacobs, Robert T.; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-75</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis is a fatal parasitic infection caused by the protozoan Trypanosoma brucei.  The development of novel antitrypanosomal agents is urgently needed.  Here authors report the synthesis and structure-activity relationship of a new class of benzoxaboroles as antitrypanosomal agents.  These compds. showed antiparasitic IC50 values ranging from 4.02 to 0.03 μg/mL and satisfactory cytotoxicity profile.  Three of the lead compds. were demonstrated to cure the parasitic infection in a murine acute infection model.  The structure-activity relationship of the pyrrolobenzoxaboroles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQOnvv25q8bVg90H21EOLACvtfcHk0ljjDrDQ0IRAfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltb8%253D&md5=07aa0344d601ef45da9ae409363f3eae</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.079%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DNovel%2520pyrrolobenzoxaboroles%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520against%2520Trypanosoma%2520brucei%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D59%26epage%3D75%26doi%3D10.1016%2Fj.ejmech.2014.04.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent benzoxaborole-based anti-pneumococcal agent</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">2475</span> <span class="refDoi"> DOI: 10.1038/srep02475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fsrep02475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=23959225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC3sbhtFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&author=Q.+Huauthor=R.+Liuauthor=Z.+Fangauthor=J.+Zhangauthor=Y.+Dingauthor=M.+Tanauthor=M.+Wangauthor=W.+Panauthor=H.+Zhouauthor=E.+Wang&title=Discovery+of+a+potent+benzoxaborole-based+anti-pneumococcal+agent&doi=10.1038%2Fsrep02475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase</span></div><div class="casAuthors">Hu Qing-Hua; Liu Ru-Juan; Fang Zhi-Peng; Zhang Jiong; Ding Ying-Ying; Tan Min; Wang Meng; Pan Wei; Zhou Hu-Chen; Wang En-Duo</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2475</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Streptococcus pneumoniae causes bacterial pneumonia with high mortality and morbidity.  The emergency of multidrug-resistant bacteria threatens the treatment of the disease.  Leucyl-tRNA synthetase (LeuRS) plays an essential role in cellular translation and is an attractive drug target for antimicrobial development.  Here we report the compound ZCL039, a benzoxaborole-based derivative of AN2690, as a potent anti-pneumococcal agent that inhibits S. pneumoniae LeuRS (SpLeuRS) activity.  We show using kinetic, biochemical analyses combined with the crystal structure of ZCL039-AMP in complex with the separated SpLeuRS editing domain, that ZCL039 binds to the LeuRS editing active site which requires the presence of tRNA(Leu), and employs an uncompetitive inhibition mechanism.  Further docking models establish that ZCL039 clashes with the eukaryal/archaeal specific insertion I4ae helix within editing domains.  These findings demonstrate the potential of benzoxaboroles as effective LeuRS inhibitors for pneumococcus infection therapy, and provide future structure-guided drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFg4yvXGLu5u98rul4nhSdfW6udTcc2eaqwyyS9UXUmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbhtFKqtg%253D%253D&md5=6378664efa8609e30e2bade33e3aa469</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsrep02475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep02475%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520benzoxaborole-based%2520anti-pneumococcal%2520agent%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26doi%3D10.1038%2Fsrep02475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1021/jm2012408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3553-3557&author=Z.+Qiaoauthor=Q.+Wangauthor=F.+Zhangauthor=Z.+Wangauthor=T.+Bowlingauthor=B.+Nareauthor=R.+T.+Jacobsauthor=J.+Zhangauthor=D.+Dingauthor=Y.+Liuauthor=H.+Zhou&title=Chalcone-benzoxaborole+hybrid+molecules+as+potent+antitrypanosomal+agents&doi=10.1021%2Fjm2012408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-Benzoxaborole Hybrid Molecules as Potent Antitrypanosomal Agents</span></div><div class="casAuthors">Qiao, Zhitao; Wang, Qi; Zhang, Fenglong; Wang, Zhongli; Bowling, Tana; Nare, Bakela; Jacobs, Robert T.; Zhang, Jiong; Ding, Dazhong; Liu, Yangang; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3553-3557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the novel chalcone-benzoxaborole hybrids and their structure-activity relationship againstTrypanosoma brucei parasites.  The 4-NH2 deriv. 29 and 3-OMe deriv. 43 were found to have excellent potency.  The synergistic 4-NH2-3-OMe compd. 49 showed an IC50 of 0.010 μg/mL and resulted in 100% survival and zero parasitemia in a murine infection model, which represents one of the most potent compds. discovered to date from the benzoxaborole class that inhibit T. brucei growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3nXM7LHIG8LVg90H21EOLACvtfcHk0ljvnk-1Wx2SRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVagurc%253D&md5=626a1fb63f3749953b64c9acca267d3f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2012408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012408%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DChalcone-benzoxaborole%2520hybrid%2520molecules%2520as%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3553%26epage%3D3557%26doi%3D10.1021%2Fjm2012408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of <i>Trypanosoma brucei</i> leucyl-tRNA synthetase inhibitors as antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1276</span>– <span class="NLM_lpage">1287</span>, <span class="refDoi"> DOI: 10.1021/jm101225g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101225g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1276-1287&author=D.+Dingauthor=Q.+Mengauthor=G.+Gaoauthor=Y.+Zhaoauthor=Q.+Wangauthor=B.+Nareauthor=R.+Jacobsauthor=F.+Rockauthor=M.+R.+K.+Alleyauthor=J.+J.+Plattnerauthor=G.+Q.+Chenauthor=D.+Liauthor=H.+Zhou&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+Trypanosoma+brucei+leucyl-tRNA+synthetase+inhibitors+as+antitrypanosomal+agents&doi=10.1021%2Fjm101225g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents</span></div><div class="casAuthors">Ding, Dazhong; Meng, Qingqing; Gao, Guangwei; Zhao, Yaxue; Wang, Qing; Nare, Bakela; Jacobs, Robert; Rock, Fernando; Alley, Michael R. K.; Plattner, Jacob J.; Chen, Guoqiang; Li, Dawei; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1276-1287</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">African trypanosomiasis, caused by the protozoal pathogen Trypanosoma brucei (T. brucei), is one of the most neglected tropical diseases that are in great need of new drugs.  The design and synthesis of T. brucei leucyl-tRNA synthetase (TbLeuRS) inhibitors and their structure-activity relation is reported.  Benzoxaborole was used as the core structure and C(6) was modified to achieve improved affinity based on docking results that showed further binding space at this position.  Indeed, compds. with C(7) substitutions showed diminished activity due to clash with the eukaryote specific I4ae helix while substitutions at C(6) gave enhanced affinity.  TbLeuRS inhibitors with IC50 ≥1.6 μM were discovered, and the structure-activity relation is discussed.  The most potent enzyme inhibitors also showed excellent T. brucei parasite growth inhibition activity.  This is the 1st time that TbLeuRS inhibitors are reported, and probably leucyl-tRNA synthetase (LeuRS) is a potential target for antiparasitic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGQVCRyjEerVg90H21EOLACvtfcHk0ljvnk-1Wx2SRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeju7g%253D&md5=e72df282e5806c3fa66dc38d412cf0fd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101225g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101225g%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DRock%26aufirst%3DF.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DG.%2BQ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520Trypanosoma%2520brucei%2520leucyl-tRNA%2520synthetase%2520inhibitors%2520as%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1276%26epage%3D1287%26doi%3D10.1021%2Fjm101225g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Ding, D.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Zhang, Y.-K.</span>; <span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Boron-Containing Small Molecules as Antiprotozoal Agents</span>. <span class="NLM_patent">WO2011/022337 A1</span>, Feb 24, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+Zhou&author=D.+Ding&author=Y.+Zhou&author=Y.-K.+Zhang&author=J.+J.+Plattner&title=Boron-Containing+Small+Molecules+as+Antiprotozoal+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DBoron-Containing%2520Small%2520Molecules%2520as%2520Antiprotozoal%2520Agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvest, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2054</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2011.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=21353550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2048-2054&author=X.+Liauthor=S.+Zhangauthor=Y.+K.+Zhangauthor=Y.+Liuauthor=Z.+Charlesauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=W.+M.+Kazmierskiauthor=M.+S.+Duanauthor=R.+M.+Grimesauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.+J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=Z.+J.+Niauthor=W.+X.+Zouauthor=J.+Wright&title=Synthesis+and+SAR+of+acyclic+HCV+NS3+protease+inhibitors+with+novel+P4-benzoxaborole+moieties&doi=10.1016%2Fj.bmcl.2011.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties</span></div><div class="casAuthors">Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang; Kazmierski, Wieslaw M.; Duan, Maosheng; Grimes, Richard M.; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Ni, Zhi-Jie; Zou, Wuxin; Wright, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2048-2054</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acyclic P4-2,1-benzoxaboroles I (5a-j; X = 6-OCO, 6-NHCO, 6-CO, 6-CH2NHCO, 7-NHCO, 4-NHCO, 6-bond; Y = H, Cl, F; R = H, Me) were prepd. and evaluated as a new series of HCV NS3 protease inhibitors.  Structure-activity relationships were investigated, leading to the identification of compds. 5g and 17 with low nanomolar potency in the enzymic and cell-based replicon assay.  The linker-truncated compd. 5j (X = 6-bond, R = Y = H) was found to exhibit improved absorption and oral bioavailability in rats, suggesting that further redn. of mol. wt. and polar surface area could result in improved drug-like properties of this novel series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRXjiaRgnNMLVg90H21EOLACvtfcHk0liPz3Rq4lsamA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCktr8%253D&md5=54ff9010e0afd00ae45dceda0b40e7c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCharles%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DDuan%26aufirst%3DM.%2BS.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%2BX.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520acyclic%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520novel%2520P4-benzoxaborole%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2048%26epage%3D2054%26doi%3D10.1016%2Fj.bmcl.2011.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2129</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=19303290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2129-2132&author=T.+Akamaauthor=S.+J.+Bakerauthor=Y.+K.+Zhangauthor=V.+Hernandezauthor=H.+Zhouauthor=V.+Sandersauthor=Y.+Freundauthor=R.+Kimuraauthor=K.+R.+Maplesauthor=J.+J.+Plattner&title=Discovery+and+structure-activity+study+of+a+novel+benzoxaborole+anti-inflammatory+agent+%28AN2728%29+for+the+potential+topical+treatment+of+psoriasis+and+atopic+dermatitis&doi=10.1016%2Fj.bmcl.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis</span></div><div class="casAuthors">Akama, Tsutomu; Baker, Stephen J.; Zhang, Yong-Kang; Hernandez, Vincent; Zhou, Huchen; Sanders, Virginia; Freund, Yvonne; Kimura, Richard; Maples, Kirk R.; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2129-2132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release.  5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo.  This compd. is now in clin. development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdD-T7O2W57Vg90H21EOLACvtfcHk0liPz3Rq4lsamA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjsb4%253D&md5=a526278d0506fc5916432cf20c6ff5e5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-activity%2520study%2520of%2520a%2520novel%2520benzoxaborole%2520anti-inflammatory%2520agent%2520%2528AN2728%2529%2520for%2520the%2520potential%2520topical%2520treatment%2520of%2520psoriasis%2520and%2520atopic%2520dermatitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2129%26epage%3D2132%26doi%3D10.1016%2Fj.bmcl.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baade, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics in China, 2015</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.3322/caac.21338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.3322%2Fcaac.21338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=26808342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC28njvVykug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=115-132&author=W.+Chenauthor=R.+Zhengauthor=P.+D.+Baadeauthor=S.+Zhangauthor=H.+Zengauthor=F.+Brayauthor=A.+Jemalauthor=X.+Q.+Yuauthor=J.+He&title=Cancer+statistics+in+China%2C+2015&doi=10.3322%2Fcaac.21338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics in China, 2015</span></div><div class="casAuthors">Chen Wanqing; Zheng Rongshou; Baade Peter D; Zhang Siwei; Zeng Hongmei; Bray Freddie; Jemal Ahmedin; Yu Xue Qin; Yu Xue Qin; He Jie</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem.  Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year.  With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015.  Data from 22 registries were used for trend analyses (2000-2011).  The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death.  Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death.  Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively).  For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females.  In contrast, the mortality rates since 2006 have decreased significantly for both males (-1.4% per year; P < .05) and females (-1.1% per year; P < .05).  Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkZeZPQ7Kk7ntlzo9xastyfW6udTcc2eYRoTAJ-EubQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28njvVykug%253D%253D&md5=2affa5f8beab6f885ccd830cbb249707</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21338%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DBaade%26aufirst%3DP.%2BD.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DBray%26aufirst%3DF.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DX.%2BQ.%26aulast%3DHe%26aufirst%3DJ.%26atitle%3DCancer%2520statistics%2520in%2520China%252C%25202015%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D115%26epage%3D132%26doi%3D10.3322%2Fcaac.21338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2015</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.3322%2Fcaac.21254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=25559415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=5-29&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2015&doi=10.3322%2Fcaac.21254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2015</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015.  During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women.  The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.  However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%).  For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress.  Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7d8BN92t5_sNIRw0GKUoEfW6udTcc2eYRoTAJ-EubQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D&md5=9b569d8b3f5e9da465900f1c428a9218</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21254%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202015%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2015%26volume%3D65%26spage%3D5%26epage%3D29%26doi%3D10.3322%2Fcaac.21254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaeybroeck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, P. G.</span></span> <span> </span><span class="NLM_article-title">Cancer drug resistance: an evolving paradigm</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1038/nrc3599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fnrc3599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=24060863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=714-726&author=C.+Holohanauthor=S.+Van+Schaeybroeckauthor=D.+B.+Longleyauthor=P.+G.+Johnston&title=Cancer+drug+resistance%3A+an+evolving+paradigm&doi=10.1038%2Fnrc3599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer drug resistance: an evolving paradigm</span></div><div class="casAuthors">Holohan, Caitriona; Van Schaeybroeck, Sandra; Longley, Daniel B.; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">714-726</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research.  The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific mol. targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death.  With the increasing arsenal of anticancer agents, improving preclin. models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clin. assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrykBEUSgvv7Vg90H21EOLACvtfcHk0liU7cEZwFK7Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE&md5=b497a823bbd968904ce1591b918d0679</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrc3599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3599%26sid%3Dliteratum%253Aachs%26aulast%3DHolohan%26aufirst%3DC.%26aulast%3DVan%2BSchaeybroeck%26aufirst%3DS.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DCancer%2520drug%2520resistance%253A%2520an%2520evolving%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D714%26epage%3D726%26doi%3D10.1038%2Fnrc3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuczynski, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerbel, R. S.</span></span> <span> </span><span class="NLM_article-title">Drug rechallenge and treatment beyond progression-implications for drug resistance</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2013.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1038%2Fnrclinonc.2013.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=23999218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWqtrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=571-587&author=E.+A.+Kuczynskiauthor=D.+J.+Sargentauthor=A.+Grotheyauthor=R.+S.+Kerbel&title=Drug+rechallenge+and+treatment+beyond+progression-implications+for+drug+resistance&doi=10.1038%2Fnrclinonc.2013.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Drug rechallenge and treatment beyond progression-implications for drug resistance</span></div><div class="casAuthors">Kuczynski, Elizabeth A.; Sargent, Daniel J.; Grothey, Axel; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">571-587</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The established dogma in oncol. for managing recurrent or refractory disease dictates that therapy is changed at disease progression, because the cancer is assumed to have become drug-resistant.  Drug resistance, whether pre-existing or acquired, is largely thought to be a stable and heritable process; thus, reuse of therapeutic agents that have failed is generally contraindicated.  Over the past few decades, clin. evidence has suggested a role for unstable, non-heritable mechanisms of acquired drug resistance pertaining to chemotherapy and targeted agents.  There are many examples of circumstances where patients respond to reintroduction of the same therapy (drug rechallenge) after a drug holiday following disease relapse or progression during therapy.  Addnl., albeit limited, evidence suggests that, in certain circumstances, continuing a therapy beyond disease progression can also have antitumor activity.  In this Review, we describe the anticancer agents used in these treatment strategies and discuss the potential mechanisms explaining the apparent tumor re-sensitization with reintroduced or continued therapy.  The extensive no. of malignancies and drugs that challenge the custom of permanently switching to different drugs at each line of therapy warrants a more in-depth examn. of the definitions of disease progression and drug resistance and the resulting implications for patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGVmbq8ucsa7Vg90H21EOLACvtfcHk0lhRI8jfLe6uHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWqtrzJ&md5=513ca799d7cabdd8208b0c4ae9507753</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2013.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2013.158%26sid%3Dliteratum%253Aachs%26aulast%3DKuczynski%26aufirst%3DE.%2BA.%26aulast%3DSargent%26aufirst%3DD.%2BJ.%26aulast%3DGrothey%26aufirst%3DA.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DDrug%2520rechallenge%2520and%2520treatment%2520beyond%2520progression-implications%2520for%2520drug%2520resistance%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D10%26spage%3D571%26epage%3D587%26doi%3D10.1038%2Fnrclinonc.2013.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sravan
Kumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsello, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mereddy, V. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel benzoxaboroles as potential antimicrobial and anticancer agents</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1002/jhet.1777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1002%2Fjhet.1777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOju7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=814-820&author=J.+Sravan%0AKumarauthor=M.+A.+Alamauthor=S.+Gurrapuauthor=G.+Nelsonauthor=M.+Williamsauthor=M.+A.+Corselloauthor=J.+L.+Johnsonauthor=S.+C.+Jonnalagaddaauthor=V.+R.+Mereddy&title=Synthesis+and+biological+evaluation+of+novel+benzoxaboroles+as+potential+antimicrobial+and+anticancer+agents&doi=10.1002%2Fjhet.1777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Benzoxaboroles as Potential Antimicrobial and Anticancer Agents</span></div><div class="casAuthors">Sravan Kumar, J.; Alam, M. A.; Gurrapu, Shirisha; Nelson, Grady; Williams, Michael; Corsello, Michael A.; Johnson, Joseph L.; Jonnalagadda, Subash C.; Mereddy, Venkatram R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">1943-5193</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Several novel benzoxaborole derivs. were synthesized starting from 2-formylphenylboronic acid utilizing Baylis-Hillman reaction, Barbier allylation, Passerini reaction, and aldol reaction protocols as the key step.  All the synthesized benzoxaboroles have been evaluated for their antibacterial, antifungal, and anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmNCNFVMQU7Vg90H21EOLACvtfcHk0lgTnUpo5o38eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOju7bN&md5=b008fb1c41ec2ff40f9e9ccadab93fa2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjhet.1777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.1777%26sid%3Dliteratum%253Aachs%26aulast%3DSravan%2BKumar%26aufirst%3DJ.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DGurrapu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DCorsello%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26aulast%3DJonnalagadda%26aufirst%3DS.%2BC.%26aulast%3DMereddy%26aufirst%3DV.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520benzoxaboroles%2520as%2520potential%2520antimicrobial%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2013%26volume%3D50%26spage%3D814%26epage%3D820%26doi%3D10.1002%2Fjhet.1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel benzoxaborole-containing phenylalanine analogues</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4924</span>– <span class="NLM_lpage">4926</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.tetlet.2011.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=4924-4926&author=X.+F.+Liauthor=J.+J.+Plattnerauthor=V.+Hernandezauthor=C.+Z.+Dingauthor=W.+Wuauthor=Y.+Yangauthor=M.+S.+Xu&title=Synthesis+of+novel+benzoxaborole-containing+phenylalanine+analogues&doi=10.1016%2Fj.tetlet.2011.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel benzoxaborole-containing phenylalanine analogues</span></div><div class="casAuthors">Li, Xianfeng; Plattner, Jacob J.; Hernandez, Vincent; Ding, Charles Z.; Wu, Wei; Yang, Yang; Xu, Musheng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">4924-4926</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of novel benzoxaborole-contg. phenylalanine analogs has been developed.  The key steps involve the prepn. of appropriate precursors from the readily available amino acids and the formation of benzoxaborole ring directly in the corresponding amino acid fragment.  The resulting compds. show improved water soly. at physiol. pH, suggesting their potential use as boron delivery agents for boron neutron capture therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CFGGBQUvw7Vg90H21EOLACvtfcHk0lgTnUpo5o38eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtb3F&md5=900abe32054bc9cb28ae54fd083f0974</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BF.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%2BS.%26atitle%3DSynthesis%2520of%2520novel%2520benzoxaborole-containing%2520phenylalanine%2520analogues%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D4924%26epage%3D4926%26doi%3D10.1016%2Fj.tetlet.2011.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Chalcone-benzoxaborole hybrids as novel anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5801</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2016.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=28327308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5797-5801&author=J.+Zhangauthor=F.+Yangauthor=Z.+Qiaoauthor=M.+Zhuauthor=H.+Zhou&title=Chalcone-benzoxaborole+hybrids+as+novel+anticancer+agents&doi=10.1016%2Fj.bmcl.2016.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-benzoxaborole hybrids as novel anticancer agents</span></div><div class="casAuthors">Zhang, Jiong; Yang, Fei; Qiao, Zhitao; Zhu, Mingyan; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5797-5801</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we report the synthesis of a series of chalcone-benzoxaborole hybrid mols. and the evaluation of their anticancer activity.  Their anticancer potency and toxicity were tested on three human cancer cell lines and two normal cell lines.  The 4-fluoro compd. 15 was found to be the most potent compd. with an IC50 value of 1.4 μM on SKOV3 cells.  The 4-iodo compd. 18 and 3-methyloxy-4-amino compd. 47 showed good potency on SKOV3 cells while exhibiting low toxicity on normal cells.  This work extended the application of benzoxaboroles to the field of anticancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQt3p0JOBnCLVg90H21EOLACvtfcHk0lgTnUpo5o38eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnsbvM&md5=eccffe08b7b7b2bd001ef379cda06fef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DChalcone-benzoxaborole%2520hybrids%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5797%26epage%3D5801%26doi%3D10.1016%2Fj.bmcl.2016.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Convenient and versatile synthesis of formyl-substituted benzoxaboroles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">8738</span>– <span class="NLM_lpage">8744</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2009.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.tet.2009.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=8738-8744&author=L.+Yeauthor=D.+Dingauthor=Y.+Fengauthor=D.+Xieauthor=P.+Wuauthor=H.+Guoauthor=Q.+Mengauthor=H.+Zhou&title=Convenient+and+versatile+synthesis+of+formyl-substituted+benzoxaboroles&doi=10.1016%2Fj.tet.2009.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient and versatile synthesis of formyl-substituted benzoxaboroles</span></div><div class="casAuthors">Ye, Long; Ding, Dazhong; Feng, Yiqing; Xie, Dongsheng; Wu, Puhua; Guo, Hui; Meng, Qingqing; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8738-8744</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite of the medicinal significance of benzoxaboroles, with the newly discovered clin. compd. AN2690 as an example, the synthetic method for rapid diversification of this novel scaffold is lacking.  To this end, a versatile and scalable synthesis of formyl-substituted benzoxaboroles is described here.  A key step is the mono-oxidn. of the two hydroxyls in 7-hydroxymethyl-1-hydroxy-1,3-dihydro-2,1-benzoxaborole by taking advantage of the stable oxaborole ring in non-coordinating solvents, which was devised based on the study of the intramol. coordination and exchange properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTlwtJ_jhnQLVg90H21EOLACvtfcHk0lga0u3g4qd34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakt7zN&md5=2ed6ca54eb1f2cfc48ecfc94e56d1165</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DConvenient%2520and%2520versatile%2520synthesis%2520of%2520formyl-substituted%2520benzoxaboroles%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D8738%26epage%3D8744%26doi%3D10.1016%2Fj.tet.2009.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. part 2: discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.bmcl.2011.12.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=22243961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1299-1307&author=Y.+K.+Zhangauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=E.+Easomauthor=Y.+Zhouauthor=L.+Yeauthor=H.+Zhouauthor=D.+Watersonauthor=F.+Gamoauthor=L.+Sanzauthor=M.+Geauthor=Z.+Liauthor=L.+Liauthor=H.+Wangauthor=H.+Cui&title=Benzoxaborole+antimalarial+agents.+part+2%3A+discovery+of+fluoro-substituted+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1016%2Fj.bmcl.2011.12.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Freund, Yvonne R.; Easom, Eric E.; Zhou, Yasheen; Ye, Long; Zhou, Huchen; Waterson, David; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Zhiya; Li, Lingchao; Wang, Hailong; Cui, Han</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1299-1307</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New boron-contg. benzoxaborole compds. were designed and synthesized for a continuing structure-activity relation (SAR) study to assess the antimalarial activity changes derived from side-chain structural variation, substituent modification on the benzene ring and removal of boron from five-membered oxaborole ring.  This SAR study demonstrated that boron is required for the antimalarial activity, and discovered that three of the newly prepd. fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles have excellent potencies (IC50 0.026-0.209 μM) against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqR7ILmo50S7Vg90H21EOLACvtfcHk0lga0u3g4qd34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D&md5=1b1dfbd62c694f926255c6edb7016b0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.096%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DGamo%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DH.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520part%25202%253A%2520discovery%2520of%2520fluoro-substituted%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1299%26epage%3D1307%26doi%3D10.1016%2Fj.bmcl.2011.12.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibotla, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solano, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, S. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of functionalized aminobenzoboroxoles as potential anti-cancer agents</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>798</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2015.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1016%2Fj.jorganchem.2015.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFehsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=798&publication_year=2015&pages=125-131&author=P.+Sumanauthor=B.+P.+Patelauthor=A.+V.+Kasibotlaauthor=L.+N.+Solanoauthor=S.+C.+Jonnalagadda&title=Synthesis+and+evaluation+of+functionalized+aminobenzoboroxoles+as+potential+anti-cancer+agents&doi=10.1016%2Fj.jorganchem.2015.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of functionalized aminobenzoboroxoles as potential anti-cancer agents</span></div><div class="casAuthors">Suman, Pathi; Patel, Bhawankumar P.; Kasibotla, Agasthya V.; Solano, Lucas N.; Jonnalagadda, Subash C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">798</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">125-131</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several aminobenzoboroxole derivs. have been prepd. starting from o-boronobenzaldehyde employing reductive amination protocol.  The corresponding aminobenzoboroxole derivs. have been further functionalized as N-nitrosoaminobenzoboroxoles as well as N-benzoboroxolylureas.  These derivs. have been evaluated for their anti-cancer activity on human pancreatic cancer MIAPaCa-2 and human breast cancer MDA-MB-231 cell lines. 2015 Elsevier Ltd.  All rights reserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzdeGQBYfEsLVg90H21EOLACvtfcHk0lga0u3g4qd34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFehsrjJ&md5=b1f391f82ec18f65e6323b7f616b0dd7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2015.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2015.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DSuman%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DB.%2BP.%26aulast%3DKasibotla%26aufirst%3DA.%2BV.%26aulast%3DSolano%26aufirst%3DL.%2BN.%26aulast%3DJonnalagadda%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520functionalized%2520aminobenzoboroxoles%2520as%2520potential%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2015%26volume%3D798%26spage%3D125%26epage%3D131%26doi%3D10.1016%2Fj.jorganchem.2015.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Psurski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupicka-Slowik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamczyk-Wozniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wietrzyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporzynski, A.</span></span> <span> </span><span class="NLM_article-title">Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology-phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1007/s10637-018-0611-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1007%2Fs10637-018-0611-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=29779163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=35-46&author=M.+Psurskiauthor=A.+Lupicka-Slowikauthor=A.+Adamczyk-Wozniakauthor=J.+Wietrzykauthor=A.+Sporzynski&title=Discovering+simple+phenylboronic+acid+and+benzoxaborole+derivatives+for+experimental+oncology-phase+cycle-specific+inducers+of+apoptosis+in+A2780+ovarian+cancer+cells&doi=10.1007%2Fs10637-018-0611-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology - phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells</span></div><div class="casAuthors">Psurski, Mateusz; Lupicka-Slowik, Agnieszka; Adamczyk-Wozniak, Agnieszka; Wietrzyk, Joanna; Sporzynski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objective The aim of the study was to evaluate the antiproliferative potential of simple phenylboronic acid and benzoxaborole derivs. as well as to provide preliminary insight into their mode of action in cancer cells in vitro.  Methods The antiproliferative activity was assessed in five diverse cancer cell lines via the SRB method (sulforhodamine B) or MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method after 72 h of treatment.  Further studies of the mechanism of action consisted of the influence of the compds. on cell cycle progression and apoptosis induction, which was assessed by flow cytometry, caspase-3 enzymic activity, fluorescence microscopy and western blot anal.  Results A clear structure-activity relationship was obsd. for both groups of compds. with several representatives evaluated as highly active antiproliferative agents with low micromolar IC72h50 values. 2-Fluoro-6-formylphenylboronic acid (18) and 3-morpholino-5-fluorobenzoxaborole (27) exhibited strong cell cycle arrest induction in G2/M assocd. with caspase-3 activation in an A2780 ovarian cancer cell line.  These events were accompanied by a mitotic catastrophe cell morphol. and an increased percentage of aneuploid and tetraploid cells.  Further expts. indicated that the compds. were phase cycle-specific agents since cells co-treated with hydroxyurea were less sensitive.  The obsd. cell cycle arrest resulted from significant p21 accumulation and was assocd. neither with cyclin B1 nor β-tubulin degrdn.  Conclusion Phenylboronic acid and benzoxaborole derivs. were found to be highly promising antiproliferative and proapoptotic compds. with a cell cycle-specific mode of action.  The presented data support their candidacy for further studies as a novel class of potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZxTHMmIC3zrVg90H21EOLACvtfcHk0lj_4icpMKYBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVShtrY%253D&md5=644f65a5cd14d0fdb77ecd611c801084</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0611-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0611-z%26sid%3Dliteratum%253Aachs%26aulast%3DPsurski%26aufirst%3DM.%26aulast%3DLupicka-Slowik%26aufirst%3DA.%26aulast%3DAdamczyk-Wozniak%26aufirst%3DA.%26aulast%3DWietrzyk%26aufirst%3DJ.%26aulast%3DSporzynski%26aufirst%3DA.%26atitle%3DDiscovering%2520simple%2520phenylboronic%2520acid%2520and%2520benzoxaborole%2520derivatives%2520for%2520experimental%2520oncology-phase%2520cycle-specific%2520inducers%2520of%2520apoptosis%2520in%2520A2780%2520ovarian%2520cancer%2520cells%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D35%26epage%3D46%26doi%3D10.1007%2Fs10637-018-0611-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole as a new chemotype for carbonic anhydrase inhibition</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">11983</span>– <span class="NLM_lpage">11986</span>, <span class="refDoi"> DOI: 10.1039/C6CC06399C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1039%2FC6CC06399C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=27722534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sis7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=11983-11986&author=V.+Alterioauthor=R.+Cadoniauthor=D.+Espositoauthor=D.+Vulloauthor=A.+D.+Fioreauthor=S.+M.+Montiauthor=A.+Caporaleauthor=M.+Ruvoauthor=M.+Sechiauthor=P.+Dumyauthor=C.+T.+Supuranauthor=G.+D.+Simoneauthor=J.+Y.+Winum&title=Benzoxaborole+as+a+new+chemotype+for+carbonic+anhydrase+inhibition&doi=10.1039%2FC6CC06399C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole as a new chemotype for carbonic anhydrase inhibition</span></div><div class="casAuthors">Alterio, Vincenzo; Cadoni, Roberta; Esposito, Davide; Vullo, Daniela; Di Fiore, Anna; Monti, Simona Maria; Caporale, Andrea; Ruvo, Menotti; Sechi, Mario; Dumy, Pascal; Supuran, Claudiu T.; De Simone, Giuseppina; Winum, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">80</span>),
    <span class="NLM_cas:pages">11983-11986</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the synthesis of a series of benzoxaborole derivs., their inhibitory properties against some carbonic anhydrases (CAs), recognized as important drug targets, and the characterization of the binding mode of these mols. by the CA active site.  The data provide the 1st exptl. evidence that benzoxaboroles can be efficiently used as CA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_khysGipBbVg90H21EOLACvtfcHk0lj_4icpMKYBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sis7zJ&md5=e07f69485cbda00926c92e2972d85439</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FC6CC06399C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC06399C%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DCadoni%26aufirst%3DR.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DFiore%26aufirst%3DA.%2BD.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DCaporale%26aufirst%3DA.%26aulast%3DRuvo%26aufirst%3DM.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDumy%26aufirst%3DP.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DSimone%26aufirst%3DG.%2BD.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DBenzoxaborole%2520as%2520a%2520new%2520chemotype%2520for%2520carbonic%2520anhydrase%2520inhibition%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D11983%26epage%3D11986%26doi%3D10.1039%2FC6CC06399C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nocentini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1473379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=10.1080%2F13543776.2018.1473379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=29727210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=493-504&author=A.+Nocentiniauthor=C.+T.+Supuranauthor=J.+Y.+Winum&title=Benzoxaborole+compounds+for+therapeutic+uses%3A+a+patent+review+%282010-2018%29&doi=10.1080%2F13543776.2018.1473379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018)</span></div><div class="casAuthors">Nocentini, Alessio; Supuran, Claudiu T.; Winum, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Benzoxaborole is a versatile boron-heterocyclic scaffold which has found in the last 10 years a broad spectrum of applications in medicinal chem., due to its physicochem. and drug-like properties.  Use of benzoxaborole moiety in the design of compds. led to the discovery of new classes of anti-bacterial, anti-fungal, anti-protozoal, anti-viral as well as anti-inflammatory agents with interesting drug development perspectives.  This article reviews the patent literature as well as chem. literature during the period 2010-2018 where in several benzoxaborole derivs. with therapeutic options were reported.  Two benzoxaborole derivs. are already clin. used for the treatment of onychomycosis (tavaborole) and atopic dermatitis (crisaborole), with several others in various phases of clin. trials.  By inhibiting enzymes essential in the life cycle of fungal, protozoan, bacterial and viral pathogens, it is probable that other compds. may soon enter the armamentarium of anti-infective agents.  On the other hand, phosphodiesterase 4 seems to be the human target responsible of the anti-inflammatory action of some benzoxaboroles.  The chem. versatility, peculiar mechanism of action related to the electron deficient nature of the boron atom, and ease of prepn. make benzoxaboroles a highly interesting field for the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSG_ztCy7KlrVg90H21EOLACvtfcHk0lj_4icpMKYBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlSjt7o%253D&md5=07549982342b406a7e036d20dfe6aa4a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1473379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1473379%26sid%3Dliteratum%253Aachs%26aulast%3DNocentini%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DBenzoxaborole%2520compounds%2520for%2520therapeutic%2520uses%253A%2520a%2520patent%2520review%2520%25282010-2018%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D493%26epage%3D504%26doi%3D10.1080%2F13543776.2018.1473379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i142"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00736">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70863"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00736">10.1021/acs.jmedchem.9b00736</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC traces of synthesized compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_001.pdf">jm9b00736_si_001.pdf (4.45 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00736/suppl_file/jm9b00736_si_002.csv">jm9b00736_si_002.csv (14.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-14%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00736" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00736" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab744a8173cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
